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ontrol of the internal structure of organic crystals is paramount in producing materials
functionalised in a predictable, practical and reproducible manner. This thesis explores and
builds upon the current knowledge of organic crystal growth, intending to expand the tools
available to crystallographers, along with testing our ability to predict the properties that crystalline
materials exhibit. The first section of this work looks at developing a new tool for the crystallisation of
organic materials. The first chapter highlights how the use of volatile deep eutectic solvents affords an
element of crystallographic control in a variety of pharmaceuticals, including the production of the
elusive form II paracetamol at room temperature and pressure, without the use of additives. Following
this, the second chapter looks at the structural and thermodynamic properties of the volatile deep
eutectic solvents during thermal cycling. These data were collected using the concurrent techniques
of synchrotron powder X-ray diffraction and differential scanning calorimetry, which was carried
out using the I12 beamline at Diamond Light Source. This analysis is the first of its type to be carried
out on deep eutectic systems, allowing an insight into the fundamental structure that these mixtures
exhibit at different temperatures. In particular, the formation of metastable crystalline phases during
the thermal cycles is revealed, strongly supporting the hypothesis that intermediary phases can direct
the crystallographic pathway of organic molecules during their formation from the volatile deep
eutectic solvent medium.
The final chapter of this thesis looks at the crystallographic case study of two functionalised
chalcones, which exhibit polymorphism of crystals ranging in colour across the optical spectrum. A
variety of crystallographic techniques are used to acquire structural control, to analyse the crystals
in terms of structural, optical and thermodynamic properties. Theoretical modelling is applied to
these structures, demonstrating our current ability to predict crystalline properties using quantum
chemical calculations. In particular, a new method for determining optical properties is established,
which gives information about the relative shifts in absorption spectra between crystals, while also
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1.1 The Crystalline State
T
he structure of a material is inexorably linked to the fundamental properties that it exhibits.
As humans, we are used to realising the macroscopic properties of the materials that we come
into contact with: metals tend to be shiny, whereas woods are dull; we see sapphires as blue,
whereas emeralds are green; water spreads out on a surface, whereas ice will hold the shape it is
frozen in indefinitely. The extent to which we can functionalise the matter around us, to exhibit
properties necessary for human survival and evolution, is directly linked to our understanding and
control of the particular properties exhibited by materials.
Crystals are a group of materials with a well defined internal structure. Their uniqueness lays in
the structural symmetries that they possess, which leads to a plethora of distinctive properties and
possibilities. As such, in the last 400 years, we have come from the point of observing a correlation
between certain uniquely faceted materials, to being able to determine the exact atomic structure
of a crystal, and now to the point where it is common practice to try and predict the formation of
unknown crystalline materials.
Crystalline materials are defined by the translational symmetry of a repeating motif, with the
assertion that each repeating unit must be indistinguishable from all others. Consequently, the
concept of a crystal is an idealism, where it is assumed that the translational symmetry extends
infinitely with no defects or boundaries. Nevertheless, the length-scale of the building blocks of crys-
talline materials means that this approximation tends to sit very close to reality, with fundamentally




1.1.1 Types of Crystalline Structures
Within the class of crystalline materials, there are a vast range of different properties that can be
exhibited, which depend both on the building block that makes up the structure, and how it is held
together in space. In general, the building blocks contain atoms, ions or molecules, held in place via
covalent, ionic or weaker intermolecular forces. In the case of molecules, we define intermolecular
forces (forces between different molecules) and intramolecular forces (the forces holding the atoms
of the molecule together). The contrasting strength and character of these interactions are the main
factors leading to crystalline materials with dramatically different properties. Moreover, there are
several different ways that these interactions can be combined, each of which forming its own crystal
structure sub-class.
The most frequently observed crystal structure classes are highlighted in Figure 1.1, represented
in 2-dimensions for simplification. Each of the grey dashed boxes represents a repeating motif that
extends infinitely in space, though only four of the repeating units are shown. A purely ionic crystal is
highlighted in Figure 1.1a. Within this crystal class, electrons are transferred between atoms, leading
to the formation of oppositely charged ions. Due to the discrete nature of the charges formed, the
forces between ions tend to be very strong, leading to the well-known salts, such as table salt (NaCl).
Similarly, Figure 1.1b depicts a covalently bonded crystal structure, where each of the connecting
black lines represents a covalent bond. Covalent bonds involve the sharing of electrons between
atoms and tend to be very strong, leading to the high melting point and hardness of materials like
diamond.
Intermolecular forces describe interactions far weaker than pure ionic and covalent forces, occur-
ring in part due to partial charges caused by intramolecular charge transfer and the displacement of
weakly bound electrons. The interplay between intramolecular and intermolecular bonding opens
up the possibility for sequential classes of crystal structures, bonding via different forces in different
directions. As discussed in Desiraju’s Crystal Engineering: A Textbook,1 the idea of molecularity is a
helpful tool in defining how intermolecular bonding is responsible for the translation of a crystal
structure in any number of crystallographic dimensions. The degree of molecularity describes direc-
tions in which there are breaks in the covalently bonded chain of the crystal. For example, graphite is
well known to exist as a crystal containing 2-dimensional sheets connected via intermolecular forces,
described as having molecularity only in the direction perpendicular to the sheets.2 Figure 1.1c
shows a modification of the covalent crystal in Figure 1.1b to a crystal with molecularity in one
dimension. Following this process, there becomes a point at which molecularity translates in all crys-
tallographic dimensions. At this point, the crystal consists of molecules of finite size, each comprised
of intramolecular bonds and attracted to each other by intermolecular forces. Such a crystal is known
as a molecular crystal, as highlighted in Figure 1.1d. These molecular crystals can be further classified,
depending on whether they contain more than one different species (co-crystals - Figure 1.1e) or
contain discretely charged elements (molecular salts - Figure 1.1f). The anisotropic interactions
exhibited by molecules mean that these crystals can possess various complex symmetries, leading to
2
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vast differences caused by only marginal molecular modifications. As such, the field of molecular
crystallography is accustomed to the observation of unforeseen phenomena, including disappearing
structures,3 unobtainable structures4 (appendix A), and unsolved structures.5
Figure 1.1: Representation of the different types of crystals in two dimensions: a) ionic
crystal, b) covalent crystal, c) molecular crystal, d) covalent crystal with 1-dimensional
molecularity, e) molecular co-crystal, and f) molecular salt.
1.1.2 Describing Crystal Structures
The smallest repeating motif in a crystal is known as the unit cell. The unit cell definition requires
that translational symmetry leads to an unambiguous description of the crystal in space; that is, there
should be no coordinate in which the crystal is not defined. The shape and size of the unit cell are
defined by the parameters a, b and c, which represent the length of each side of the unit cell, and
the angles α, β and γ, which represent the direction in space of the unit cell axes. These parameters
are highlighted in Figure 1.2, where the unit cell axes are shown in their common colours: blue (a),
green (b) and red (c). At each corner of the unit cell sits a lattice point, representing an element of the
crystal that is translated in space. Arbitrarily, an origin is chosen at one of the lattice points, where
the coordinates of the crystal system are chosen to be (0,0,0) in 3-dimensional space.
Within the unit cell, there may be additional symmetry elements, which include: reflections,
inversions, rotations, rotary inversions, glide planes, screw axes, and additional translations. The
smallest motif within the unit cell that can not be reduced via symmetry relationships is the asym-
metric unit. A combination of the asymmetric unit with the symmetry, angles and lengths of the unit
cell gives a full representation of a crystal structure. Additional translational symmetry within the
unit cell is known as cell centring. Given that the asymmetric unit is placed at the origin, additional
lattice points can occur in the centre of the unit cell or at the centre of the faces of the unit cell. The
3
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possible cell centring follows the notation: P - primitive, I - body centred, F - all face centred, A or C -
face centred, as shown in Figure 1.3.
Figure 1.2: Unit cell parameters in 3-dimensional space, highlighting the unit cell lengths
a, b and c, and angles α, β and γ.
Figure 1.3: The possible crystallographic centring that can occur: P - primitive, I - body
centred, F - all face centred, A or C - face centred.
Restriction of the unit cell parameters reduces the number of possible crystallographic sym-
metries that can occur. For example, if none of the unit cell angles are equal to 90°, then the only
available symmetry within the unit cell is an inversion. Such a crystal is said to be in the triclinic
crystal system. The full mathematical description of the possible symmetries that can occur within a
unit cell has an interesting history, with several iterations of the possible groups suggested6 before
the, now well-established, 230 space groups were determined.7 These space groups are distributed
across seven crystal systems, each representing a restriction of the unit cell parameters. A summary of
the possible crystal systems is given in Table 1.1. Within crystallography, a well-established notation
for the 230 space groups exists, highlighting the centring of the unit cell and any symmetries that
occur with respect to each of the crystallographic axes. An example of space group notation is shown
in Figure 1.4.
4
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Table 1.1: Crystal systems grouped by valid point group operations, including the possi-
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Figure 1.4: A description of the notation of the space group P21/c , given in the long-hand
notation P 1 21/c 1
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1.1.3 Emergent Properties of Materials: Pharmaceutical Relevance
Within this thesis, I will be focused on the discussion of the crystallisation of molecular compounds.
In this subset of crystals, the covalent forces acting between a finite group of atoms allows them
to be considered as an independent chemical species.8 This entity in itself may be constructed to
exhibit certain bespoke properties, such as pharmaceutical9 or agrochemical10 potency. However, our
utilisation of such molecules is dependent on how well we can control their properties in the solid-
state. In particular, I will focus on molecules that are effective as active pharmaceutical ingredients
(APIs), which interact with the human body to gain a positive medicinal outcome. The molecularity
of these crystals extends in all three spatial dimensions, meaning that their melting or solubilisation
leads to a mobile form of the API that the human body can absorb.
The formulation of a new small-molecule pharmaceutical will inevitably go through the process
of finding an optimum solid-state structure. This optimisation should consider the solubility of the
final form, the purity of the crystal after formation, the processability of the drug, and the stability
of both the molecule in the crystal and the crystal structure itself.11 Large numbers of potentially
life-saving drugs never progress through solid-state formulation due to their low water solubility
(bioavailability), which is proportional to the strength of the interactions present between molecules
in the crystal structure. Additionally, the optical properties of pharmaceutical crystals are critical
for both consumer compliance in taking the drugs,12 and utilisation for unique purposes such as in
biologically active tracers.13 Hence, our ability to control the properties of APIs in the solid-state has
far-reaching implications for our capacity to expand the tools available within healthcare.
1.2 The Thermodynamics of Crystal Formation
The most basic understanding of the crystalline state emerges from the laws of thermodynamics. As
a system tends towards absolute zero, the most stable state of a pure substance that can exist is a
perfect crystalline structure. This crystalline stability is a consequence of the minimisation of the
entropy of the system, that is, the number of possible micro-states that can exist.14 Therefore, to
understand the properties of crystals at a finite temperature, it is necessary to determine how the
system increases in internal energy as it is heated.
1.2.1 The Stability of The Crystalline State
The equilibrium state of a system can be understood in terms of the state functions known as
thermodynamic potentials. When considering systems at constant pressure, it is common to use the
Gibbs Free Energy, given by the equation,
G = H −T S, (1.1)
where H is the enthalpy, T is the temperature, and S is the entropy of the system. At any given
temperature, the system will minimise the Gibbs Free Energy,
6






where t is time, and p is pressure, which allows a theoretical basis to the understanding of phase
transitions.15
When a material is heated at constant pressure, it absorbs heat equal to the enthalpy change
needed to raise the temperature by a certain amount. The rate of the enthalpy change of a material
with respect to temperature is known as the specific heat capacity Cp (the p subscript is used when
assuming a system at constant pressure). The additional energy in the system will also cause an
increase in entropy due to the accessibility of extra micro-states. The enthalpy and entropy of a












The difference in Gibbs Free Energy between the crystalline and liquid states can be determined
by calculating the differences in enthalpy and entropy between them,
∆Gc,l (T ) =∆H c,l (T )−T∆Sc,l (T ), (1.5)
where the superscript c, l represents the difference between the crystalline and liquid states. As
the crystalline phase has the lowest entropy at absolute zero, this is the state that we observe at
low temperatures. Figure 1.5 shows the characteristic trend in Gibbs Free Energy and entropy as a
material is heated past its melting (Tm) and vaporisation (Tv ) temperatures. At each of the phase
transitions, there is a discontinuity in the entropy of the system. As the Gibbs Free Energy at the
temperature of the phase transition must be equal to zero, this change is given by,
∆Sc,l (Tm)
Tm
=∆H c,l (Tm). (1.6)
At the transition temperature, the entropy of the system can increase by ∆H c,l (Tm), which is known
as the enthalpy of fusion.
7
CHAPTER 1. INTRODUCTION
Figure 1.5: Graphical representations of the Gibbs Free Energy and the entropy of a
material as it is heating through the solid, liquid and gas phases.
A mathematical description for the difference in Gibbs Free Energy between the solid and liquid
states can be determined by constructing a Hess diagram of the process, involving the heating,
melting and cooling of the crystalline solid, as shown in Figure 1.6. Following this cycle leads to the
expressions,16
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which are commonly used in the pharmaceutical industry to determine solid-state stability as a
function of temperature. These expressions simply rely on the determination of the specific heat
capacity of a material and its liquid form, and the enthalpy of fusion.17 An archetypal graph of
∆Gc,l as a function of temperature is shown in Figure 1.7. The point at which ∆Gc,l goes below zero
represents the melting point of the crystal Tm , at which point the enthalpy of fusion can be calculated
as ∆H c,l .
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Figure 1.6: Hess cycle for calculating the Gibbs Free Energy difference between the crys-
talline and liquid states of a material. The numbers represent which terms in equations
1.7 and 1.8 each step of the cycle represents.
Figure 1.7: The difference in Gibbs Free energy and enthalpy of the solid and liquid states
of a material as a function of temperature. The horizontal line represents the point at





Polymorphism in molecular crystals is the ability of a single molecular unit to pack in a number
of different ways.18 This phenomenon has many implications for the solid-state formulation of
crystals, as even small changes in intermolecular interactions can change a variety of properties,
including the colour,19 solubility20 and processability21 of a material. A simple two-dimensional
representation of polymorphism is shown in Figure 1.8, highlighting two different valid crystallo-
graphic structures of the same repeating motif. Strictly speaking, this type of polymorphism is termed
‘packing polymorphism’22 to differentiate it from structural differences where molecular flexibility
allows the molecules to change conformation, known as ‘conformational polymorphism’.23
Figure 1.8: An example of packing polymorphism using a simple repeating motif in two
dimensions.
The relative stability of the polymorphic forms of a molecule is temperature-dependent, much
like the relative stability of the crystalline and liquid states discussed in the previous section. A
crystal structure that is not the most stable at a particular temperature is defined as metastable. The
lifetime of a metastable polymorph can vary dramatically depending on how easily the molecules
can rearrange to form the necessary bonding motifs for a solid-state transformation. Polymorphs
whose relative stability cross over with temperature are known as enantiotropic, and those with no
such cross-over are termed monotropic. Examples of Gibbs Free Energy curves for monotropic and
enantiotropic systems are shown in Figure 1.9. The idealised plots were created using specific heat
capacities calculated from the Debye model,24 along with equations 1.1, 1.7 and 1.8. Given enough
mobility, an enantiotropic system will reversibly convert between polymorphic forms at a transition
temperature (Tt ), at which point a change in enthalpy ∆Ht will be observed. In a monotropic system,
an irreversible transformation to a lower energy polymorph will only be seen if the thermal energy of
the system can overcome any energy barrier caused by the restricted movement of molecules in the
crystal structure.
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Figure 1.9: Graphs of the Gibbs Free Energy (solid lines) and enthalpy (dashed lines)
against temperature for two crystal polymorphs (red and black lines). The top graphs
show an enantiotropic behaviour with the Gibbs Free Energy crossing over. The bold
lines on the right-hand graph highlight a possible transition between the two struc-
tures on heating from 0 K. Below this, a similar plot is shown for a monotropic system.
The right-hand graph of the monotropic system assumes that the original crystal is
metastable (red). The bottom graph shows the heat capacities used to produce the
graphs, calculated using the Debye model.
1.3 The Kinetics of Crystal Formation
The rules of thermodynamics highlight the conditions under which the crystalline state is most
stable at equilibrium. However, the molecular order necessary in such systems and the ideas of
polymorphism highlight that observable systems are not always present in their equilibrium state.
Crystallisation, the formation of a crystalline material, occurs via the process of nucleation from
a system where molecules have enough mobility to rearrange into a more stable structure. The
driving force leading to the formation of a crystalline material is known as supersaturation. When
crystallisation occurs using a solvent medium, the two main ways of producing a supersaturation are
cooling or evaporation of a saturated solution. These processes are highlighted in Figure 1.10.
1.3.1 Nucleation
The process of nucleation involves an energy barrier in going from a disordered to an ordered state. In
general, this energy barrier can be thought of as the energetically unfavourable formation of a surface,
11
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Figure 1.10: Graphs highlighting the formation of a supersaturated solution from a
saturated solution via a) cooling and b) evaporation.
which causes surface tension. A basic understanding of nucleation is given by classical nucleation
theory (CNT), which assumes a stabilisation force proportional to the volume of a sphere and a
destabilisation force proportional to the surface area,
∆GCNT = 4
3
πr 3∆GV + 4πr 2∆GS (1.9)
where ∆GCNT is the difference in Gibbs Free Energy between the nucleus and the disordered system,
r is the radius of the sphere, ∆GV is the loss of free energy due to the formation of the nucleus per
unit volume, and ∆GS is the gain of free energy due to the formation of a surface per unit area. A plot
of the free energy of a nucleus as a function of its diameter is shown in Figure 1.11, where the surface
and bulk free energy functions are included as dashed and dotted lines respectively. The radius at




as a nucleus reaching this size via thermal fluctuations can grow indefinitely without increasing the
Gibbs Free Energy of the system. The simplistic view of CNT is not without flaws, rarely describing
the nucleation rates of real systems with any degree of accuracy, and often relying on additional cor-
rections in the energy terms.25 Even with corrections for the differing shapes and bonding strengths
present in molecular crystalline systems, it has become clear that it is necessary to consider nucle-
ation processes that rely on several steps.26 Such nucleation theories are known as non-classical
nucleation theories (NCNTs), which have seen a recent increase in interest due to an improvement in
our ability to observe processes on the length-scale of a single crystal nucleus.
The most recent understanding of NCNTs is a combination of the ideas of two-step nucleation
theory (TSNT)27,28 and pre-nucleation clusters (PNCs).29 TSNT describes the formation of a stable,
dense cluster within the crystallisation medium prior to crystallisation. This cluster may have some
of the interactions present in the final crystal structure; however, ordering of the molecules is needed
12
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Figure 1.11: A graph of the Gibbs Free Energy of a nuclei with respect to a disordered
state, as a function of nucleus radius. The critical radius of the nucleus is labelled Rc
after the dense cluster is formed. TSNT is well established for the crystallisation of a number of
proteins.30 For smaller molecules forming from a solvated state, such as the APIs of interest in this
work, it has become apparent that solute rich clusters often form before crystallisation.31 These
clusters can be stable for long periods of time and have recently been observed directly during the
crystallisation of flufenamic acid.32 Figure 1.12 highlights the difference in crystallographic pathways
between CNT and NCNT, showing how intermediate clusters can be stable in solution over long
periods of time.
Figure 1.12: The Gibbs Free Energy of a nucleus during classical nucleation theory (left)
and two-step nucleation theory (right). A dense cluster forms during two-step nucleation




1.3.2 Crystallisation of Metastable Polymorphs
The complex nature of nucleation helps to give further insight as to why we observe the formation of
metastable crystal structures. If we consider the ordering phase of a process following NCNT, the
pre-nucleation dynamics of the molecules will determine the first crystalline structure that will form.
Indeed, it has been shown that changes in pre-nucleation clusters can directly affect the dynamics
of crystallisation.33 If the first crystal structure to grow is metastable, it may transform or persist
depending on the similarity of the other possible polymorphs, and how big the transformation energy
barrier is between them. This is described by the empirical Ostwald’s rule of stages, which highlights
that the first appearing crystalline state is often metastable.34
Experimentally it is not possible to know if a particular polymorph of a molecule is the most
stable structure; all that is known about a particular polymorph is whether it is the most stable known
polymorph at a specified temperature. This fact can have far-reaching consequences. A common
example of the implications of metastable polymorphs is that or Ritonavir,35 an antiretroviral medi-
cation used in the treatment of HIV/AIDS, which was initially distributed in the solid-state in the
only known crystal structure, form I. The form I structure turned out to be metastable with respect to
another form, form II, which was less soluble. The appearance of this new polymorph led to lower
bioavailability of the drug, forcing production to be halted. Occurrences such as this now mean that
it is now commonplace to rigorously investigate the polymorphic landscape of drugs before they are
moved forwards in production.36
Knowledge of the polymorphic landscape of a drug can be a powerful tool during solid-state
formulation. Not only can it help prevent the formation of unknown structures, but it can also be used
to search for potential long-lived metastable structures that may have improved material properties,
such as bioavailability37 and processability.38 Computationally it is becoming common practice to
search for the possible polymorphs of an API using crystal structure prediction (CSP),39 allowing
both a level of confidence that the lowest energy polymorph has been found, and the ability to
suggest possible metastable polymorphs to try and crystallise experimentally. The outcome of these
calculations is complex; many more polymorphs are predicted computationally by CSP than are
seen via crystallisation experiments. The reasoning behind this is clearly laid out by Price,40 who
states that the necessary solution is in both improving our experimental capability to search for
new polymorphs and our ability to rank the energies of the crystal structures at finite temperatures
computationally.
1.4 Crystal Morphology
When considering the thermodynamic properties of crystalline materials, it is often useful to use
the idealised picture of a material that extends infinitely in space and ignore the implications of not
accounting for the boundaries that must occur in reality. However, discussion of crystal nucleation
dynamics highlights that the finite size of such a material must be considered for a full kinetic
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understating. Moreover, the anisotropy present in crystalline materials means that they rarely grow
at equal rates in all directions, and their properties can differ depending on the particular crystal
faces exposed.
One of the first observations of crystalline materials, before their internal structure was even
understood, is that their edges are faceted, forming at specific angles. These facets are caused due
to crystals cleaving down lattice planes and were the first indication of the internal structure of
the crystalline state.41 The morphology of a crystal is dependent on the growth rate in each of the
crystallographic directions. The faster a crystal grows perpendicular to a particular plane, the less of
that plane will be present in the final morphology. A general set of morphological rules were set out
by Bravais and Friedel, which stated that: the most prominent faces present in the final morphology
of a crystalline material are those with the highest density of lattice points. Equally, the growth rate
perpendicular to a particular plane is inversely proportional to the distance between planes.42 This
rule is valid in many systems, simply because it is less easy to attach a crystallographic unit to a
plane with smaller ‘gaps’ for the unit to sit in. An extension to this rule was formulated by Donnay
and Harker, who took into account the change in density in certain crystallographic dimensions
when glide planes and screw axes are symmetrically allowed.43 Based on these rules, one can predict
the morphology of crystals from a purely geometrical perspective given the unit cell of a particular
polymorph. Such calculations are common in crystallographic programs, with the prediction known
as the BFDH morphology (after Bravais, Friedel, Donnay and Harker). An example of a change in
crystalline morphology due to differing directional growth rates is shown in Figure 1.13a,b.
However, in many cases, the crystal morphology may differ from that proposed by the BFDH
morphology due to strong intermolecular interactions between crystalline surfaces and solvent or
additive molecules during crystal growth (Figure 1.13c,d). Therefore, it may be more accurate to
calculate the attachment energy of a ‘slice’ of each of the possible planes, which gives a growth
rate based on how energetically favourable it is to form a new layer of molecules. Many codes have
be written to run this type of calculation and can even include solvent molecules attached at the
surface, which need to be displaced to form the new layer.44 Finally, it may be necessary to calculate
the thermodynamic morphology of a crystal, which minimises the surface energy of a particular
structure. This is particularly useful if crystals are left in solution and allowed to ‘ripen’ into their
equilibrium state.
The morphology of crystals can be a significant factor for properties that are dependent on
the orientation of the unit cell, such as conductivity and refractive index. Most importantly in the
pharmaceutical industry, crystalline morphology can affect the processability of the final API form
due to changes in flowability45 and surface adhesion.46 In general, the formation of needle-like
crystals is undesired due to the large surface areas they exhibit. As such, many studies have looked
into changing the morphology of grown crystals by modifying crystallisation conditions, such as the
tuning of solvent crystallisation media,47–49 additives50–53 and temperature profiles.54
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Figure 1.13: A 2-dimensional representation of the effect of differing crystal growth
rates on the final crystalline morphology. a) Example growth rates expected from the
BFDH morphology rules. The less-dense faces grow more rapidly, leading to the crystal
morphology shown in b). c) A representation of the effect of slowing the growth rate at
certain faces due to solvent or additive attraction. This modification to the growth rates
leads to the morphology shown in d).
1.5 Novel Approaches to the Controlled Formation of Crystal Polymorphs
Given the detrimental implications of a late-forming metastable polymorph, along with the possibili-
ties of control of material properties if long-lived metastable structures can be discovered, it is not
surprising that the study of polymorphic control in organic crystal systems is an area of a tremen-
dous amount of modern cutting-edge research. The ability for minimal changes in crystallisation
conditions to change the polymorph of a molecular crystal means that pharmaceutical companies
must perform thorough crystallographic screening studies before an API can be sold commercially.55
These screens involve crystallisation of the target API in an array of solvents,56,57 including binary and
higher-order mixtures,58 which are used as crystallisation media. The crystallisation process within
these systems is highly dependent on how supersaturation is achieved,59,60 and any polymorphic
changes after initial crystallisation must be carefully tracked61,62 to ensure stability.
Beyond the well-established methods for polymorph screening that are used industrially, there are
a plethora of alternative methods that have been studied in the search for structural control of organic
crystals. Recent advances in applying pressure to organic systems have allowed pressure-temperature
phase diagrams to be produced, highlighting a number of high-pressure polymorphs63–65 and
polymorphic phase transitions.66 The application of external fields has also shown promise as
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a method for polymorphic control, utilising strong electric fields67,68 or lasers with carefully cho-
sen polarisation.69,70 Similarly, the application of external magnetic fields was shown to cause a
polymorphic change in the polyaromatic hydrocarbon coronene.71
Recent studies have looked into the production of new polymorphs using premeditated templates,
such as modified growth surfaces.72–77 This polymorphic control relies on seeding the growth of poly-
morphs by forcing the initial heterogeneously-grown layers of molecules to form a particular packing
motif, which seeds subsequent growth. Work by Price built on this work, using CSP on molecules in
the fenamate family to determine possible structural similarities. Using these similarities, previously
experimentally-unrecognised polymorphs were successfully seeded.78
The use of templates to control polymorphism utilises the favouring of certain bonding motifs
in the region of the template. In a sense, this is likely very similar to what happens when solvent
interactions control polymorphism; it is just that one needs to find the correct system to achieve
the desired intermolecular interactions. The difference is that the interactions with the solvent will
be happening across the whole system, whereas templated growth can only occur at the template
surface. An intermediary between these systems is the formation of viscous, tightly-bound solutions,
where interactions between the target molecule and solvent are strong, but not so strong that co-
crystals form or molecular mobility is completely halted. An example of this is the polymorphic
control that has been seen by utilising supra-molecular gels,79,80 and via the heating of molecules in
their glassy state.81
The first two experimental chapters of this thesis will look at a novel route towards crystallographic
control, which utilises low-melting mixtures of materials known as deep eutectic solvents. The first
chapter will highlight how crystallisation is achieved in these systems, leading to crystallographic
control of a number of APIs. The second chapter will look more deeply into the formation of the deep
eutectic systems, highlighting how it is likely that metastable solvates are mediating crystal growth of
the final API product.
The final chapter of the thesis looks at another set of molecules known as chalcones, which sit
as the backbone to several pharmaceutically active molecules. This chapter looks at the occurrence
of colour in a set of polymorphic chalcones, which is compared to a new computational method of















ll materials were all purchased from chemical suppliers, and care was taken during crystallisa-
tion experiments to minimise contamination of samples. Paracetamol (Sigma: A7085, >99%),
benzamide (Sigma: 135828, >99%), estradiol (Sigma: E8875, >98%), 2-ethoxybenzamide (Alfa
Aesar: B25455, >97%), 2-methoxybenzamide (Alfa Aesar: A12520, >98%), verapamil hydrochloride
(Sigma: V4629, >99%) and phenol (Sigma: P1037, >99%) were all purchased and stored in a fridge
below 10 °C. Crystallisation experiments were carried out in dry, pure solvents (>99%) purchased
from Sigma to avoid the unwanted formation of hydrate crystal structures. Laboratory grade solvents
were used during cleaning procedures.
2.1.2 Glassware Cleaning
All glassware to be used for crystallisation experiments was cleaned thoroughly before use. New
glassware was cleaned with de-ionised water, acetone, and ethanol, respectively before use, and kept
in a 65 ° C oven to dry. Any reused glassware was first thoroughly cleaned with soap and water.
2.1.3 Crystallisation Methods
All crystallisation was carried out in a temperature and humidity controlled room. Temperature and
humidity were constantly recorded so that any anomalous crystallisation results could be attributed
to atmospheric changes if necessary. Prior to experiments, solutions of desired concentration were
prepared in sealed vials at the required temperature for the start of the crystallisation experiment.
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Solvent volumes were measured using an M1000E Gilson Microman. Solid samples were weighed
using a Fisherbrand analytical 4-point scale.
Cooling crystallisation experiments were carried out using a copper sample holder designed to
house six test tubes. The blocks were cooled by a Julabu water bath via internal pipes. De-ionised
water mixed with 20% glycerol (by mass) was used to reduce the freezing point of the coolant water.
Using this system, samples could be cooled and heated between -10 °C and 80 °C using the Julabu
EasyTEMP Professional (Version: 3.10.1) software. The design of the cooling apparatus is highlighted
in Appendix B.
2.2 Structural Analysis of Crystals
2.2.1 Diffraction of Crystals
Powder X-ray diffraction (pXRD) data were collected using a Bruker D8 Advance diffractometer with
an X-ray wavelength of 1.5418 Å (Cu-Kα), using a PDS LynxEye detector attachment. Before mea-
surements, samples were powdered using a pestle and mortar to reduce the preferential orientation
of crystallites. A low-background silicon wafer holder was used to reduce any background signal.
Unless stated, scans were taken over the 2θ range 5-50° at a rate of 0.75°·min−1 and compared to
simulated patterns using the Mercury software package.82 Low-temperature diffraction experiments
were carried out using a Phenix sample stage, allowing data to be collected between 12 K and 300 K.
Single crystal X-ray diffraction data were acquired using a Bruker Apex II CCD diffractometer
with an X-ray wavelength of 0.71073 Å (Mo-Kα). Unless stated, the temperature of the crystal was
held at 100 K to reduce the thermal motion of the atoms. Intensities were integrated in SAINT,83 and
absorption corrections based on equivalent reflections were carried out using SADABS.84 Structural
solution was performed in Olex285 using Superflip86,87 and refined in SHELXL.88
2.2.2 Calculating Powder Patterns
A basic understanding of X-ray crystallography can be acquired on the basis of Bragg reflection.
Incoming X-rays are reflected by the planes of a crystal, producing a diffraction pattern following
Bragg’s Law,
nλ= 2d sinθ, (2.1)
where n is an integer, λ is the X-ray wavelength, d is the distance between lattice planes, and θ is
the angle between the incident ray and the lattice plane (Figure 2.1). Powder samples are prepared
by grinding crystals small enough that their planes are distributed isotropically. X-rays irradiate the
sample, scanning an angle 2θ. This process means that there will always be an angle that will satisfy
Bragg’s law for each plane.
Points within the lattice can be written in terms of direct lattice vectors,
R = ha1 +ka2 + l a3, (2.2)
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Figure 2.1: A representation of Bragg reflections leading to constructive interference in
powder diffraction.
where [h,k, l ] are integers, and ax are the direct lattice vectors. It then holds that R can represent
every point in the lattice. As diffraction is concerned with the planes of the crystal, it is useful to
transform into a system with vectors that describe such planes. This transformation leads to the well
known reciprocal lattice vectors,
G = hb1 +kb2 + l b3, (2.3)
where bx are reciprocal lattice vectors so that G contains information for all the possible planes of the
crystal. The reciprocal lattice vectors are defined so that their magnitudes are inversely proportional
to the distance between the planes,













where V is the volume of the unit cell, and dhkl is the distance between the (hkl ) planes. Directions
in real space are given by Miller indices, denoted using square brackets - [hkl ] and directions in
reciprocal space given in curved brackets - (hkl ). Figure 2.2 highlights the definition of reciprocal
and real space lattice vectors along with examples of Miller indices.







where hkl are miller indices denoting a particular plane.
To calculate the intensities of the constructive interference, the position of atoms in the crystal
must be considered. Each atom will contribute to the interference of the X-rays, causing a phase





2πi (hx j+k y j+l z j ) (2.6)
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Figure 2.2: Example unit cell highlighting the definition of real space and reciprocal
space vectors. The cross product a1×a2 is highlighted, which is in the same direction as
b1, along with the distance between the (001) planes. Examples of Miller indices for the
real space directions a1, a2 and a3, and in the reciprocal space direction of b2 are given.
where f j is the atomic form factor (a number dependent on the type of atom and the incoming
wavevector) and (x j , y j , z j ) represents the position of the j th atom in the unit cell. The intensity
of each peak is then proportional to the square of the structure factor. Several other factors have
to be considered in real systems, including anomalous scattering (a change in phase due to X-ray
absorbance), the Lorentz correction, a polarization correction and multiplicity (the fact that several
planes will cause the same reflection).
By considering the possible symmetries of the crystalline state, further insight into the structure
of the crystal can be achieved. Certain symmetries in a crystal will guarantee that the form factor
will become zero for particular planes. These missing points of intensity are known as systematic
absences and are essential for determining the space group of a crystal. An example of crystal
absences is shown in Table 2.1 for the different types of lattice centring.







I h +k +1 = 2n +1 (100),(300),(120)
F
h + l 6= 2n,
k + l 6= 2n,
h +k 6= 2n
(100),(110),(011)
C h +k = 2n +1 (100),(120),(124)
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2.2.3 Rietveld Refinement
Comparative analysis of pXRD patterns with known crystal structures was carried out using Profex
(version: 3.14.3),89 a graphical interface for the BGMN Reitveld refinement backend. This refinement
method allows pXRD data fitting by modelling peak positions and intensities to generate experimental
crystal structures from previously solved systems. Fitting involves a combination of parameters based
on both the sample and the experimental setup. Parameters for the Bruker D8 Advance diffractometer
have been carefully calibrated to give accurate peak shapes and relative shifts. Care was taken to
grind samples to reduce preferential orientation, which increases the intensity of certain peaks due
to crystallites in the sample not being of uniform size and distribution. Modelling of preferential
ordering can be carried out in Profex; however, reducing the effect leads to more accurate analysis.
Reitveld analysis outputs both a predicted unit cell for an experimental powder pattern (based
on a previously solved structure) and a confidence level for the fit. Gaining an acceptable confidence
level is imperative before drawing any conclusions from the data. Therefore, Rietveld analysis allows
for the determination of unit cells at finite temperature, and allows a confidence level to be applied
to whether a powder pattern matches a particular structure. Additionally, the analysis can be carried
out with multiple phases, allowing a percentage of each phase to be calculated.
2.2.4 Single-Crystal X-ray Diffraction
An extension to pXRD comes from using a crystal with a single domain. Equation 2.5 shows that when
using powder diffraction a single angle θ is used, resulting in all vectorial information about Ghkl to
be lost. When using a single crystal, diffraction will appear as points in 3D space and information
about Ghkl is retained. The intensity of the spots will still be proportional to the square of the form
factor in equation 2.6, meaning the phase information will still be lost. However, there are methods to
overcome this,90 and full structure solution via single-crystal X-ray diffraction (sc-XRD) is routinely
carried out.
2.2.5 Solving Crystal Structures Via Electron Diffraction
Although sc-XRD is the most common method used for crystal structure determination, the technique
can be difficult or impossible to use in certain situations. The main constraint on structures that can
be solved via X-ray diffraction is the need for a single crystal domain of appropriate size (ideally 0.2
mm in all dimensions). The crystal is needed to fill the incident X-ray beam to generate diffraction
spots with appreciable intensities. Another factor to take into account is that crystals that look to
be singular may be twinned. Twinning occurs when multiple crystal domains are packed together
due to energetically competitive unit cell boundaries, which are common with space groups such as
P21/c with β close to 90◦.91
Multiple methods can be used when sc-XRD cannot be applied; however, each comes with a
substantial amount of work. A common method is the use of crystal structure prediction along with
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pXRD data to search for a particular structure.92 This technique requires the powder data to be of a
single phase, and for large unit cells can use a huge amount of computational power. A recent novel
approach to overcome the downfalls of powder diffraction is the use of magnetic fields to align the
polycrystalline domains.93 However, these ideas lack the routine use available with sc-XRD.
An emergent technique in the field of crystal structure solution is 3-dimensional electron diffrac-
tion (3DED).94 The use of a scanning transition electron microscope (STEM) allows for the detection
of nano-sized crystals, the diffraction of which can be observed with extremely sensitive single-
electron detectors.95 Although the use of 3DED is becoming more common, several factors are
hindering routine use. One of these issues is secondary electron scattering due to the high cross-
section of electron-electron interactions compared to photon-electron scattering. This secondary
scattering leads to predicted systematic absences having finite intensities, resulting in difficulties
when determining the space group.96 In many cases, small crystals (of a few 10s of nanometers) are
actually preferred in 3DED to minimise the amount of secondary scattering. The first pharmaceutical
to be solved ab-initio by 3DED, without the use of sc-XRD to confirm the structural model, was that
of orthocetamol.5
2.3 Optical Spectroscopy
Ultraviolet-visible spectroscopy (UV-Vis) of solutions was carried out using a PerkinElmer Lambda
650 spectroscope. Solution measurements were taken using two 10 mm path length quartz cu-
vettes, one containing a reference solvent and the other the sample solution, as shown in Figure 2.3.
Absorption of the sample is calculated by comparing the intensity of each beam, using the equation,
A = log(I /I0), (2.7)
where I is the intensity of the sample beam, and I0 that of the reference beam.
Figure 2.3: Experimental setup for solution UV-Vis spectroscopy utilising a sample and
reference beam. Reproduced from [97].
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UV-Vis spectra of solid-state samples were collected using a 60 mm integrating sphere attachment
to the spectrometer. Samples were crushed with a pestle and mortar before being added to a sample
holder, and reference spectra were taken using a spectralon®sample.
2.4 Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) of samples was carried out using a TA Instruments Discovery
DSC25. N2 gas was used as a purge gas, which was flowed into the sample chamber at a rate of 50
mL.min−1. The TRIOS software package (version: 4.5.0.42498) was used to analyse the thermograms
of each sample. Temperature and cell constant calibrations were performed using a certified indium
standard (temperature = 156.6 ± 0.5 °C, enthalpy = 28.72 J.g−1 ± 4%).
2.4.1 Modulated Differential Scanning Calorimetry
Modulated differential scanning calorimetry (MDSC) of samples was carried out using a TA Instru-
ments Discovery DSC25. The temperature was modulated with an amplitude of 1 °C and a period of
60 s. Samples were heated with an underlying rate of 1 °C.min−1. A sapphire reference sample was
used for specific heat calibrations. As a technique, MDSC is useful for accurate measurements of
specific heat and the deconvolution of overlapping thermodynamic transitions. The technique has
been shown to produce accurate heat capacities for a number of systems using the TA Instruments
Discovery DSC25. During the heating ramp, the total and non-reversing heat flow to the samples are





+ f (t ,T ), (2.8)
where dQd t is the total heat flow of the sample relative to the reference, Cp is the heat capacity of the
sample at constant pressure, dTd t is the heating rate of the DSC and f (t ,T ) is a function that describes
the heat flow of kinetic processes (such as crystallisation and evaporation) at time t and temperature
T . During MDSC, the total heat flow is given by the rolling average of the modulated heat flow. The
heat capacity of a sample can be calculated using a discrete Fourier transform of the modulated heat
flow,98 from which the reversing (Cp
dT
d t ) and non-reversing ( f (t ,T )) heat flows can be calculated.
Figure 2.4 shows idealised MDSC curves, including the total and modulated heat flows.
2.4.2 Concomitant Synchrotron X-Ray Diffraction and Differential Scanning
Calorimtery
Concomitant synchrotron X-ray diffraction and differential scanning calorimetry (CXRD-DSC) was
carried out using a modified TA Instruments Q20 DSC, with holes drilled (entry: 3 mm, exit: 5 mm) to
allow an X-ray beam to pass through. Experiments were carried out at the I12 beamline (JEEP) at
Diamond Light Source. A 0.5 mm diameter X-ray beam was used, and diffraction was collected using
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Figure 2.4: Example parameters during a modulated differential scanning calorimetry
experiment. The temperature is increased linearly with an underlying sinusoidal period-
icity (top). The derivative of the temperature as a function of time follows a sinusoidal
function. The resultant heat flow is shown in the bottom pane, with an example transi-
tion highlighted in the orange area.
a Pilatus 2M CdTe detector placed 1.887 m behind the sample. The detector was calibrated using a
cerium dioxide sample. Each diffraction pattern was collected for 4 s, with a 2 s pause between each
pattern.
A TA Instruments RSC 90 cooler controlled the temperature of the DSC. Samples were sealed
hermetically in TZero aluminium pans, which could be placed so that encased sample was in the
path of the X-ray beam. The aluminium pan did cause diffraction, but the peaks occurring due to
this could be easily disregarded. In general, DSC measurements were performed at a heating rate of
10 °C.min−1, so that powder patterns were produced at 1 °C intervals.
Diffraction data were analysed using the DAWN99 software package, where the 2-dimensional
diffraction data were integrated to produce 1-dimensional traces.100 Unrepresentative spots of
high intensity, caused by large crystal grain sizes, were removed in post-processing. DSC and syn-
chrotron diffraction data were aligned via interpolation of absolute time using MATLAB 2019a
(version: 9.6.0.1072779). The interpolated data were calibrated using a snapshot of the DSC data
taken when a trigger was received from the DAWN software. This trigger allows alignment of the Q20
and Pilatus data. DSC data were analysed using TA Instruments Universal Analysis software (version:
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5.5.24). Data was combined an overlaid using MATLAB, along with all subsequent analysis.
2.5 Nuclear Magnetic Resonance Spectroscopy
Nuclear Magnetic Resonance (NMR) characterisation experiments were carried out on a JEOL ECS-
400. Solutions for NMR were prepared by dissolving each sample in 0.5 ml of deuterated solvent.
Analysis of all samples was carried out using MestreNova (12.0.4).
2.6 Computational Analysis
2.6.1 Visualisation Tools
Solved crystal structures were analysed and viewed using the Mercury82 software package. Gaussian09101
was used for the quantum chemical calculations of molecular properties using density functional
theory, which were analysed using GaussView 5.102 Within GaussView 5, molecular orbitals and
molecular electrostatic potential (ESP) maps were produced. ESP maps were plotted onto a total elec-
tron density isosurface to give information of both the steric and electronic properties of molecules.
The 64-bit intel cluster Grendel was used to carry out computationally expensive calculations. Basis
sets and functionals were chosen based on each particular calculation and given in the text alongside
any calculations discussed.
2.6.2 Molecular Optimisations Using ORIENT
The software package ORIENT44 was used to carry out large numbers of optimisations on rigid
molecules. ORIENT uses distributed multipoles to model molecular interactions, which can be
calculated using a combination of the Gaussian09 and GDMA103 programs. Multipole analysis of all
atoms was carried out up to rank 4 (hexadecapole). Multiple optimisations using the same sets of
molecules were run using scripts written in Perl, and executed on the Grendel cluster. Example input











VOLATILE DEEP EUTECTIC SOLVENTS
The results of this chapter were published in part in the paper: Crystallisation from Volatile Deep
Eutectic Solvents,104 which was first-authored by Dr Jason Potticary. I would like to thank everyone
who took part in this work. Unless stated, the research presented in this chapter was carried out by
myself.
3.1 Interactions in Solution as a Crystal Engineering Tool
T
he use of crystallisation as a tool to form reproducible materials of known composition is
highly dependent on the control that one has during the process of crystal formation. Al-
though there is now substantial expertise in analysing the crystalline form once it is produced,
the process of crystallisation is still not well understood, with nucleation dynamics being particularly
difficult to probe. Nonetheless, protocols for the experimental exploration of the crystallographic
landscape of a molecule are well established. One of the major routes to crystallisation is via the
liquid form, often using solvents as effective media. The use of solvents allows for the mobility
of the target crystallisation molecule while still allowing species in the solution to interact via in-
termolecular interactions. In studies concerning the tuning of the final crystalline product, these
intermolecular interactions are particularly important. In many cases, it has been shown that the
strategic selection of solvent molecules and crystallisation conditions can lead to changes in both
crystal morphology105,106 and polymorphism.107,108
Many solvents are appropriate for use as crystallisation media, which tend to be small organic
molecules with melting points below room temperature. For crystallisation, the pairing of solvent
and solvate is carefully chosen so that the solute can be dissolved at concentrations high enough
to produce reasonable material yields. In these solutions, the supersaturation of the solvate (via
cooling or evaporation) is increased until the solvate crystallises out into the remaining solvent-solute
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solution. In this sense, the solute crystallisation has little effect on the phase of the solvent, meaning
the solvent and solute are well-defined entities (Figure 3.1).
Figure 3.1: The process for the formation of crystalline material via the cooling of a
common solute-solvent system.
Although there are a large number of molecules that are used ubiquitously as solvents, their
diversity is limited by the need for solvents to be in the liquid phase. In this chapter, I discuss a
diversion from this limitation by exploring the use of a class of ionic liquids (ILs), known as deep
eutectic solvents (DESs), as a medium for crystal growth.
3.2 Ionic Liquids and Deep Eutectic Solvents
Over the last century, the study of ILs has grown exponentially into a field that has found uses in a
huge range of disciplines. Their discovery is rooted in an early search for neoteric solvents that could
exhibit a range of properties that were not well established in common solvents.109 The particular
solvents explored were molten salts, which were known to be highly stable, non-volatile, cheap and
have a large electrochemical window. However, the issue with molten salts was that they tended to
need very high temperatures to form, and were therefore particularly difficult to handle, introduced
material incompatibilities and also cost a lot to maintain in the liquid phase. Given this restraint,
the acquisition of a low-temperature molten salt was highly sought after. Over 150 years since the
observation of such a material, a low-temperature molten salt is now termed an IL.
Although not understood at the time, the first known observation of an IL was the appearance
of a "red oil" from Friedel-Crafts reactions in the mid-19th century. The advent and expanded use
of NMR spectroscopy more recently determined that this liquid resulted from the formation of an
aluminium chloride salt (Figure 3.2), which was suppressing the melting point of the mixture. P.
Walden made another early observation of an IL in 1914, where he recorded the formation of a low
melting alkylammonium nitrate,110 subsequently leading to a class of ILs analysed for their use as
30
3.2. IONIC LIQUIDS AND DEEP EUTECTIC SOLVENTS
liquid propellants.111 These materials are also still of modern theoretical interest when trying to
determine the hydrogen bonds present in ILs.112
Figure 3.2: Chemical components of the "red oil" observed in early Friedel-Crafts experi-
ments. Structures are taken from a review of ionic liquids by Wilkes.109
The active search for IL systems began with the need for efficient and stable electrolyte systems,
the work on which was funded by the U.S. Air Force Academy. This saw the rise in CuCl alkylam-
monium chlorides,113–115 before the field really started to grow after the invention of water-stable
1-ethyl-3-methylimidazolium based ILs in 1992.116 The ideas gained from these studies resulted in
the discovery of a large number of possible anion and cation combinations, and in 1998 Freeman
termed the phrase "designer solvent" to describe this new group of neoteric solvents.117 It appears
that this idea sold itself easily to the chemical community and lead to the utilisation of ILs in a variety
of fields, including chemical reaction solvents,118–120 biomass processing,121 lubrication,122 solvent
separation123 and pharmaceutical applications.124
In 2003 Abbott discovered a new IL-type system containing choline chloride (m.p. 302 ◦C) and
urea (m.p. 133 ◦C), which, when mixed at a ratio of 1:2 choline chloride:urea, had a melting point
of 12 ◦C.125 This type of mixture was not considered an IL, as it did not consist entirely of discrete
ions, and was given the name deep eutectic solvent (DES) to distinguish them from classic ILs.126
In DESs, the depression in melting point is attributed to the formation of large ions containing
combinations of urea and Cl− or choline chloride and urea via hydrogen bonding.127 Following the
first observations of DESs, many similar systems were found and hailed as a green alternative to
common organic solvents due to their low volatility and high stability.128 The hydrogen bonding
capability of DESs has since led to their use as solvents in metal extraction,129 catalysis130 and
pharmaceutical formulation.131 The group of DESs has also further expanded to include mixtures
that do not necessarily include an ionic element; the natural deep eutectic solvents (NADES)132 and
therapeutic deep eutectic solvents (THEDES)133 can contain mixtures of neutral molecules, such
as the 3:1 menthol:benzoic acid mixture. These systems exemplify how the competition between
different hydrogen-bonding motifs can be strong enough to significantly reduce the melting point of
a mixture without ionic species.
The road to the discovery of room temperature molten salts was therefore transformed into a
continuous search for new solvent systems. With the current understanding of ILs and DESs, it is
estimated that there could be in the region of 106 possible such systems. The understanding of the
formation of ILs is still not well-defined, as the length scales needed to observe to fully understand
31
CHAPTER 3. VOLATILE DEEP EUTECTIC SOLVENTS
them are in a particularly difficult region for current technology. The use of neutron scattering134
and theory135 show us that extensive hydrogen bonding is present in the molecular mixtures, and
the melting points of mixtures tend to reduce with increased hydrogen bond strength and reduced
molecular symmetry. Therefore, any processes requiring liquid media with strong hydrogen bonding
are at the forefront of prospective interest in the field.
3.3 Deep Eutectic Solvents Containing a Volatile Component
Fundamentally, the properties of DESs do not seem to make them particularly compelling candidates
to consider as crystallisation media for pharmaceutical compounds. Although they have shown their
efficacy as reaction media, the known solutions tend to be inherently non-volatile, and the fact that
their phase behaviour is concentration-dependent makes cooling-crystallisation parameters difficult
to predict. However, disregarding these apparent difficulties, the strong hydrogen bonding present in
the DESs could present a possible pathway to engineering interactions that could not be produced
from standard solvent-mediated crystallisation.
In this vein, it was considered that a molecule with inherent volatility and strong hydrogen bond-
ing potential could be used to produce deep eutectic systems amenable to evaporative crystallisation.
The molecule chosen to test this hypothesis was phenol. Phenol is the smallest molecule containing
both an aromatic ring and a hydroxy group, which are both ubiquitous groups of pharmaceutical
compounds. Moreover, phenol has a melting point of 40 ◦C, meaning that even small melting point
depressions can cause the formation of a liquid at room temperature, and the vapour pressure of
phenol allows for milligrams of sample to be evaporated over a time period of hours.
Phenol was found to produce stable liquid solutions when mixed with several common active
pharmaceutical ingredients containing functional groups amenable to hydrogen bonding, such
as amino and hydroxy groups. In these binary systems, phenol is termed the volatile component
(VC) and the second constituent the non-volatile component (NVC). To distinguish eutectic systems
containing a VC from common DESs of low volatility, the name volatile deep eutectic solvent (VODES)
is used. The stoichometries of interest when crystallising from these mixtures often contain a high
proportion of the VC, and therefore it is useful to describe VODES in terms of a molar ratio (VC:NVC).
Figure 3.3 highlights the simple process for producing crystals of the NVC from VODESs. In step
one, the VC and NVC are mixed at a specific ratio and gently heated and shaken to increase the rate
at which the liquid phase is formed. Once formed, a droplet of the VODES can be exposed to the
atmosphere to evaporate off the VC, leaving the NVC to crystallise. Figure 3.4 shows the full process
of VODES formation and NVC crystallisation.
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Figure 3.3: The process for the formation of volatile deep eutectic solvents and the
subsequent crystallisation of the non-volatile component via evaporation of the volatile
component.
Figure 3.4: A time-lapse of the formation of a VODES. The two samples were put in
contact and left to mix without any external interference. Tx represents the time at
which the first crystal nuclei was seen. By the end of the time-lapse only crystals of
2-methoxybenzamide remain.
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3.4 The Control of Polymorphism in Paracetamol
Paracetamol (4-acetaminophen) is one of the most well known and rigorously studied pharmaceu-
ticals in the world. It is a small organic molecule (Figure 3.5), first synthesised in 1877, which is
generally distributed in tablets containing a crystallised form of the molecule. The polymorphic
landscape of the molecule has been thoroughly analysed both experimentally and computationally.21
It is known to be polymorphic, crystallising as the thermodynamically stable, monoclinic form I from
standard solvent crystallisation routes, and as the metastable, orthorhombic form II from the melt.
Figure 3.5: Chemical scheme of paracetamol (4-acetaminophen).
Many non-routine crystallisation procedures for the crystallisation of paracetamol have been
experimentally conducted to find more crystallographic forms with high bioavailability. At this point
in time, many of these investigations are likely purely academic, as it is well established that parac-
etamol is distributed as form I with no major bioavailability issues. Nevertheless, nine polymorphs of
paracetamol have been discovered to date, having utilised crystallisation conditions involving high
pressures,136 precise temperature profiles from the melt137,138 and targeted additives.139
Other than form I, the crystallographic form considered most widely to have commercial viability
is form II. The differences in properties between form I and form II paracetamol are the most common
introductory example of the possibilities that can arise from manipulating polymorphic forms. Due
to the planar-like structure of form II paracetamol, its compressibility is greater than that of form
I, and the fact that it is metastable compared to form I means that it is more soluble. Many studies
have used these facts as suggestions for the medicinal use of form II paracetamol, but the ease of
production of form I and the establishment of processes to produce the drug in this form have made
the use of form II thus far unviable.
Paracetamol forms a VODES at room temperature when mixed with phenol at molar ratios of
4:1 - 9:1 phenol:paracetamol. These mixtures begin a spontaneous transition to a liquid form when
in contact with each other. However, heating to 60 ◦C greatly increases the transition speed. When
kept under sealed conditions at room temperature, the mixtures remained stable, clear liquids for at
least a year. However, if left at elevated temperatures, the solutions started to go red. This reddening
is likely caused by the oxidation of phenol, as the quinones produced from phenol degradation are
known to be red in solution.140 1H NMR spectroscopy of red solutions showed no evidence of any
oxidised phenol in any measurable proportion. The red samples remained liquid over the same time
period as the colourless liquids.
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Crystals of paracetamol were produced from VODESs via evaporation of the VC from a drop of
liquid. The drop of liquid was placed on a glass slide and exposed to the air in a dust-free environment.
The temperature and humidity of the room were measured at all times to ensure that there were no
dramatic changes in environmental conditions. Figure 3.6 shows images of the resultant paracetamol
crystals from VODESs of ratio 4:1 - 9:1 VC:NVC. A clear change was seen between plate-like crystals
and needle-like crystals as the ratio of phenol was increased. A transition appears around the ratio
6:1, above which the needle-like morphology is dominant. The 6:1 sample appears to contain both
morphologies. In all cases, crystallisation from the VODES solution was fully completed within 24
hours, with no residual solution present.
Figure 3.6: Images of paracetamol crystals obtained from volatile deep eutectic solvents
of ratios varying from 4:1 - 9:1 phenol:paracetamol. Images were taken directly of the
crystallised sample on the slide that it was grown on.
To determine the crystal structure of the paracetamol crystallised from the VODESs of various
ratios, powder X-ray diffraction (pXRD) was acquired after each experiment. Figure 3.7 shows the
diffraction patterns for the 4:1 and 9:1 samples shown in Figure 3.6. Each pattern was compared
to the known polymorphs of paracetamol, and Rietveld analysis used to determine the dominant
polymorph. The analysis of each pattern clearly showed that the crystals produced from VODESs
with ratios 4:1 - 6:1 exhibited predominantly the form I crystal structure, wheres samples grown from
ratios of 7:1 - 9:1 displayed the structure of form II. This is a clear case of polymorphic control, arising
from a simple preparation based only on sample concentration at room temperature and pressure.
To assess the consistency of these results, a 5 g sample of each VODES ratio was prepared and kept
in a sealed vial at room temperature. Each day a drop of the sample was taken from this solution and
exposed to the atmosphere. These experiments allowed both the assessment of the reproducibility of
the crystallisation procedure and the effect of ageing of the solution. The results of these experiments
taken over 10 days are shown in Figure 3.8. The crystallographic form of each sample was determined
primarily via the crystalline morphology; however, 10 samples were analysed via pXRD at random to
ensure that this assumption was accurate. From the resultant tabulated data, it is clear that the crystal
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Figure 3.7: Experimental powder X-ray diffraction patterns of crystals produced from a
5:1 and 8:1 phenol:Paracetamol VODES. The experimental patterns are shown in black,
and a fit to known crystallographic parameters using Reitveld refinement shown in red.
a) Fit to paracetamol form I. b) Fit to paracetamol form II. Samples were crushed before
powder X-ray diffraction was carried out.
structure of paracetamol produced depends on the ratio of the VODES used. Below the ratio of 7:1
VC:NVC 87% of samples produced form I paracetamol, whereas of the 7:1 - 9:1 mixtures 77% produced
form II. This trend generally follows closely to that discussed with the first set of data. There does not
appear to be any correlation between the age of the sample and the resultant crystallographic form.
However, deviations from the expected crystal structure are seen, which are likely caused by small
differences in experimental conditions such as humidity, temperature or the presence of unwanted
nucleation sites. For example, all of the samples crystallised as form II paracetamol in the second set
of experiments, and almost all in the seventh. Although these results appear to be anomalous, any
commercial use of this process would require specific experimental parameters to ensure that the
desired crystallographic structure is always produced.
Other than ensuring the production of the correct crystallographic phase, another issue when
considering VODES as a potential commercial crystallisation medium is the quantity of phenol left
in the sample. 1H NMR of crystallised samples was assessed to determine the amount of phenol left
in the sample after crystallisation. Figure 3.9 shows the NMR for a sample of paracetamol crystallised
from a 9:1 VODES. It is clear that there was no detectable level of phenol to the sensitivity of the NMR
(<0.25% w/v). This is below the FDA allowed limit for ingestion, topical application, and injection.141
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Figure 3.8: Results from 10 repeat crystallisations of paracetamol from VODESs of ratio
4:1 - 9:1 phenol:paracetamol. Crystallisation experiments resulting in form I paracetamol
are shown in red (left), and form II shown in blue (right). Each repeat experiment
was taken after 24 hours of the previous experiment. The Crystallographic form was
determined primarily through observation of morphology, but some samples were
selected to be analysed by powder X-ray diffraction to ensure correct determination.
Adapted from reference [104].
Figure 3.9: Nuclear magnetic resonance spectra for paracetamol following crystallisation
from an 9:1 phenol:paracetamol VODES. Each peak is numbered depending on the
hydrogen that it relates to. Water and solvent peaks are also highlighted.
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The fact that the initial ratio of a VODES should affect the final crystallographic form of a sample
after the VC has evaporated is not immediately intuitive. Any sample that is grown via the evaporation
of a component goes through a progressive change in concentration. In general, the evaporation
of solvent at a constant rate will lead to a supersaturation proportional to time, albeit not a linear
proportionality. Considering VODESs as a crystallisation media, however, the driving force for crys-
tallisation will actually decrease until the eutectic concentration is reached. In essence, this should
not make any difference, as each sample will still go through the same set of concentrations and
eventually reach that same supersaturation at which crystallisation occurs.
The formation of a VODES mixture is inherently connected to the competition between possible
hydrogen bonding motifs that can form between the NVC and the VC. The difference between the
VODES system and that of an ordinary solvent system is that the phase of the VC is directly related to
the amount of NVC in the mixture. Hence, it is likely that the molecular dynamics of the solutions
are highly concentration-dependent. Figure 3.10 and Figure 3.11 show time-lapse images of the
formation of paracetamol crystals from 5:1 and 8:1 VC:NVC VODESs, respectively. In both cases, it
took over 10 hours for all of the liquid in the system to have gone; however, there is a dramatic change
in the time of the first onset of crystal nucleation. Even though there is only 10% more phenol in
the 8:1 VC:NVC system, it takes an additional 9 hours before the first observable nucleation event.
This strongly suggests that the internal structure of the liquid is different. In the following chapter, I
discuss how differential scanning calorimetry is used to analyse this structure. However, advances in
Brownian motion microscopy31 and liquid cell electron diffraction32 will also aid in confirming this
in the future.
The morphologies of the crystals produced via crystallisation from the different VODES ratios
may also provide some evidence of the cause of the polymorphic control. There is an obvious
distinction between the crystals of form I and form II paracetamol that grew from the VODES
media. Form I crystals are generally large with obvious single-crystalline properties, whereas form II
crystals are polycrystalline and thin as if grown rapidly. The morphology of the grown paracetamol
samples was assessed by carrying out pXRD without crushing the sample. Form I showed a clear
preference of growth direction perpendicular to the (001) plane, which may be expected due to the
plate-like appearance of the crystals. Although form II paracetamol grew as needles, there was a
clear preference for growth perpendicular to the (002) face. The pXRD patterns highlighting the
morphologies are shown in Figure 3.12, with BFDH predicted morphologies shown. For form II
paracetamol, it appears that layers of molecules form perpendicular to the (002) face, which may be
mediated by the movement of phenol through the system during the equilibrium process from phenol
evaporation. This may indicate an intermediary phase where phenol and paracetamol molecules are
tightly bound enough to modify the pre-nucleation dynamics of the system.
To assess the strongest intermolecular interactions between paracetamol and phenol, molecular
optimisations of variable numbers of molecules were carried out using ORIENT.44 Multipole analysis
was carried out using the 6-31G(d)/B3LYP basis-set/functional combination, which is common for
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Figure 3.10: Time-lapse of the crystallisation of paracetamol form I from a 5:1 phe-
nol:paracetamol VODES. The time is given in hours and minutes.
optimisations of small organic molecules.142 To allow for a large number of calculations, molecules
were kept rigid from the starting point of the calculation. Assessment of the crystal structures of form
I and form II paracetamol shows that form I contains a herringbone-like structural motif, whereas
form II contains planes of molecules. The basis of each motif can be represented by four molecules,
as shown in Figure 3.13. For each structure, molecular optimisations were carried out, with the
paracetamol motif of four molecules kept stationary and a phenol molecule allowed to move to a
local energy minimum. Optimisations were carried out for 10,000 initial phenol positions, selected
randomly from an isosurface of constant distance from the central structure.
The large number of optimisations highlighted only a small number of stable positions for each
structure that the phenol molecule would sit in. In each case, the hydroxy group of the phenol sat
in a region of local minima or maxima of electrostatic potential. The calculations highlighted that
form II paracetamol had 14 possible phenol positions, whereas form I only had 11. Although having
positions of lowest energy (most stable), the form I motif allowed for less possible phenol positions,
and so would be a less favourable motif as more phenol molecules are introduced to the mixture.
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Figure 3.11: Time-lapse of the crystallisation of paracetamol form II from an 8:1 phe-
nol:paracetamol VODES. The time is given in hours and minutes.
There are obvious drawbacks to this kind of calculation, as only a single phenol molecule was
optimised at a time, which neglected effects from phenol-phenol interactions. However, as a basic
theoretical approach, this does suggest a difference in the stability of the eutectic as the ratio of the
solution is changed, which could lead to the observed polymorphic selectivity. The position of the
oxygen of the phenol from each optimisation is shown in Figure 3.13. The colour is proportional to
the energy of the conformation, with red being the most stable and white the least.
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Figure 3.12: Powder X-ray diffraction patterns taken from crystals grown from 4:1 (top)
and 9:1 (bottom) phenol:paracetamol VODES. To highlight the growth morphology,
samples were not crushed during preparation. References to form I (HXACAN19) and
form II (HXACAN21) are highlighted, and Miller indices for each experimental peak are
given. The BFDH morphology for form I and form II paracetamol is shown to give a
theoretical prediction for the morphology of each polymorph.
Figure 3.13: The final configurations of 10,000 optimisations of phenol with a) paraceta-
mol form II and b) paracetamol form I using the ORIENT software package. Dots indicate
the position that the oxygen of the phenol will adopt, with the colour representing the
relative energy. Red indicates the most stable configurations and white the least stable.
The 10,000 optimisations indicate 14 potential positions in form II and 11 in form I.
41
CHAPTER 3. VOLATILE DEEP EUTECTIC SOLVENTS
3.5 Form III Benzamide from Volatile Deep Eutectic Solvents
Benzamide is a small organic molecule (Figure 3.14) that sits as the backbone structure for a large set
of antipsychotic medications. It is a simple amide derivative of benzoic acid, known for being the first
observed case of organic crystal polymorphism. It is well documented historically that Wöhler and
Liebig observed the solid-state transformation of a needle-shaped crystalline form to a rhombohedral
form.143 This is now known to be the transformation of the metastable form II benzamide to the
thermodynamically stable form I benzamide.144 Following this work, another metastable form (form
III) of benzamide was observed, described as having been "hiding" behind the thermodynamic stable
form I.145 Both form I and form III appear concomitantly and have very similar pXRD due to similar
crystallographic dimensions and symmetry (crystallographic space group P21/c). The structure of
form III benzamide was solved using pXRD data, which was made difficult due to overlapping peaks
with form I. Optimisation of crystallisation conditions eventually allowed single crystals of form III
benzamide to be grown,146 although form I was still present. Most recently, the use of nicotinamide
as a nucleation seed allowed the isolation of form III,147 with a small amount of nicotinamide present
in the structure.
Figure 3.14: Chemical scheme of benzamide.
Benzamide forms a stable VODES when mixed with phenol at ratios of 3:1 - 10:1 phenol:benzamide
at room temperature. Similarly to paracetamol mixtures, these samples are stable when kept in sealed
conditions for at least a year. Storage above room temperature causes the sample to gradually turn a
reddish colour, but does not cause any sample solidification. Keeping the samples at higher tempera-
tures increases the rate of reddening.
A set of 10 repeat crystallisations was carried out for each stable VODES ratio at room temperature.
As for paracetamol, each repeat was started 24 hours after the previous, under controlled conditions.
The results are highlighted in Figure 3.15. Throughout the experiments, two different outcomes were
observed. In the first case, plate-like crystals were observed, with a small amount of polycrystalline
sample present on the edges of the crystals. In the second observed case, all the resultant crystals
appeared polycrystalline due to an opaque, white appearance. In general, the polycrystalline sample
seemed to follow a needle-like morphology; however, there were opaque, plate-like crystals in some
cases.
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Figure 3.15: Results from 10 repeat crystallisations of benzamide from VODESs of ratio
3:1 - 9:1 phenol:benzamide. Crystallisation experiments resulting in form III benzamide
are shown in orange (left), and a mixture of form I and form III shown in purple (right).
Each repeat experiment was taken after 24 hours of the previous experiment. The crys-
tallographic form was determined primarily through observation of morphology, but
some samples were selected to be analysed by powder X-ray diffraction to ensure correct
determination.
Powder X-ray diffraction of the samples, shown in Figure 3.16, determined that there was a
structural difference between the two different crystallographic cases. In the first case, crystals of
benzamide form III were produced and, in the second case, crystals of both form I and form III
were present. The polycrystalline nature of the crystals produced in the second case appeared to be
the result of the transformation from a metastable state. Thus, it is likely that the resultant form I
benzamide forms as phenol is evaporated from a solvate crystal structure. Hence, the observation of
these two cases can be explained as the stochastic appearance of a solvate crystal structure during
crystallisation.
The stochastic nature of this polymorphic behaviour explains why there is no trend in the
occurrence of the different crystallisation cases as a function of the VODES molar ratio. Although
this highlights that the production of form III benzamide in this way is not polymorphic control, it
is still a way of producing form III benzamide without the concomitant growth of crystals of form I.
Therefore, this is the first case of the growth of pure form III benzamide without the use of additives,
albeit that the phenol may be playing the same role as nicotinamide does in previous work. The
advantage of this method is that the volatility of the phenol allows it to evaporate after the production
of the form III crystal structure, meaning a pure sample of form III benzamide can be produced.
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Figure 3.16: Example powder X-ray patterns for the two cases of crystallisation from
VODESs containing phenol and benzamide, plate-like crystals (top) and opaque needles
(bottom). Both patterns are referenced for form I and form III benzamide. Orange
dots represent peaks from form III benzamide, and yellow squares represent form I
benzamide. The region highlighted in green contains the peaks that most obviously
distinguish the crystal structures of benzamide form I and form III.
3.6 Phenol as a Solvate Molecule
2-Ethoxybenzamide (Figure 3.17), otherwise known as ethanzamide, is a common anti-inflammatory
drug used for minor pain relief. It is a small organic molecule with the benzamide structural motif as
the backbone. It has only one known polymorph; however, is it predicted that kinetically hindered,
lower stability structures may exist.148 The known polymorph grows as fine needles and sits in the BCS
class II (high permeability, low solubility), meaning inherent efficacy and processing improvements
can be made. Due to this, co-crystals of 2-ethoxybenzamide with a variety of co-formers have been
grown, which show stark improvements in both morphology and solubility.149,150
Figure 3.17: Chemical scheme of 2-ethoyxbenzamide.
2-Ethoxybenzamide produced VODESs with phenol at room temperature for ratios 5:1 - 9:1
phenol:2-ethoxybenzamide. These samples fully converted from solid to liquid after several minutes
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of mixing. Gentle heating increased the rate of the conversion but was not necessary. Storage above
room temperature led to a slight reddening of the sample, but at a much slower rate than for parac-
etamol and benzamide solutions. The liquid mixtures formed were stable for time periods greater
than a year. Repeat experiments for crystals grown from VODESs containing 2-ethoxybenzamide and
phenol are shown in Figure 3.18. In general, crystallisation from these VODESs resulted in thin, silky
needles, which nucleated from a single point. However, in some cases, a large opaque mass was seen,
which appeared to be the result of the transformation from a metastable crystal. It was clear that the
original crystal was plate-like with well-defined edges, and a depletion of the needle-like crystals
could be seen around the growth area. There did not appear to be any correlation between the ratio
of the VODES and whether the plate-like crystals formed.
Figure 3.18: Results from 10 repeat crystallisations of 2-ethoxybenzamide from VODESs
of ratio 5:1 - 9:1 phenol:2-ethoxybenzamide. Crystallisation experiments resulting in
needles of 2-ethoxybenzamide are shown in green (left), and samples including an
opaque plate-like crystal in pink (right). Each repeat experiment was taken after 24
hours of the previous experiment. The crystallographic form was determined primarily
through observation of morphology, but some samples were selected to be analysed by
powder X-ray diffraction to ensure correct determination.
Analysis via pXRD highlighted that the final crystal structure in all cases was the ubiquitous
polymorph of 2-ethoxybenzamide. Figure 3.19 shows pXRD patterns for each case, fit to the known
structure of 2-ethoxybenzamide. Scanning electron microscopy of an area of the opaque crystal
is shown in Figure 3.20, confirming that the opacity of the crystal was caused by fracturing on the
micron scale.
To assess the formation of the plate-like crystals, the crystallisation of several experiments were
assessed in real-time. Due to the stochastic nature of the formation of the crystal, 20 experiments
were run before the formation of the crystal could be followed. Figure 3.21 shows images of the
metastable plate-like crystals before and after transformation to the ubiquitous 2-ethoxybenzamide
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Figure 3.19: Powder X-ray Diffraction of 2-ethoxybenzamide samples grown from
VODESs. The case of pure needle growth (left) and the concomitant needle and plate-like
crystal growth are highlighted. Experimental patterns (black) are fit to the known crystal
structure for 2-ethoxybenzamide (red) using Reitveld refinement.
Figure 3.20: Scanning electron microscopy image of an opaque plate grown from a
phenol:2-ethoxybenzamide VODES. The region shows the needle-like crystal morphol-
ogy on the nano-scale, caused by the transformation of an intermediate metastable
phase. Images were taken by Dr. Jason Potticary.
crystal structure. These experiments highlighted that the transformation happened rapidly after the
liquid around the crystal had been depleted. However, the crystals were of the required quality and
size to be solved by single-crystal X-ray diffraction. Therefore, subsequent experiments were run,
and the crystals were moved to a fridge after they appeared so that further evaporation of the phenol
could not occur.
Single crystal X-ray diffraction of the plate-like crystals revealed a monoclinic (P21/c) unit cell
containing eight 2-ethoxybenzamide molecules and four phenol molecules (CCDC Ref code: VUK-
SEC). Therefore, the opaque crystals initially observed are formed via the desolvation of the phenol
molecules from this crystal structure. Figure 3.22 shows the asymmetric unit (with thermal ellipsoids)
and the unit cell for this new 2-ethoxybenzamide phenolate. Analysis of the crystal structure shows
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Figure 3.21: Optical images taken during the crystallisation of 2-ethoxybenzamide from
a VODES. a) Clear plate-like single crystals can be seen during the evaporation of the
phenol. b) After all the phenol has evaporated, the metastable crystals transform, causing
them to become opaque.
that the phenol molecule sits between two 2-ethoxybenzamide molecules, allowing the favourable
intramolecular N-H. . . O bond to form (Figure 3.23a). This interaction is not possible in the pure
2-ethoxybenzamide crystal structure due to the steric hindrance of the ethoxy group (Figure 3.23b).
Figure 3.22: a) Thermal ellipsoid plot of the asymmetric unit of the solved 2-
ethoxybenzamide phenolate crystal. b) Unit cell of the 2-ethoxybenzamide phenolate
crystal viewed down the a-axis. Thermal ellipsoid plots are shown to the 50% probability
level.
The observation of the phenol solvate of 2-ethoxybenzamide highlights the clear interplay be-
tween the formation of VODESs and co-crystals. Although it seemed to be the case that intermediary
phases influenced the crystals of benzamide and paracetamol formed from VODESs, the structural
solution of a phenol solvate is more definitive proof that phenol is affecting the crystallisation process.
In the case of the 2-ethoxybenzamide, the phenol solvate did not cause any interesting subsequent
crystal structures, but it does present a clear example of the complexities that can arise during
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crystallisation when strong competing intermolecular interactions are present.
Figure 3.23: Dimer motifs present in the crystal structure of a) the 2-ethoxybenzamide
phenolate and b) the stable form of 2-ethoxybenzamide. Intermolecular short contacts
are shown in black and intramolecular contacts are highlighted in red.
3.7 Other Molecules Forming Volatile Deep Eutectic Solvents
In the process of exploring pharmaceutical molecules that would form VODESs with phenol, a large
number of prospective NVCs were tested, containing an array of functional groups. In each case,
mixtures of VC:NVC were produced of ratios between 1:1 - 10:1. Samples which did not spontaneously
turn liquid were placed in an oven at 65 ◦C overnight. They were subsequently removed and placed
on an insulated surface to cool. If there was no apparent crystallisation after 24 then crystallisation
experiments were carried out.
The following section highlights a number of samples that were not exemplary crystallographi-
cally, but are essential in exploring the mechanism for VODES formation and subsequent use as a
crystallographic medium.
3.7.1 Formation of Glasses in Verapamil Hydrochloride Volatile Deep Eutectic Solvents
Verapamil is a cardiovascular medication that sits on the list of essential medications distributed by
the World Health Organisation.151 It is often administered in the form of a salt (verapamil hydrochlo-
ride), which has one known polymorph.152 Investigation of the formation of a VODES with a salt NVC
is interesting to explore, as charged species are historically at the centre of the formation of eutectic
mixtures. Verapamil hydrochloride formed stable VODESs with phenol at ratios of 3:1 - 10:1 VC:NVC.
At these ratios, the mixture became liquid on contact, with only small amounts of mixing necessary.
For all VODESs ratios, evaporation of the VC leads to the formation of a glassy phase which
persisted for at least a year. To understand this transition, differential scanning calorimetry (DSC) was
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carried out on samples sealed in hermetic pans. Samples were cycled thermally between -70 ◦C and
70 ◦C. An initial ramp, up to the melting point of verapamil hydrochloride, was carried out to ensure
that there was no remaining solid sample in the sample. Figure 3.24 shows DSC traces for the cooling
and subsequent heating of verapamil hydrochloride VODESs of ratio 2:1 - 10:1 VC:NVC. Although
no crystallisation or melting transitions occur, a clear, singular glass transition can be seen for the
ratios 2:1 - 7:1. The temperature of this transition shows a clear trend to higher temperatures as the
proportion of phenol is decreased. For a 10:1 VODES the midpoint of the glass transition on heating
is at -55 °C, which linearly increases to -30 °C as the ratio is increased to 5:1. From here, the transition
temperature increases more rapidly as ratios approach 2:1, where it is above room temperature.
Figure 3.24: Thermograms for VODESs of verapamil hydrochloride and phenol across
the range of ratios 10:1 (dark blue) - 2:1 (light green). The left panel shows the initial
cooling from 70 ◦C to -70 ◦C, and the right panel the subsequent heating from -70 ◦C to
70 ◦C. A grey circle represents the start of each run, blue the point at which the heating
begins and red the end of the cycle. A dashed line shows an approximate trend in the
increase of the glass transition temperature.
This DSC analysis of the glass transition suggests that the VC evaporates off until the glass transi-
tion is reached, at which point stronger interactions will slow down the evaporation. An interesting
observation for samples of ratio 8:1 - 10:1 is that multiple glass transitions appear to occur. To
highlight this, an enlarged heating trace of the 9:1 VODES is shown in Figure 3.25, with red arrows
highlighting the possible glass transitions. The transitions are difficult to resolve because of the small
change in heat capacity and the appearance of a relaxation enthalpy on heating. Their appearance,
however, helps to strengthen the suggestion that there is a complex structure within the liquid VODES
mixtures, in this case, even a separation of glassy phases of different stoichiometry.
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Figure 3.25: Enlarged view of the thermal trace for the heating of a 9:1 phenol:verapamil
hydrochloride VODES. The black arrow shows the direction of heating. Red arrows are
included to indicate the position of possible glass transitions.
3.7.2 2-Methoxybenzamide Volatile Deep Eutectic Solvents
The molecule 2-methoxybenzamide was evaluated due to the molecular similarity it has with ben-
zamide and 2-ethoxybenzamide. In both of the previously discussed molecules, the formation of
dimers plays an important role in the formation of the final crystal structure. There was evidence
of the formation of a phenol solvate during the crystallisation of form I benzamide from VODESs,
and a phenol solvate of 2-ethoxybenzamide was observed and solved for the first time. Both ben-
zamide and 2-ethoxybenzamide form a large number of co-crystals with small organic molecules
that can form similar hydrogen-bonding motifs.149,153 Particularly in 2-ethoxybenzamide, the in-
clusion of an extra molecule allows for a more relaxed conformation of the molecule, allowing
an intramolecular N-H. . . O bond to form. In contrast to these molecules, the stable and ubiqui-
tous form of 2-methoxybenzamide forms a catemeric hydrogen-bonding motif,154 while still al-
lowing the intermolecular N-H. . . O bond to form. Furthermore, there are far fewer co-crystals of
2-methoxybenzamide on the CCDC; however, this may be due to less interest in the structure for
pharmaceutical applications.
2-methoxybenzamide formed stable VODESs at room temperature with phenol for mixtures of ra-
tio 2:1 - 9:1 VC:NVC. Solutions were stable under sealed conditions for at least a year. Transformation
to the liquid phase occurred rapidly, as highlighted in the time-lapse shown in Figure 3.4. Similarly to
2-ethoxybenzamide, the liquids turned slightly pink over time when left at elevated temperatures (65
◦C). Crystallisation from all ratios of the VODESs mixtures resulted in the formation of the ubiquitous
crystalline form of 2-methoxybenzamide. There was no evidence of phenolate formation from any of
the solutions.
Analysis of the sequence of the related molecules benzamide, 2-methoxybenzamide and 2-
ethoxybenzamide allowed an insight into the propensity of VODES formation via sequential molec-
ular alteration, in this case, the modification of an ortho- positioned side chain. The clearest ini-
50
3.7. OTHER MOLECULES FORMING VOLATILE DEEP EUTECTIC SOLVENTS
tial difference is the formation of VODESs as the amount of VC is varied. 2-methoxybenzamide
forms a VODES at the lowest ratio (2:1 VC:NVC), followed by benzamide (3:1 VC:NVC) and finally
2-ethoxybenzamide (5:1 VC:NVC). This trend intuitively aligns with the propensity of co-crystal
formation with phenol, as the formation of such a state suggests that there are interactions within
the VODES that favour the crystalline state over the liquid state. Correlation with the melting points
of each of the pure NVC components suggests that the trend is not due to an increased propensity
for the molecules to form as a pure crystal, as each of the pure crystalline phases have very similar
melting points (benzamide - 127 °C; 2-methoxybenzamide - 127 °C; 2-ethoxybenzamide - 133° C).
3.7.3 Estradiol - A Hydrate Forming Volatile Deep Eutectic Solvent
Estradiol (17β-estradiol) is the major female sex hormone, playing a natural regulatory role in the
human body. It is used in a pharmaceutical role as a medication for a number of hormone therapies.
Crystallographically, estradiol forms very strong hydrogen bonds with water and therefore is almost
always present as a hemihydrate.155 The anhydrous form is only crystallised via sublimation or by
dehydration of the hydrate at 170 ◦C. The difficulty in crystallisation is due to the hydrate being
thermodynamically and kinetically favoured over the pure phase.
Crystallisation from VODESs containing estradiol and phenol were evaluated to see if the strong
hydrogen bonding within the solution could disrupt the interactions forming the hydrate. VODESs
of ratio 6:1 - 9:1 VC:NVC we stable at room temperature, although the samples needed to be left
in an oven at 65 ◦C over 24 hours for the mixture to form within a reasonable time-frame. Repeat
crystallisations of estradiol from each VODES ratio was carried out every day for 10 days. The resultant
crystals were polycrystalline (Figure 3.26) and pXRD matched the known hemihydrate structure.
Therefore, it is reasonable to assume that that water present in the initial sample and the atmosphere
was enough to make the formation of the hemihydrate kinetically favourable. The crystalline nature
of the sample may suggest a transformation from a transient phase, but if this was the case, the
transformation was too rapid to observe during these experiments.
Figure 3.26: Resultant crystals from the crystallisation of estradiol from VODESs of ratio
6:1 - 9:1 phenol:estradiol.
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3.7.4 Metaxalone, Metacetamol and Orthocetamol Volatile Deep Eutectic Solvents
The experimental results covered in this subsection were carried out by V. Hamilton (Metaxalone) and
J. Potticary (Metacetamol).
Metacetamol (3-acetaminophen) forms stable VODESs with phenol at ratios of 5:1 - 10:1 VC:NVC.
In a crystallisation experiment identical to that carried out for paracetamol, metacetamol showed a
difference in crystal morphology for samples grown from 5:1 - 7:1 VODESs and 8:1 - 10:1.104 Figure 3.27
shows the crystallisation experiments carried out for metacetamol. From these experiments, the
metacetamol polymorph produced was always the stable form I, highlighting that the crystallographic
change is purely morphological.
Similar work was carried out on metaxalone systems, with stable VODESs forming with phenol
at ratios of 4:1 - 10:1 VC:NVC. In metaxalone, several metastable phases were directly observed
crystallising from VODESs via pXRD. One of these metastable phases, which formed from 3:1 phe-
nol:metaxalone VODESs, was shown to transform into a new conglomerate form A-R/S.156
Figure 3.27: Results from 10 repeat crystallisations of metacetamol from VODESs of ratio
5:1 - 10:1 phenol:metacetamol. Crystallisation experiments resulting in rods of metac-
etamol are shown in blue (left), and needles in yellow (right). Each repeat experiment
was taken after 24 hours of the previous experiment. Image created by J.Potticary104
The use of paracetamol, metacetamol and orthocetamol allows the evaluation of VODES for-
mation propensity with changes in the position of the hydroxy functional group. Evaluation of the
formation of VODESs shows that the minimum VC ratio at which a stable VODES forms for paraceta-
mol is 4:1 VC:NVC, 5:1 VC:NVC for metacetamol, and no formation of VODES was seen at any ratio
for orthocetamol. A comparison of the properties of each isomer highlighted that orthocetamol had
a higher melting point than both paracetamol and metacetamol (paracetamol - 169 ° C; metacetamol
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- 148 ° C; orthocetamol - 208 °C). Moreover, the crystal structure of orthocetamol had never been
solved due to its tendency to form crystallites too small for single-crystal X-ray diffraction. In an
attempt to decipher the differences in VODES formation propensity between the related molecules,
the crystal structure of orthocetamol was solved via 3D electron diffraction (appendix D).5
Analysis of the orthocetamol crystal structure shows a particularly close interaction between the
hydroxy and carbonyl groups of neighbouring molecules, leading to ribbons of molecules throughout
the crystal. This strong interaction is not present in any paracetamol or metacetamol structures,
where a combination of longer intermolecular interactions make up the 3D structures. Therefore,
the VODES formation propensity in orthocetamol is either reduced by its more stable interactions
with itself or an inability to form a large enough array of hydrogen bonds with phenol. This case
study highlights that predicting mixtures of molecules that will form a VODES involves the same
complexities as crystal structure prediction, as knowledge of all the possible phases a mixture can
form needs to be evaluated. These phases will include all of the pure structures that the constituents
of the mixture can form, any potential co-crystals, and any non-crystalline phases such as glasses.
3.8 Summary
The search for a crystallisation medium utilising DESs led to the discovery of VODESs, which rely on
the same bonding interactions as DES but contain a volatile component. In a sense, this appears to
be a modification of one of the defining features of DESs; however, the fundamental suppression
of the mixture’s melting point is still seen. It appears to be common that throughout the history of
ILs and DESs, the properties of a few ILs are presented as general properties for all mixtures.157 This
initially helped to spark interest in ILs across multiple disciples but has left their definition very loose.
In the cases discussed in this chapter, the main interest has been the depression of the melting point
of a particular mixture. Such a depression allows crystallisation from the liquid state using molecules
that would not normally be liquid at room temperature. Moreover, the fact that these molecules are
liquid at these temperatures means that there are strong, competing hydrogen bonding interactions
throughout the mixture.
The examples highlighted in this chapter show clear cases of crystallographic control and modifi-
cations. The cases of paracetamol, metacetamol and metaxalone all showed changes in crystalline
properties, which depended on the ratio of the VODES mixture they were crystallised from. Further-
more, in benzamide, isolation of the form III polymorph was achieved within a solvent medium for
the first time without the need for additive molecules.
The crystallographic modifications presented indirectly implied to formation the metastable
phases, acting as intermediaries to the crystal structures and morphologies experimentally observed.
This hypothesis is strengthened by the direct observation of metastable phases in metaxalone and 2-
ethoxybenzamide. In 2-ethoxybenzamide, single-crystal X-ray diffraction showed that the metastable
phase was a phenol co-crystal. Although solvates are not unusual from common solvent systems, it
seems that the interplay of molecules forming a VODES makes it more likely for these metastable
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phases to form, leading to a system that is susceptible to the presence of novel crystallisation dynam-
ics.
The additional cases of verapamil hydrochloride, 2-methoxybenzamide and estradiol highlighted
that there are many cases that the use of VODESs show little difference to conventional solvent
crystallisation. However, these counter cases are useful when trying to establish an understanding
of molecules that will form VODESs and be of interest crystallographically. The following chapter
presents a method of evaluating VODESs in terms of their thermodynamic stability and internal
crystallographic structure during thermal cycling. This is the first time these two properties have
been assessed concomitantly in DESs, allowing an ability to highlight the complex interplay between










METASTABLE CRYSTALLINE PHASE FORMATION IN DEEP EUTECTIC SYSTEMS
The results of this chapter were published in part in the paper: Metastable crystalline phase formation
in deep eutectic systems revealed by simultaneous synchrotron XRD and DSC.158 I would like to thank
Dr Asma Buanz for running all synchrotron experiments presented. Rietveld analysis was carried out
by Dr Jason Potticary. Unless stated, the results presented in this chapter were analysed by myself.
4.1 Differential Scanning Calorimetry
D
ifferential scanning calorimetry (DSC) is a well established technique for evaluating ther-
modynamic and kinetic properties of a variety of systems. The basic setup of a differential
scanning calorimeter is shown in Figure 4.1. It consists of a cell that can house two pans (7
mm diameter), which sit on separate area thermocouples. The cell is purged with an inert gas (often
N2), and the temperature is carefully controlled. One of the pans contains the sample of interest and
the other is an empty reference pan. The area thermocouples below the pans allow the difference
in heat flow between them to be calculated, while the temperature of the cell is measured using a
separate thermocouple. Any difference in heat flow between the sample and reference pans is directly
related to exothermic and endothermic changes in the sample of interest, following the relationship





+ f (t ,T ). (4.1)
DSC experiments are generally run at constant pressure, meaning that integration of the total heat
flow as a function of time yields the change in enthalpy of the sample. The mass of the reference and
sample pans are weighed to allow a normalised enthalpy to be calculated.
With modern advances in DSC technology, the furnace can be heated at ramp rates < 1 °C per
minute and > 100 °C per minute. As an experiment is being run, a thermogram is produced like
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Figure 4.1: Schematic of the experimental setup of a differential scanning calorimeter. A
reference and sample pan sit on separate area thermocouples which allows a measure-
ment of the heat flow difference between them. The sample pan contains the sample
of interest, whereas the reference pan is empty. Both pans sit inside a furnace, where a
separate thermocouple measures the temperature. The cell is filled via the gas purge
inlet with an inert gas.
those seen in Figure 4.2. An offset between the total heat flow on heating and cooling is caused
by the heat capacity of the sample, making the output appear cyclic. The use of DSC to assess the
thermal stability of molecular compounds has become an invaluable tool when studying organic
molecules,159 particularly in the pharmaceutical industry.160
Figure 4.2a shows the thermogram of a solid being heated above its melting point and then cooled
past the point of re-crystallisation. Upon heating (red line), a trough is seen in the thermogram,
representing an endothermal event due to the melting of the solid. Integration of this trough with
respect to time gives the enthalpy of fusion of the solid. The onset of the endothermic transition gives
the melting point of a pure solid; however, impurities often cause the beginning of the transition
to be smeared out over a few degrees. In these cases, an extrapolated onset is calculated using the
baseline and a tangent to the inflexion point of the trough (Figure 4.2b). Glass transitions can also
be seen via DSC, which appear as a change in the baseline due to a difference in heat capacity
between the liquid and glassy states (Figure 4.2c). On heating, glass transitions may occur with an
enthalpy relaxation caused by a local redistribution of molecules below the glass transition. These
enthalpy relaxations cause a trough in the thermogram, similar to a melting transition. Polymorphic
or structural transitions can also be observed during DSC cycles, which can appear in several different
ways. Figure 4.2d shows three possible cases of polymorphic transitions: (i) an endothermic solid-
solid transition, (ii) a rapid melt-mediated transition and (iii) and slow melt-mediated transition.
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Figure 4.2: Example thermograms from differential scanning calorimetry experiments.
a) A Crystalline material that melts on heating (red line) and crystallises on cooling (blue
line). b) Inset of a) showing how extrapolated onset temperatures are determined. c) A
liquid system passing through a glass transition on cooling (blue) and a glass transition
with an enthalpy relaxation on heating (red). d) Solid crystalline samples going through a
solid-solid transformation on heating and subsequently melting. (i) Endothermic solid-
solid transition. (ii) Overlapping melt-mediated phase transformation endothermic and
exothermic transitions. (iii) Melt-mediated phase transition.
4.2 The Phase Behaviour of Deep Eutectic Solvents
As phase changes can be easily analysed by utilising DSC, it is a particularly useful tool when evaluat-
ing the phase behaviour of DESs. In general, the phase behaviour of eutectic systems is presented
on a phase diagram, highlighting the particular state of a system based on the temperature and
molar fraction of each species. Figure 4.3 shows a simplified phase diagram for two molecules, A and
B, with melting temperatures Tm,a and Tm,b , respectively. In this scenario, it is assumed that both
components are either liquid or solid, although approximations can also be made to include partial
crystallisation of components.161 The molar fraction at which the mixture has the lowest melting
point is known as the eutectic point (Xe ).
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Figure 4.3: A theoretical phase diagram for a binary eutectic system containing species
A and B. Regions at which the liquid and solid phases are more stable are highlighted,
calculated based on the Gibbs free energy of the system.
To fully understand the phase diagrams of DESs, it is important to delve into how such a plot
would be evaluated experimentally. In each DSC experiment, only a single molar fraction can be used,
cycled in temperature to record crystallisation and melting points. As crystallisation is a stochastic
event, the melting point of the solid after crystallisation tends to be used as the boundary between
the liquid and solid regions of the phase diagram. The melting temperature used is the extrapolated
onset temperature, as this is independent of sample mass and heating rate and ignores the peak
broadening effect of impurities. This means that the experimental boundary between the liquid and
solid regions of the phase diagram is dependent on which crystalline form is produced on cooling
and requires a single melting event to occur.
Interestingly, work on the choline chloride:urea deep eutectic system highlighted that the forma-
tion of co-crystals might complicate the phase behaviour..162 In this work, a choline chloride:urea
co-crystal was observed via powder X-ray diffraction, forming at the eutectic point, whereas only pure
choline chloride and urea were seen at other molar ratios. This difference in crystalline formation
will clearly influence the shape of the eutectic curve. Moreover, given the crystalline phase behaviour
of the VODESs seen in the previous chapter, it may be expected that interesting phase behaviour can
occur in various systems and manners. To evaluate this, thermograms of the VODESs discussed in
the previous chapter were produced.
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4.3 Thermograms of Volatile Deep Eutectic Solvents
4.3.1 Preliminary Screening Using Phenol:Paracetamol Volatile Deep Eutectic Solvents
The first step in carrying out thermodynamic analyses of deep eutectic systems using DSC was to
determine the ideal conditions for carrying out each experiment. As the DSC experiments aimed to
compare the thermodynamics of each system, it was decided that the same experimental parameters
should be used for each experiment unless a particular exception was identified.
The main parameters to consider were the temperature ramp rate, sample mass, type of pan
and temperature bounds. In DSC, the ramp rate of a sample (usually measured in °C.min−1) is
important for both the resolution and signal magnitude. A higher ramp rate will cause a decrease in
resolution due to the sampling rate of the DSC; however, the heat flow at any one time will increase
with increasing ramp rate. Thus, the choice of ramp rate is a compromise between these two effects.
Samples exhibiting very weak signals may need to be run at faster heating rates to increase the heat
flow to a detectable level. Furthermore, the faster the ramp rate, the less time the sample has to
reach thermodynamic equilibrium, leading to a number of kinetic effects. This kinetic effect can
have implications for the formation of different crystalline phases and has been heavily studied
for the characterisation of polymorphs,163–166 formation of new crystalline forms167 and accessing
of amorphous phases.168 The sample mass is a similar compromise to the ramp rate. Using more
sample increases the heat flow during the DSC experiment. However, transitions will be less distinct,
as the sample will not be completely homogeneous across the pan (grain size, thermal contact, etc.).
The phenol:paracetamol mixture was chosen as a model system to determine the correct parame-
ters for the thermal cycling of VODESs. As the samples contained a volatile component, the sample
pans were chosen to be sealed hermetically to reduce evaporative loss. Only samples that were
liquid at room temperature were evaluated, which were pipetted into aluminium pans and weighed
to a precision of 0.1 mg. Between 10 mg and 20 mg of sample was used to ensure a practicable
signal-to-noise ratio without rupturing the pan due to evaporation of the volatile component at high
temperatures. Upper a lower temperature bounds were chosen to be 70 °C and -70 °C. The upper
limit was to ensure that all sample was liquid and the lower was based on the limit of the calorimeter.
Heating rates between 1 °C.min−1 and 20 °C.min−1 were evaluated to determine an ideal value.
Thermograms of three of the phenol:paracetamol VODES are shown in Figure 4.4. Each sample
showed both an endothermic and exothermic event, along with a glass transition at low temperatures.
The glass transition is most easily observed in the 4.5:1 phenol:paracetamol system. As a glass
transition is seen for all ratios, it is likely that a partial crystallisation of the system is occurring
(exothermic event), followed by a glassy transition of the remaining mixture (glass transition) and the
subsequent melting of the crystalline mixture on re-heating (endotherm).
Two trends can be seen in the thermograms shown in Figure 4.4. Firstly, as the heating rate of the
sample is increased, the point at which the exothermic event occurs appears later in time. As crys-
tallisation is a stochastic event, this trend is expected. In some cases, the crystallisation is suppressed
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long enough that it does not happen until the sample is heated back up again, which is known
as cold-crystallisation. In these cases, the whole system goes through (and back out of) the glassy
phase before the exothermic event. Cold-crystallisation can become an issue if the endothermic and
exothermic events overlap, making the determination of transition onsets difficult due to distortion
of peaks. The second trend that can be seen is that the onset set of the endothermic event moves
to lower temperatures as the molar ratio of phenol is reduced. Together, the two trends mean that
the heating rate is most important when considering samples with lower phenol molar fractions. It
is clear that in the 4.5:1 phenol:paracetamol system, the exothermic and endothermic events are
overlapping.
Figure 4.4: Thermograms of the phenol:paracetamol VODESs cycled between -70 °C and
70 °C. In the thermograms shown, the samples were initially cooled and subsequently
heated at a constant ramp rate. Ramp rates between 1 °C.min−1 and 20 °C.min−1 are
shown.
To evaluate the effect of the differing ramp rates on the phenol:paracetamol mixtures, the enthalpy
of fusion and onset temperature of the endothermic events were determined for each sample. This
event was far less dependent on the heating rate than the exothermic event, as would be expected
for a melting transition. It should be noted that the endothermic transition is very broad, which
is an observation often attributed to eutectic impurities.169,170 Figure 4.5 shows a summary of the
enthalpies and melting point onsets as a function of the molar fraction of paracetamol. For molar
fractions below 0.16, the calculated enthalpy of fusions have a similar difference between their
maximum and minimum values (5 J.g−1). In all cases, the value of the enthalpy increases as the ramp
rate is reduced. This is likely due to the heat capacity contribution, which will overlap more with the
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transition at higher ramp rates. Above molar fractions of 0.16 there is a larger difference between the
enthalpy values, which is caused by the overlap of crystallisation and melting transitions. The onset
temperatures for ramp rates between 1 °C.min−1 and 10 °C.min−1 are all much closer together than
at 20 °C.min−1. This is likely due to the change in the shape of the melting transition peak, which is
critical when calculating onset temperatures via linear extrapolation.
Due to the features seen in thermograms of the phenol:paracetamol systems, a compromise
was made between the quality of the data and the time and resources necessary to carry out the
experiments. As the main focus of the experiments was to acquire accurate melting point onsets, a
ramp rate of 10 °C.min−1 was used to screen thermograms of VODES.
Figure 4.5: Graphs of the enthalpy of fusion and melting onset temperature of phe-
nol:paracetamol VODESs. The enthalpy was calculated using a linear baseline and the
melting onset using a linear extrapolation.
4.3.2 Screening of Volatile Deep Eutectic Solvent Thermograms
Due to the difficulties of accurately measuring out VODESs in the small quantities needed for DSC,
an alternate method to standard weighing and mixing was used to produce samples of specific
ratios. Initially, phenol and the chosen non-volatile component were dissolved in ethanol at a known
concentration. The solutions were then mixed at the correct ratio, and the ethanol evaporated off
in a 60 °C oven. As it has already been seen that phenol evaporated very slowly in a vial under such
conditions, it was assumed that the ethanol would evaporate off far more quickly, leaving samples
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of the correct ratio. In hindsight, this method caused more issues because it introduced a third
component into the system (either ethanol or water). The consequences and resolution of this
observation will be presented later in the chapter. The following sections highlight the thermograms
for the VODESs systems discussed in chapter 3.
4.3.3 Paracetamol
Thermograms for the cooling and subsequent heating of phenol:paracetamol VODESs of molar ratio
4:1 to 10:1 are shown in Figure 4.6. For samples of molar ratio 6:1 - 10:1, only two transitions can
be seen. These transitions appear to be a cold-crystallisation (exothermic event) followed by the
subsequent melt of this crystalline material (endothermic event). In the 5:1 sample, the crystallisation
appears to be suppressed by such a large amount that only a small exothermic event is seen, likely
due to the overlap of a small crystallisation and subsequent melt. No enthalpic transition is seen in
the 4:1 system, highlighting a complete suppression of any crystallisation event. In the 4:1 and 5:1
systems, a glass transition is seen, with a small entropy relaxation on heating.
These thermograms show stark differences to those seen in the preliminary screening. The
melting onsets are at a lower temperature, and the crystallisation exotherms appear at a later time.
This may be because of a small amount of water or ethanol in the system due to the difference
in sample preparation, which has previously been shown to cause large differences in the choline
chloride:urea DES phase behaviour.171
Figure 4.6: Thermograms for the cooling and subsequent heating of phenol:paracetamol
VODES from 70 °C to -70 °C. Samples of molar ratios 4:1 (green) to 10:1 (blue) are shown,
from top to bottom. The start of the DSC cycle is highlighted with a grey circle, the point
between cooling and heating by a blue circle and the end of the cycle by a red circle. The
black arrow shows the direction of the temperature ramp.
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4.3.4 Benzamide
Thermograms for the cooling and subsequent heating of phenol:benzamide VODESs of molar ratio 3:1
to 10:1 are shown in Figure 4.7. The thermogram of the 10:1 mixture clearly shows three exothermic
transitions on cooling and three endothermic transitions on heating. These transitions suggest
that either three different crystalline structures form or multiple solid-state transformations occur
between different phases. As the number of exotherms matches the number of endotherms seen
on heating, this is likely showing three different crystalline phases. The 9:1 and 8:1 samples appear
to have similar thermograms, with the highest melting peak shifting to lower temperatures as the
amount of phenol is reduced. This peak also appears to reduce in size (melting enthalpy), suggesting
that less of this phase is crystallising. For the 7:1, 6:1 and 5:1 samples, suppression of the final
crystallisation exotherm results in a cold-crystallisation, distorting the melting endotherms. The
final melting endotherm seems to have shifted to occur at the same temperature as the second
exotherm, meaning it is difficult to distinguish the number of transitions. Only one exothermic and
one endothermic transition is seen in the thermogram of the 4:1 sample, and no transitions are seen
for the 3:1 sample.
Figure 4.7: Thermograms for the cooling and subsequent heating of phenol:benzamide
VODES from 70 °C to -70 °C. Samples of molar ratios 3:1 (green) to 10:1 (blue) are shown,
from top to bottom. The start of the DSC cycle is highlighted via a grey circle, the point
between cooling and heating by a blue circle and the end of the cycle by a red circle. The
black arrow shows the direction of the temperature ramp.
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4.3.5 2-Ethoxybenzamide
Thermograms for the cooling and subsequent heating of phenol:2-ethoxybenzamide VODESs of
molar ratio 3:1 to 10:1 are shown in Figure 4.8. Thermograms of 10:1 and 9:1 mixtures show no transi-
tions on cooling and a likely cold-crystallisation (exothermic transition) and melting (endothermic
transition) on heating. The 8:1, 7:1 and 6:1 samples all show two melting endotherms on heating,
suggesting that two crystallographic structures are forming. The crystallisation of these structures is
suppressed as the amount of phenol is reduced, and in the 5:1 system, a single cold-crystallisation
and melting endotherm seem to overlap. No transitions are seen in the thermogram of the 4:1 sam-
ple. The 3:1 sample exhibits two cold-crystallisation events on heating, followed by two melting
endotherms.
Figure 4.8: Thermograms for the cooling and subsequent heating of phenol:2-
ethoxybenzamide VODES from 70 °C to -70 °C. Samples of molar ratios 3:1 (green)
to 10:1 (blue) are shown, from top to bottom. The start of the DSC cycle is highlighted
via a grey circle, the point between cooling and heating by a blue circle and the end of
the cycle by a red circle. The black arrow shows the direction of the temperature ramp.
4.3.6 2-Methoxybenzamide
Thermograms for the cooling and subsequent heating of phenol:2-methoxybenzamide VODESs of
molar ratio 3:1 to 10:1 are shown in Figure 4.9. The thermograms of samples of molar ratios 5:1 to 10:1
show a single melting endotherm on heating. It appears that the crystallisation is suppressed least in
the 8:1 and 7:1 samples, which also have the highest melting onset temperatures. This is unusual, as
the viscosity of the system is normally seen to decrease as more phenol is added. The 6:1 sample has
an exothermic event on cooling and heating, but it is likely that the exothermic event on heating is
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the completion of the initial crystallisation. The exothermic and endothermic events overlap in the
5:1 sample. The 4:1 and 3:1 samples show no visible transitions.
Figure 4.9: Thermograms for the cooling and subsequent heating of phenol:2-
methoxybenzamide VODES from 70 °C to -70 °C. Samples of molar ratios 3:1 (green) to
10:1 (blue) are shown, from top to bottom. The start of the DSC cycle is highlighted via a
grey circle, the point between cooling and heating by a blue circle and the end of the
cycle by a red circle. The black arrow shows the direction of the temperature ramp.
4.3.7 Metacetamol
Thermograms for the cooling and subsequent heating of phenol:metacetamol VODESs of molar ratio
3:1 to 10:1 are shown in Figure 4.10. The thermogram for the 10:1 sample shows a single exothermic
event on cooling and an endothermic even on heating, likely relating to the crystallisation and
melt of a single crystalline phase. A similar exothermic event is seen in the thermogram of the 9:1
sample. However, two obvious endothermic events are seen on heating of the 9:1 sample, with a small
third endothermic event. In the 8:1 system, similar endothermic transitions are seen, along with
two exothermic crystallisation events on cooling and a cold-crystallisation event on heating. This
highlights the possibility of three crystalline phases in the 9:1 and 8:1 systems. In the thermograms of
the 7:1, 6:1 and 5:1 samples, a single cold-crystallisation event is seen, followed by a single melting
endotherm. As the amount of phenol is reduced in these samples, the crystallisation becomes
more suppressed, with the endothermic and exothermic events overlapping in the 5:1 sample.
Thermograms of 4:1 and 3:1 samples show no observable transitions, other than a glass transition at
-50 °C, which exhibit an enthalpy relaxation on heating.
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Figure 4.10: Thermograms for the cooling and subsequent heating of phe-
nol:metacetamol VODES from 70 °C to -70 °C. Samples of molar ratios 3:1 (green) to 10:1
(blue) are shown, from top to bottom. The start of the DSC cycle is highlighted via a grey
circle, the point between cooling and heating by a blue circle and the end of the cycle by
a red circle. The black arrow shows the direction of the temperature ramp.
4.4 Metastable Phases in Volatile Deep Eutectic Solvents
It is clear from the thermograms presented in the previous section that there is a range of transitions
that can occur during the thermal cycling of deep eutectic systems. The theoretical eutectic curve
shown in Figure 4.3 depends on comparing the Gibbs free energy of the solid and liquid forms of the
constituents of the system. In reality, however, DSC thermograms show that it is not the case that the
pure components always crystallise out separately. As previously stated, the choline chloride:urea
system was shown to form a co-crystal at the eutectic point. Moreover, many of the thermograms
seen in the previous section showed multiple endotherms, exotherms and glass transitions. It is
important to understand the crystalline landscape of deep eutectic systems, as such understanding
may lead to more accurate predictions of possible molecular combinations and explanations of the
structural phenomena seen via crystallisation from VODESs.
Due to the complex thermograms observed, it was hypothesised that a hierarchy of crystal
structures can form as VODESs are cooled. A schematic of such a process is shown in Figure 4.11,
highlighting how the formation of different co-crystals could lead to the observation of multiple
crystalline forms.
Although DSC is very sensitive to phase transitions, accurate determination of the nature of
specific transitions can require supplementary experiments. Much work has gone into the analysis
of peak shapes for different DSC transitions,173 however it can be easy to misinterpret structural
changes that exhibit similar signals. For example, glass transitions with enthalpy relaxations often
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Figure 4.11: Schematic showing how a deep eutectic system could separate into phases
as it is cooled from (a–d). In this example, (a) depicts a homogeneous liquid DES A, (b)
one coformer crystallises out, leaving a liquid eutectic B with an altered stoichiometry,
(c) co-crystal A forms, leaving a liquid C with a third stoichiometry. Finally, (d) a third
crystalline phase forms as co-crystal B, with a different stochiometry to co-crystal A,
leaving the whole system as a three-phase solid. Figure and caption from [172].
exhibit peak shapes very similar to melting endotherms. As the main interest of this project is the
crystallographic structure of the eutectic systems, the most useful supplementary data to the DSC
thermograms would be X-ray diffraction data of the sample in the DSC pan.
4.4.1 Concomitant Synchrotron X-Ray Diffraction and Differential Scanning
Calorimtery
Concomitant synchrotron X-ray diffraction and differential scanning calorimetry (CXRD-DSC) is
a technique, first used in 2016, that allows synchronous collection of X-ray diffraction and DSC
data.174 It has been successfully utilised to analyse a range of polymorphic transitions, includ-
ing the stabilisation of form III paracetamol,137 phase transitions in carbamazeipine and 10,11-
dihydrocarbamazeipine,175 analysis ofβ-estradiol hydrates,155 the discovery of form IV olanzapine,176
analysis of the phase transitions of mefenamic acid177 and evaluation of the process of formation
of a number of organic co-crystals.178 The high-intensity monochromatic radiation available from
the synchrotron source allows for high-quality powder X-ray diffraction data, meaning that accurate
identification of known phases, and potentially structural solution of unknown phases, can be carried
out using the data.
The setup for a CXRD-DSC experiment is shown in Figure 4.12. It consists of a standard heat-flux
DSC setup (Figure 4.1), with pin-holes drilled to allow X-ray radiation to pass through the sample
pan. A detector is placed in the path of the beam that has propagated through the sample, which
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records a diffraction ring pattern. Aluminium pans are used to hold the sample. These pans exhibit
diffraction at a known angle, which can be easily distinguished and disregarded, as there is often
little overlap with the organic and inorganic peaks.
Figure 4.12: Experimental setup for a CXRD-DSC experiment. X-ray radiation, generated
from a synchrotron, is passed through the sample pan and diffection patterns (b) col-
lected on a detector.
As available experiment time was limited, only a small number of samples could be initially
analysed. The samples chosen were phenol:metacetamol 8:1 molar ratio, phenol:2-ethoxybenzamide
8:1 and phenol:benzamide 9:1. These samples were chosen as they each exhibited more than one
obvious phase transition from the preliminary DSC screen.
The representation of diffraction data as a function of DSC temperature is highlighted in Fig-
ure 4.13. Each diffraction pattern was matched with a temperature from the DSC thermocouple
(Figure 4.13a), which was then mapped onto a surface plot using interpolated shading (Figure 4.13b).
The use of the colour map allowed the data to be represented in 2D (Figure 4.13c). For ease of
comparison of X-ray diffraction patterns to literature values, the 2θ axis was scaled to match data
collected using a CuKα X-ray source. The experiments were carried out using a temperature ramp of
10 °C.min−1 on heating, with diffraction data collected in 1 °C intervals. Due to time constraints, the
cooling of the samples was run with a ramp of 30 °C.min−1.
Figure 4.13: Representation of diffraction data from CXRD-DSC experiments. a) Each
diffraction pattern is mapped to a temperature from the DSC. b) A colour map based on
the diffraction intensity is applied, using shaded interpolation between patterns. c) The
colour allows the mapping of diffraction patterns with temperature to be viewed in 2D.
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4.4.2 CXRD-DSC of Phenol:Metacetamol VODES
Simultaneous X-ray diffraction and DSC data for the cooling and subsequent heating of the phe-
nol:metacetamol 8:1 molar ratio sample is shown in Figure 4.14. The sample was initially heated from
room temperature to 70 °C, followed by cooling to -70 °C and reheating to 70 °C. These parameters
were chosen to keep the data in line with the preliminary DSC screen. At the start of the experiment
the sample was in the liquid phase, meaning that only an amorphous peak can be seen, with a
maximum intensity at 19 ° 2θ. As the sample is cooled, a clear exothermic crystallisation transition
occurs at Tc = -12 °C, highlighted by both a peak in the DSC thermogram and the appearance of
diffraction peaks. This transition occurs with a large reduction of the amorphous peak, highlighting
the change from the amorphous liquid phase to a crystalline phase. This crystalline structure exists
down to -70 ° with no additional change in the DSC or diffraction data, other than a continuous shift
in diffraction peaks due to cell expansion and contraction. A small exotherm is seen on heating at Tt
= 18 °C, which overlaps with an endothermic transition. Analysis of the diffraction data shows that
the first event coincides with the appearance of a new set of diffraction peaks, before both sets of
peaks disappear during the endothermic event, with all peaks depleted by Tm = 45 °C. The point
where the new set of peaks occurs is denoted Tt, as it appears at the same time as the first phase is
melting, highlighting that a phase transformation may be taking place. It should be noted here that
Tm is stated as the point where the diffraction peaks have completely disappeared and not as the
melting onset.
Figure 4.14: Simultaneous X-ray diffraction and DSC data for the cooling and subsequent
heating of the phenol:metacetamol 8:1 molar ratio sample. The DSC and diffraction
data are shown on the sample temperature x-axis, with the black arrow highlighting the
direction of the temperature ramp. Figure adapted from [172].
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A closer examination of the phase transition at Tt is shown in Figure 4.15. By looking at the
range of 2θ between 7 ° and 17 °, it is clear that as the new phase appears, a reduction of the first
phase occurs. It should also be noted that this transition is much more clear via analysis of the X-ray
diffraction that it would have been by looking at the DSC data alone, where the small exotherm could
have been easily missed or ignored.
Figure 4.15: A detailed view of the pXRD data for metacetamol over the 2θ range 7 ° -
17 ° and temperature range 0 °C to 36 °C to show the crystallisation of the unknown
phase from an 8:1 phenol:MAP VODES. The data shown are from the heating ramp
starting at -70 °C. (left) Stacked pXRD patterns with a colour scale showing the change
in temperature. Peaks due to the ambient phase of phenol are highlighted with orange
arrows and peaks due to the unknown phase with blue arrows. (Right) Surface plot of the
pXRD data with temperature to highlight to appearance of the peaks from the new phase.
White arrows are used to indicate the appearance of each peak. Figure and caption from
[172].
Rietveld analysis highlighted that the phase appearing at Tc corresponded to the ambient struc-
ture of phenol.179 Additionally, fitting using the structures of the known forms of metacetamol180,181
was attempted on the peaks appearing at Tt, which did not fit given any reasonable constraint of
the structures. Figure 4.16 shows the fitting of X-ray diffraction patterns below and above Tt. Due to
calibration of the refinement, the 2θ range is shown based on the synchrotron wavelength. Direct
comparison of the diffraction patterns of potential components is shown in Figure 4.17, where the
peaks that could not be fit to any known structures are highlighted in red.
As the structures present during the thermal cycling of the phenol:metacetamol VODES could
not be directly identified, it is not possible to directly compare the amount of each of the samples
at any temperature. However, by integration of peaks for each of the independent structures, it is
possible to see where the amount of each phase is increasing or decreasing. Figure 4.19 highlights the
appearance of each of the phases via integration of their most prominent peak. This highlights that
the appearance of the unknown phase occurs duing the melting (or transformation) of the phenol
structure.
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Figure 4.16: Rietveld analysis for diffraction patterns from the 8:1 phenol:metacetamol
VODES. (Left) Diffraction pattern after the first crystallisation event, matched to the
ambient crystal structure of phenol. (Right) Diffraction pattern after the second crystalli-
sation event. Phenol peaks are matched, and tick marks for the crystal structures of MAP
forms I and II are shown. Green arrows show the positions of unmatched reflections.
Figure and caption from [172].
Figure 4.17: Diffraction patterns of the 8:1 phenol:metacetamol VODES. The 30 °C
pattern shows both the phenol phase and the new unknown phase. The peaks from
the new phase are highlighted in red and vertical dashed lines are shown to allow
comparison to reference patterns. The diffraction pattern at 15 °C shows only the phenol
phase. The patterns shown in blue are the only known forms of MAP. Figure and caption
from [172].
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Figure 4.18: Integration of the most prominent diffraction peak for each of the phases
present in the phenol:metacetamol 8:1 VODES. Figure adapted from [172].
4.4.3 CXRD-DSC of Phenol:2-Ethoxybenzamide VODES
Simultaneous X-ray diffraction and DSC data for the cooling and subsequent heating of the phenol:2-
ethoxybenzamide 8:1 molar ratio sample is shown in Figure 4.14. The sample was run using the
same thermal cycle as the phenol:metacetamol VODES. As the sample is cooled, an exothermic
event is seen at Tc1 = -10 °C. There are no transitions seen on further cooling down to -70 ° C, but
another exotherm is seen on heating at Tc2 = -21 °C. Following this transition, two endotherms of
comparable enthalpies occur, which overlap. Analysis of the synchrotron data shows that the exother-
mic transitions both occur with the appearance of diffraction peaks. The endothermic transitions
appear with the disappearance of the diffraction peaks, respectively, with the depletion of peak
intensity occurring at Tm1 = 18 °C and Tm2 = 38 °C. The phase that crystallises first melts at the higher
temperature, highlighting that it is the more stable phase.
Rietveld analysis highlighted that the phase appearing at Tc1 corresponded to the ambient
structure of phenol.179 Additional analysis was attempted on the second set of peaks using the
known structure of 2-ethoxybenzamide182 and the phenol solvate of 2-ethoxybenzamide discussed
in the previous chapter. Refinement of the second set of peaks did not fit either of the structures
within reasonable constraints of unit cell parameters. The Rietveld fitting is highlighted in Figure 4.20.
Comparison of the unknown phase to literature X-ray diffraction patterns is highlighted in Figure 4.21,
where low-temperature powder X-ray diffraction was carried out on the 2-ethoxybenzamide structure
to determine cell expansion/contraction with temperature. The peaks from the unknown phase are
highlighted in red.
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Figure 4.19: Simultaneous X-ray diffraction and DSC data for the cooling and subsequent
heating of the phenol:2-ethoxybenzamide 8:1 molar ratio sample. The DSC and diffrac-
tion data are shown on the sample temperature x-axis, with the black arrow highlighting
the direction of the temperature ramp. Figure adapted from [172].
Figure 4.20: Rietveld analysis for diffraction patterns of the 8:1 phenol:2-
ethoxybenzamide VODES. (Left) Diffraction pattern after the first crystallisation
event, matched to the ambient crystal structure of phenol. (Right) Diffraction pattern
after the second crystallisation event. Phenol peaks are matched and tick marks for the
crystal structures of 2-ethoxybenzamide and 2-ethoxybenzamide phenolate are shown.
Green arrows show the positions of unmatched reflections. Figure and caption from
[172].
Examination of diffraction peaks during the crystallisation of the unknown phase within the
phenol:2-ethoxybenmzaide system is shown in Figure 4.22. As the new phase appears, the amorphous
background of the samples decreases, while the diffraction peaks of the phenol remain at the same
intensity. This highlights that the new phase crystallises from the amorphous material left in the
system and is therefore not a transformation of the crystalline phenol. Integration of diffraction peaks
(Figure 4.23) shows that the amount of phenol increases when the new phase appears, indicating the
crystallisation of residual phenol left after the formation of a co-crystal.
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Figure 4.21: Diffraction patterns of an 8:1 phenol:2-ethoxybenzamide VODES. The -10
°C pattern shows both the ambient phenol phase and the new unknown phase. The
peaks from the unknown phase are shown in red, and vertical dashed lines are shown
for comparison with reference patterns. A peak that overlaps with one from the phenol
structure is shown in orange. The -30 °C pattern shows the ambient phenol phase formed
on cooling. Reference patterns for the known polymorph of 2-ethoxybenzamide are
shown in blue. Patterns for this polymorph are shown at both 30 °C and -260 °C to
illustrate how the peaks may shift with temperature. Figure and caption from [172].
Figure 4.22: A detailed view of the diffraction data for the phenol:2-ethoxybenzamide
VODES over the 2θ range 7 ° - 17 ° and temperature range - 30 °C to -5 °C to show the
crystallisation of the unknown phase from an 8:1 phenol:2-ethoxybenzamide VODES.
The data shown are from the heating ramp starting at -70 °C. (left) Stacked diffraction
patterns with a colour scale showing the change in temperature. Peaks due to the
ambient phase of phenol are highlighted with orange arrows and peaks due to the
unknown phase, with blue arrows. (Right) Surface plot of the diffraction data with
temperature to highlight to appearance of the peaks from the unknown phase. White
arrows are used to indicate the appearance of each peak. Figure adapted from [172].
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Figure 4.23: Integration of the most prominent diffraction peak for each of the phases
present in the phenol:2-ethoxybenzamide 8:1 VODES. Figure adapted from [172].
4.4.4 CXRD-DSC of Phenol:Benzamide VODES
Simultaneous X-ray diffraction and DSC data for the cooling and subsequent heating of the phe-
nol:benzamide 9:1 molar ratio sample is shown in Figure 4.24. On cooling from 70 °C two clear
exothermic transitions can be seen at Tc1 = -8 °C and Tc2 = -24 °C, which persist down to -70 °C.
On heating, there are no transitions until two overlapping endothermic events starting at 10 °C.
Evaluation of the X-ray diffraction shows that the initial endothermic events both coincide with
the appearance of independent sets of peaks. Furthermore, the endothermic events coincide with
the disappearance of diffraction peaks (Tm1 = 29 °C and Tm2 = 44 °C), with the first phase to appear
melting at the higher temperature.
Rietveld analysis highlighted that the phase appearing at Tc1 corresponded to the ambient
structure of phenol.179 Similarly to the previous samples, analysis of the peaks forming at Tc2 did
not fit to any of the known forms of benzamide145,183 to within any reasonable restraint of unit cell
parameters. Rietveld analysis fitting is shown in Figure 4.25. A direct comparison of the phases seen
from the VODES system and benzamide form I and III is shown in Figure 4.26.
As with the phenol:2-ethoxybenzamide system, the appearance of an unknown phase at Tc2
coincides with a reduction of the amorphous background. The crystallisation of the new phase does
not seem to affect the amount of phenol in the system, highlighting that the formation of this new
structure is due to the crystallisation of the amorphous phase (Figure 4.27).
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Figure 4.24: Simultaneous X-ray diffraction and DSC data for the cooling and subsequent
heating of the phenol:benzamide 9:1 molar ratio sample. The DSC and diffraction data
are shown on the sample temperature x-axis, with the black arrow highlighting the
direction of the temperature ramp. Figure adapted from [172].
Figure 4.25: Rietveld analysis for diffraction patterns from a 9:1 phenol:benzamide
VODES. (Left) Diffraction pattern after the first crystallisation event, matched to the
ambient crystal structure of phenol. (Right) Diffraction pattern after the second crys-
tallisation event. Phenol peaks are matched and tick marks for the crystal structures of
benzamide forms I and III are shown. Green arrows show the positions of unmatched
reflections. Figure and caption from [172]
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Figure 4.26: Diffraction patterns of a 9:1 phenol:benzamide VODES. The -30 °C pattern
shows both the ambient phenol phase and the new unknown phase. The peaks from
the unknown phase are shown in red and vertical dashed lines are shown to allow
comparison with reference pattern. A peak that overlaps with one from the phenol
structure is shown in orange. The -20 °C pattern shows the ambient phenol phase
formed on cooling. Reference patterns of the common benzamide form I and III are
shown in blue. Figure and caption from [172]
Figure 4.27: Integration of the most prominent diffraction peak for each of the phases
present in the phenol:benzamide 9:1 VODES. Figure adapted from [172].
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4.4.5 Evaluation of CXRD-DSC Results
CXRD-DSC of each of the VODES samples highlighted the formation of an unknown crystalline phase.
In all three samples, the new phase appeared after the crystallisation of the ambient crystal structure
of phenol and melted either before or at the same time as the crystalline phenol. This highlights that
the new phases are metastable with respect to crystalline phenol, and are likely the formation of
co-crystals from the remaining amorphous content in the system after the first crystallisation event.
The first point of discussion is that the DSC thermograms seen in the CXRD-DSC experiments
are not exactly as expected from the initial DSC screening. Of particular note is that the appearance
of three phases was expected for the metacetamol and benzamide systems, however, only two phases
were seen in CXRD-DSC. Furthermore, the temperature of the transitions appears to be shifted
to slightly higher values. As previously eluded to, the most likely cause for these differences is the
presence of ethanol or water in the samples run during the preliminary DSC screening. Additional
DSC thermograms were produced for samples to assess these differences further, prepared in the
same manner as the samples run at the synchrotron. Thermograms taken out of the synchrotron
were run using a TA Instruments DSC25, while the synchrotron experiments we run using a TA
Instruments Q20 DSC.
A comparison of DSC thermograms for the phenol:metacetamol 8:1 VODES is shown in Fig-
ure 4.28. It is clear to see that the thermograms of samples produced via straight mixing of compo-
nents are more alike than the sample produced from the evaporation of ethanol. An additional two
endotherms in the sample produced by ethanol evaporation are highlighted, which are likely caused
by the incorporation of ethanol molecules allowing more crystalline phases to form. The appearance
of the first endotherm is also at a lower temperature for both the DSC25 thermograms, and the
baselines are much flatter. Improvements in the baseline and resolution are expected with the DSC25,
due to the improved specification of the model. There does appear to be a shift in temperature of 5
°C - 10 °C, but this is probably caused by modifications made to the Q20 DSC in preparing it for use
with synchrotron radiation.
Comparison of DSC thermograms produced for the phenol:2-ethoxybenzamide 8:1 VODES is
shown in Figure 4.29. Similarly to the metacetamol system, the thermograms of samples produced via
mixing appear more comparable than those produced from the evaporation of ethanol. In this case,
no additional endothermic events are seen; however, the exothermic events are more prominent in
the mixed samples, and the endothermic events appear at more comparable temperatures.
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Figure 4.28: DSC thermograms for the phenol:metacetamol 8:1 VODES using different
sample preparations and differential scanning calorimeters. Red arrows highlight the
position of the peak of endothermic transitions. Black arrows highlight the direction of
heating.
Figure 4.29: DSC thermograms for the phenol:2-ethoxybenzamide 8:1 VODES using
different sample preparations and calorimeters. Red arrows highlight the position of the
peak of endothermic transitions. Black arrows highlight the direction of heating.
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Comparison of DSC thermograms produced for the phenol:benzamide 9:1 VODES is shown in
Figure 4.30. The three endothermic events seen in the preliminary DSC screening were reduced to
two endothermic events when the samples were prepared via solid-state mixing. It is again clear that
the thermograms of samples produced from solid-state mixing are far more comparable, with only a
slight shift in the temperature of thermodynamic transitions.
Figure 4.30: DSC thermograms for the phenol:benzamide 9:1 VODES using different
sample preparations and calorimeters. Red arrows highlight the position of the peak of
endothermic transitions. Black arrows highlight the direction of heating.
These comparisons highlight the importance of sample composition when evaluating the struc-
tural landscape of deep eutectic systems. Although the inclusion of an additional component was
not intended during sample preparation, this exercise highlights the large array of potential complex
multi-component systems that can exist. As hydrogen bonding is imperative to the formation of
the phases of the eutectic mixtures, it is clear that many possible competing metastable phases can
form on the cooling of samples. Indeed it seems likely that the energetic competition between these
metastable phases is the driving force of the melting point suppression seen in eutectic mixtures.
It was highlighted during the analysis of the CXRD-DSC data that the crystallisation of new
phases often occurred with the depletion of a proportion of an amorphous peak. This is expected,
as the amorphous material is the eutectic liquid, crystallising sequentially as the sample is cooled.
Analysis of this amorphous component, although difficult due to the number of peaks present in
the diffraction patterns, highlights that even after the crystallisation of multiple phases some liquid
component remains (Figure 4.31).
To evaluate any remaining amorphous material in the VODESs after partial crystallisation, addi-
tional DSC cycles were run using the DSC25, with samples prepared via the mixing of constituents.
Figure 4.32 shows a DSC thermogram for the 8:1 phenol:metacetamol VODES, where the sample
is held at the crystallisation temperature of the second phase and subsequently cooled back down
to -70 °C. This altered temperature cycle allows for the deconvolution of phase transitions, as the
initial crystallisation exotherm overlapped with the melting endotherm of the system. As multiple
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Figure 4.31: Amorphous backgrounds seen during different parts of the thermody-
namic cycles for phenol:metacetamol 8:1, phenol 2-ethoxybenzamide 8:1 and phe-
nol:benzamide 9:1 VODES. Figure from [172].
temperature cycles were run, the thermogram is shown with respect to time, with the temperature
highlighted using a colour gradient. The crystallisation of the unknown phase took place with a small
exothermic transition during the isothermal hold (blue arrow). On reheating after the isothermal hold,
a small endothermic transition is seen (Figure 4.32 inset) at approximately the same temperature
the crystallisation originally occurred. Integration of this transition highlights that the enthalpy is
not large enough to be a melting transition (29.0 J.g−1 exothermic transition vs. 0.5 J.g−1 endother-
mic transition), so this is likely the thermal relaxation of a glassy phase. The enthalpy of the final
endothermic event is larger than that of the first exothermic crystallisation event (55.3 J.g−1 vs. 96.1
J.g−1), meaning that both of the phases must be melting during the final event. This additional cycle
did not reveal any more crystalline phases; however, it may suggest that the amorphous content left
in the system remains glassy up to 0 °C.
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Figure 4.32: DSC thermogram of the phenol:metacetamol 8:1 VODES. The thermograms
are shown with respect to time so that multiple heating ramps can be represented. (Top)
Thermogram for a single cycle between -70 °C and 70 °C. (Bottom) Thermogram for a
cycle including a isotherm at Tc2. A blue arrow highlights the position of a small exother-
mic event during the isotherm. The inset shows a detailed section of the thermogram to
highlight a small endothermic event. The colour of the line represents the temperature
at every point in time during the thermal cycle.
A similar experiment was run for the phenol:2-ethoxybenzamide 8:1 VODES, which is shown in
Figure 4.33. When introducing a thermal cycle after the crystallisation of the unknown phase, another
small exotherm is seen on cooling (blue arrow). Furthermore, on subsequent heating, an additional
endothermic event is seen (red arrow). These events integrate to approximately the same enthalpy
(1.5 J.g−1 exothermic transition vs. 2 J.g−1 endothermic transition), highlighting that the transitions
likely represent the crystallisation and melting of a third phase. In this vein, the thermogram including
the isothermal hold in Figure 4.33 could represent a very similar structural landscape to that proposed
in Figure 4.11.
Finally, the phenol:benzamide 9:1 VODES was rerun using the DSC25 to highlight any transitions
not seen due to the baseline in the thermograms produced by the CXRD-DSC. Figure 4.34 shows that
multiple glass transitions can be seen during the heating of the sample (green arrows). This highlights
the complex structural behaviour within the VODES mixtures, even if these particular glassy phases
do not form a crystalline product at these temperatures. These multiple glassy phases show similar
behaviour to those seen in the 9:1 and 10:1 phenol:verapamil mixtures highlighted in the previous
chapter.
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Figure 4.33: DSC thermogram of the phenol:2-ethoxybenzamide 8:1 VODES. The thermo-
grams are shown with respect to time so that multiple heating ramps can be represented.
(Top) Thermogram for a single cycle between -70 °C and 70 °C. (Bottom) Thermogram
for a cycle including a isotherm at Tc2. The colour of the line represents the temperature
at every point in time during the thermal cycle.
Figure 4.34: DSC thermogram for the heating of the phenol:benzamide 9:1 VODES.
Green arrows highlight the position of glass transitions.
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4.5 Summary
The use of DSC has allowed precise thermodynamic and structural analysis of three VODES systems.
In this chapter, it has been highlighted that without concomitant structural analysis, it is almost
impossible to fully understand the phase behaviour of these complex binary systems. The CXRD-DSC
experiments ran undoubtedly showed that VODESs are inherently susceptible to metastable phase
formation, giving support to the hypothesis presented in the previous chapter that intermediary
phases are responsible for crystallographic control when using the VODES medium. This work
highlights the need to understand a hierarchy of structures that can form during the cooling of a
deep eutectic system and adds a level of complexity to the theoretical background of predicting the
formation of DESs. With this structural understanding in place, future work can look into producing
phase diagrams of VODES (appendix E), with the aim of understanding the melting point depression
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5.1 Colour and Polymorphism
T
he structural determination of a material is imperative in understanding the properties that it
exhibits. However, direct ascertainment of the particular polymorph of a crystalline material
often requires bespoke analysis, such as X-ray diffraction or calorimetric experiments. Even
if an exact set of conditions is known to produce a particular polymorph, the phenomenon of
‘disappearing polymorphs’3 means it is best practice to check the structure of each batch of a material
that is produced.
One of the main human observations that can be made to distinguish between polymorphs is
that of colour. Although many common pharmaceutical crystals exist as white powders, there are
a number of organic molecules that absorb light in the visible spectrum, and therefore exhibit a
non-white appearance. The instantaneous observation of colour is likely why the molecule ROY (5-
methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile) is often used as an archetypal exhibitor
85
CHAPTER 5. COLOUR IN DIMETHYLAMINO, NITRO SUBSTITUTED CHALCONES
of polymorphism, and the range of possible colours is probably why so many different polymorphs
of it have been found.19,185
The different colours exhibited by organic crystals are due to the distribution of vibrational and
electronic energy levels of their constituent molecules. Given that energy levels exist with the correct
energy difference, incident electromagnetic radiation can excite a molecule into a state of elevated
energy, which is dissipated either thermally (into vibrational states) or via luminescence. To humans,
the absorbance of light of a material makes it appear as a complementary colour; for example, a
material absorbing in the blue region of the visible spectrum will appear red-orange.
The energy levels of a molecule are often estimated using molecular orbital theory, which de-
scribes how the atomic orbitals of constituent atoms of a molecule interact. When considering
organic molecules, the molecular orbitals of interest most commonly consist of contributions from
σ-bonds (bonding s-orbitals), π-bonds (bonding p-orbitals) and lone pairs. Figure 5.1 highlights a
number of the molecular orbitals of formaldehyde. The difference in energy between the highest
occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) is the small-
est amount of energy (lowest wavelength radiation) that the molecule can absorb. The most tightly
bound electrons sit in σ-orbitals, which are very stable and thus difficult to excite. The delocalisation
of π-orbitals means the electrons are more ‘free’ and therefore take less energy to promote into
unoccupied energy levels. Finally, lone pairs are the least stable orbitals, as they are not stabilised by
any bonding interactions.
Figure 5.1: Molecular orbitals of formaldehyde increasing in energy from bottom to
top. Dashed and solid lines highlight the positive and negative regions of the orbital,
respectively. Dotted lines show the position of nodes.
The overlap of orbitals leading to σ- and π-bonds leads to the formation of a pair of bonding
orbitals, known as bonding (σ and π) and anti-bonding (σ* and π*). The orthogonal nature of
molecular orbitals means that orbitals of the same type spread out in energy. Anti-bonding orbitals
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tend to have more regions where electrons cannot exist, known as nodes, and therefore are higher in
energy than bonding orbitals. Due to their lower stability, HOMO-LUMO transitions are often either
of type π−→ π* or n −→ π*. Increasing the conjugation of molecules allows further delocalisation of
the molecular orbitals, reducing the energy of π−→π* type transitions. An example of increasing the
conjugation of molecules is shown in Figure 5.2a, highlighting the molecular orbitals of ethylene and
1,3-butadiene. In this system, the HOMO-LUMO transition is of π−→π* type, meaning the energy gap
of 1,3-butadiene is smaller due to increased conjugation. This progression of HOMO-LUMO energy
reduction with conjugation can be understood by looking at the quantum mechanical solutions to
the ‘particle in a box’ potential, which is remarkably accurate at predicting the absorption spectra of
cyanine dyes (Figure 5.2).186 The accuracy of this modal is due to the functional groups at either end
of the central conjugated chain acting like an infinite potential, where the π-electrons are forbidden




;n = 1,2,3 . . . , (5.1)
where h is the Planck constant, me is the mass of an electron, and L is the size of the box. Assuming
that the length of the conjugated chain in the cyanine dyes is L, it is clear that the energy difference
between states gets smaller as the length of the chain increases,
En+1 −En = 2n +1
8me L2
. (5.2)
Injection of electrons into conjugated systems is also known to increase the delocalisation of
electrons, leading to a smaller HOMO-LUMO transition. Hence electron-donating groups, such as
dimethylamino, are often seen to red-shift the absorption spectra of molecules.
Figure 5.2: a) Comparison of the molecular orbitals of ethlyene and 1,3-butadiene. b)
The ‘particle in a box’ wavefunctions highlighted on a cyanine dye.
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The idea that radiation of the correct wavelength will promote an electron between an occupied
molecular orbital and an unoccupied molecular orbital is a significant simplification. In reality, the
probability of electron promotion between two energy levels needs to be calculated using a transition
dipole moment integral. These integrals highlight how the probability of a transition is proportional
to both the overlap of the molecular orbital wavefunctions in space and their combined dipole




∣∣ µ̂ ∣∣ψm〉 , (5.3)
where ψ represents the molecular orbital wavefunction. This equation highlights that orbitals differ-
ing in symmetry or with cancelling dipole moments will have a near negligible chance of electronic
transition. The square of the transition dipole moment gives the probability of a particular transition.
In general, due to their symmetries, low-lying π−→π* transitions tend to have the highest transition
probabilities and n −→ π* transition probabilities are often orders of magnitudes lower. However,
divergence from this rule can be seen even in simple systems such as benzene, where two of the
three low lying π−→π* transitions have near-vanishing transition probabilities.187 The lifetime of an
excited state with respect to re-emission is dependent on the transition dipole moment, which is




where A is the first Einstein coefficient, τr is the lifetime of an excited state to radiative decay and µ
is the transition dipole moment. An observation of these trends was seen in work carried out by Rant
et al., where the length of the conjugated system in phenylene-based materials was correlated to an
increase in transition dipole moment between HOMO and LUMO states.188
The vibrational energy levels of molecules are also important when considering absorbance
spectra, as they define the fine structure between electronic energy levels. The Franck-Condon
approximation gives a method of calculating the transition probabilities between different vibrational
states, utilising the Born-Oppenheimer approximation to assume that electronic and vibrational
states can be decoupled. A result of this principle is that almost all transitions will result in the
excitation to an elevated vibrational state. Kasha’s rule tells us that the excited vibrational state
rapidly converts to the ground state after excitation (internal conversion), meaning that any radiative
emission occurs from the lowest vibrational energy level of an electronic state.189 Radiative emission
between the lowest vibrational state of an elevated electronic singlet state and the singlet ground state
is known as fluorescence. An excited state may also undergo intersystem crossing, which involves the
change of the system from a singlet to a triplet state (the flipping of an electron spin), leading to lower
energy emission. Transitions between singlet and triplet states are theoretically forbidden; however,
they occur due to a degree of spin-orbit coupling. The lifetimes of these transitions are therefore long,
giving rise to the phenomenon known as phosphorescence. Possible molecular transitions are often
highlighted on a Jablonski diagram, as shown in Figure 5.3.
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Figure 5.3: Jablonski diagram highlighting the different transitions that can occur be-
tween electronic and vibrational states.
Due to the time scales over which internal conversion occurs, fluorescence emission is highly
dependent on the transition dipole moment between the HOMO and LUMO levels. As a general
rule, highly conjugated molecules with low lying π−→ π* HOMO-LUMO transitions exhibit strong
fluorescence, and those with n −→π* HOMO-LUMO transitions exhibit little to no fluorescence. This
is due to the level of wavefunction overlap of the excited and ground states. An exception to this rule
is when lone pairs are donated into the conjugated system rather than sitting orthogonally to them.
Kasha defined two different types of orbital to distinguish between lone pairs, which are donated ‘`’,
and non-bonding electrons ‘n’.190 This difference is clearly seen in the example shown in Figure 5.4,
which highlights the difference in molecular orbitals between pyrrole and pyridine. When electrons
are donated into a conjugated system, they exhibit similar properties to the π-orbitals and, therefore,
can have a considerable overlap with the LUMO. On the other hand, non-bonding electron orbitals
have little resemblance to π-orbitals and have little to no overlap with the LUMO.
The above theory highlights the complexities that can arise in the excitation of molecules via
electromagnetic radiation. However, as systems grow, gaining more flexibility and molecular overlap,
there is a huge amount of computation that needs to be carried out the predict the possible electronic
and vibrational transitions of a material. The ideas of σ-, π-, `- and n-orbitals, that approximate the
absorption of simple molecules well, are less relevant as systems become more complex. Molecular
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Figure 5.4: Molecular orbitals in Pyrrine and Pyridine. Dashed and solid lines highlight
the positive and negative regions of the orbital, respectively.
orbitals of these systems tend to have the ‘character’ of the well-defined basic orbitals, but are
not strictly any of them. In the gas phase, the molecules are sufficiently separated that molecular
absorption spectra can be well approximated by calculations of an isolated molecule. However, in
solution, the peaks of the spectrum often shift (solvatochromism), and interactions of the molecules
with the solvent leads to spectral broadening, losing the sharp vibronic transitions seen for the
isolated molecule in the gas phase. Moreover, the excitation of an electronic state often causes the re-
distribution of molecular orbitals, meaning that the lowest energy transition may not be between the
HOMO and LUMO orbitals, as expected given Koopmans’ theorem.191 These excited-state relaxations
can be calculated using time-dependent density functional theory (TD-DFT); however, this requires
the optimisation of many states to acquire the accurate ordering and distribution of molecular
orbitals.192
When considering molecules in the solid-state, the absorption spectrum can shift due to changes
in conformation induced by packing or because of intermolecular interactions between neighbouring
molecules.193 For example, the variation in colour of ROY is attributed to the differences in the
conformation of the molecule leading to a change in π-delocalisation.194–197 Similarly, differences
in the position of the nitrogen lone pair relative to the aromatic rings were used to rationalise the
colour variations in the polymorphs of picrytoluidine.198 In contrast, in the case of rigid perylene
derivatives,199,200 which lack conformational degrees of freedom, the colour variation has been
explained purely in terms of differences of crystal packing and π-stacks, which are generally well-
defined in the crystals of such rigid molecules.
The difficulties predicting absorption spectra of molecules in the solid-state present a problem
where theory and experiment need to coincide before dependable theory-driven molecular design
can be carried out. Although many methods of calculations exist, such as TD-DFT utilising periodic
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boundary conditions, they are very costly as thus-far not available with an adequate range-separated
functional, such as ωB97x. As such, studies where molecular properties can be systematically mod-
ified are of great interest when looking for areas in which our current theoretical knowledge does
not match experimental observation. One system for this type of study is the group of molecules
known as chalcones ((2E)-1,3-diphenylprop-2-en-1-ones), a conjugated molecule that can readily
and systematically be synthesised with a range of functional groups.
5.2 Crystallisation of Chalcones
Chalcones ((2E)-1,3-diphenylprop-2-en-1-ones) are naturally occurring compounds studied widely
as a molecular scaffold in medicinal chemistry.201 Functionalised chalcones can be synthesised using
a number of synthetic routes,202 the most common of which is the Claisen–Schmidt condensation
reaction between appropriately functionalised acetophenone and benzaldehyde molecules. As a
result, chalcone molecules can be readily synthesised with functional groups present on either ring
in the para-, meta- and ortho-positions. The chalcone structure is highlighted in Figure 5.5, showing
the naming convention of the aromatic rings and the possible positions of functional groups. The
ring closest to the carbonyl oxygen is referred to as the 1-ring as, per the atom labelling convention, it
is connected to C1. By a similar logic, the other aromatic ring is referred to as the 3-ring.
As part of a systematic study of crystallographic packing, a wide range of substituted chalcones
have been synthesised. As such, a naming convention has been used to quickly determine which
chalcone is being referred to. For chalcones with no more than one functional group on each ring, a
four-character code is used. The first letter represents the functional group on the 1-ring. Following
this, a letter represents the position of this functional group (p - para, m - meta or o - ortho). The
following number then represents the functional group on the 3-ring, and finally the last letter
represents the position of this functional group.
In medicinal chemistry chalcones have been analysed for their use as antioxidants,203 anti-
inflammatories,204 and are known to show antibacterial properties.205 Furthermore, the use of
chalcones as anticancer treatments has been investigated for both necrosis of cells206 and prevention
of cell division.207 It is thought that the main active functional group of these compounds is the α,β-
unsaturated ketone,208 which conjugates the two aromatic rings, allowing electronic interactions that
directly affect molecular conformation and colour. Indeed, the name chalcone comes from the Greek
word ‘chalcos’ for bronze, highlighting how the compounds are often coloured.209 Hence, the chalcone
core is a relatively large conjugated system that is a model for the properties of pharmaceuticals
that are linked to the π-system, in the way that pentacene is seen as the model system for organic
optoelectronics.210–213
In general, the addition of functional groups to chalcones results in crystals differing only
marginally in colour from the unsubstituted chalcone. However, the introduction of an electron-
donating substituent, such as a dimethylamino group, onto either ring of the chalcone results in
evident optical changes. The absorbance of such functionalised chalcones has been thoroughly com-
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Figure 5.5: Representation of the chalcone backbone, highlighting the sections of the
molecule that come from the acetophenone and benzaldehyde when synthesised using
a Claisen-Schmidt condensation reaction. The para-, meta- and ortho-position on each
ring are highlighted, along with the numbering convention for the aromatic rings.
putationally studied using TD-DFT, highlighting how simple substitutions should cause apparent
differences between the HOMO and LUMO of chalcones.214 Of the functional groups studied, the
nitro-group in the para-position stabilised both the HOMO and LUMO by the most considerable
amount and the dimethylamino-group in the para-position destabilised these orbitals the most. The
relative shift of the HOMO and LUMO resulted in the largest bandgap for the nitro-group function-
alised chalcones and the smallest for the dimethylamino-functionalised chalcones. Although, the
lowest transition in unfunctionalised chalcone is considered to be n −→π*,215 it is clear that conjuga-
tion with the chalcone backbone causes a deviation from such a strict definition.216 Moreover, the
addition of functional groups has been shown to cause the reordering of the molecular orbitals in
many cases, leading to stark differences in luminescent properties..217
Although the majority of chalcones do not exhibit strong fluorescence, the fluorescent prop-
erties of certain chalcones have been investigated for their uses as biological imaging probes.
One of the main functional groups allowing for a low-lying π −→ π* HOMO-LUMO transition is
the dimethylamino-group, which is known to donate electrons into the aromatic chalcone sys-
tem. 4-Dimethylaminochalcone has been widely studied for detecting micelle formation,218,219 and
4’-dimethylamino-4-methylacryloylaminochalcone has been used to detect the water content of
solutions.220
This chapter reports the structural solution of two polymorphic isomers, 3’-dimethylamino-3-
nitrochalcone and 3’-dimethylamino-4-nitrochalcone, which, when recrystallised from acetone,
both exhibit concomitant polymorphism of crystals differing in colour and morphology. The fluo-
rescent and optical properties of each solid form are investigated spectroscopically, allowing direct
comparison to computational predictions of electromagnetic absorption. In an attempt to realise a
route to colour prediction without using computationally-expensive periodic boundary condition
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calculations, analysis of clusters of each of the molecules cut from their respective crystal structures
was carried out. These systematic calculations of the optical properties caused by different bonding
motifs allowed for the isolation of the most optically-relevant intermolecular interactions in each
system.
During the systematic synthesis of chalcones, the dimethylamino and nitro groups were denoted
as ‘G’ and ‘8’, respectively. Thus, 3’-dimethylamino-3-nitrochalcone will be referred to as Gm8m and
3’-dimethylamino-4-nitrochalcone as Gm8p. This system of four polymorphs exhibits colours ranging
across the optical spectrum, raising questions as to the cause of such colour polymorphism. The
molecules are highlighted in Figure 5.6, along with their electrostatic potential map. The electrostatic
potential map highlights to clear differences between the effect of each functional group, with the
nitro group taking charge away from the closest aromatic ring to it and the dimethylamino group
donating charge. The mixture of these functional groups makes these systems a key benchmark for
determining the accuracy of current predictions of optical absorption.
Figure 5.6: A representation of the two chalcone molecules discussed in this chapter,
3’-dimethylamino-3-nitrochalcone (Gm8m) and 3’-dimethylamino-4-nitrochalcone
(Gm8p). The electrostatic potential map for each molecule is highlighted on the right,
calculated using B3LYP/6311++G(2d,p) and plotted on the 0.0004 SCF density surface
for the optimised isolated molecules.
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5.3 Polymorphism in Gm8m and Gm8p
5.3.1 Synthesis
Chalcone synthesis was carried out following the procedure highlighted by Sweeting et al.221 Gm8m
and Gm8p were synthesised via a base-catalysed aldol condensation reaction between
3’-dimethylaminoacetophenone and an appropriately functionalised nitrobenzaldehyde. For Gm8m,
3 mmol solutions of 3’-dimethylaminoacetophenone and 3-nitrobenzaldehyde with 95% ethanol
were used. 0.30 mL of 50% NaOH(aq) was added to the 3’-dimethylaminoacetophenone mixture,
which was continuously stirred as the 3-nitrobenzaldehyde mixture was added. The solution was left
for 30 minutes to react and then neutralised using HCl. After quenching with ice, the product was col-
lected as a precipitate via vacuum filtration and washed with cold water. The resultant yellow-orange
powder was recrystallised using ethanol. Scheme 1 shows the synthesis of Gm8m.
Scheme 1: Synthesis of Gm8m via a base-catalysed aldol condensation reaction between
3’-dimethylaminoacetophenone and 3-nitrobenzaldehyde
For Gm8p, a reaction analogous to that of Gm8m was carried out, replacing 3-nitrobenzaldehyde
with 4-nitrobenzaldehyde. The precipitate from this reaction was a red powder, which was recrys-
tallised from ethanol. Scheme 2 shows the synthesis of Gm8p.
Scheme 2: Synthesis of Gm8p via a base-catalysed aldol condensation reaction between
3’-dimethylaminoacetophenone and 4-nitrobenzaldehyde
Figure 5.7 shows NMR for the final product of the Gm8m and Gm8p syntheses, which were used
for crystallisation experiments. Each of the integrated peaks matched predicted values to within 3%
in Gm8m and 9% in Gm8p. A small amount of impurity is seen in both samples, which are likely
unreacted starting materials from the aldol condensation reaction.
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Figure 5.7: 1H NMR spectrum of synthesised powders of Gm8m and Gm8p. Peaks are
numbered to match the hydrogen atoms attached to different carbons on the chemical
scheme. Peak integrals are shown below the trace, highlighting the experimental hydro-
gen relative intensity.
5.3.2 Polymorph Screening
To assess the polymorphic landscape of Gm8m and Gm8p, a screening process was carried out using
a range of crystallisation conditions and techniques. As only a small amount of sample was initially
available (< 1 g), conditions to produce high-quality crystals were first explored in a preliminary
screen, followed by a further exploration of parameter space close to these conditions.
5.3.2.1 Preliminary Screening
A preliminary polymorph screen was carried out by conducting crystallisation via solvent evaporation
of a range of solvents. Initially, crystallisation from acetone was carried out in a 100 mm diameter
petri dish. Using 1 mL of 10 mg.mL−1 solutions of Gm8m and Gm8p, this initial experiment was
carried out five times. In each case, apparent concomitant polymorphism was seen in both Gm8m
and Gm8p. In Gm8m, yellow needle-like crystals and orange block-like crystals were observed, and in
Gm8p, red garnet-like crystals and black block-like crystals formed. Each of the distinct crystals were
separated and subsequently analysed via powder X-ray diffraction (pXRD), which revealed structural
differences in the crystal structures. Due to the clear distinction in colour between the polymorphs
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of Gm8m and Gm8p observed, each polymorph was labelled in reference to their colour: Gm8m-Y
(Gm8m yellow), Gm8m-O (Gm8m orange), Gm8p-R (Gm8p Red) and Gm8p-B (Gm8p Black). Optical
images for as-grown crystals and powder samples of each of the polymorphs are shown in Figure 5.8.
Figure 5.8: Crystals of the polymorphs of Gm8m and Gm8p. Insets show the crystals
crushed into a powder in a small vial. a) Gm8m-Y b) Gm8m-O c) Gm8p-R d) Gm8p-B.
5.3.2.2 Structural Solution
The preliminary screen of Gm8m and Gm8p produced crystals of each observed polymorph (Gm8m-
Y, Gm8m-O, Gm8p-R and Gm8p-B) of high enough quality to be solved by single-crystal X-ray
diffraction (sc-XRD). The morphology of crystals of Gm8m-O, Gm8p-R and Gm8p-B meant that
crystals of appropriate thickness in each dimension could be easily isolated. Crystals diffracted
well and were stable down to a temperature of 100 K, where diffraction data were collected. The
propensity of Gm8m-Y to grow as needles presented difficulties in finding a crystal that diffracted
appropriately across each axis. Three separate collections of diffraction data provided the same
unit cell; however, the high-resolution reflections were not of publishable standard in each case. By
slowing the evaporation of ethanol during crystal growth, thicker crystals were grown which were of
high enough quality to produce publishable data. This data highlighted a level of disorder in Gm8m-Y
crystal structure (due to a rotation in the nitro group). Crystallographic data for the four polymorphs
of Gm8m and Gm8p is shown in Table 5.1.
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Table 5.1: Crystallographic data for the four polymorphs of Gm8m and Gm8p.
Gm8m-Y Gm8m-O Gm8p-B Gm8p-R
CCDC Identifier 1983905 1983906 1983902 1983910
Space group P21/c P-1 P21/c P21/n
Temperature / K 100 100 100 100
a / Å 12.5686(6) 8.3376(3) 7.8173(5) 8.3419(2)
b / Å 6.2878(4) 9.4304(3) 13.4524(8) 8.0686(2)
c / Å 18.1107(10) 10.0957(3) 13.7886(7) 21.6440(5)
α / ° 90 102.249(2) 90 90
β / ° 92.988(4) 102.697(2) 97.479(4) 91.1060(15)
γ / ° 90 104.847(2) 90 90
Z 4 2 4 4
Final R indexes
[I≥2σ (I)]
R1 = 0.0403, R1 = 0.0349, R1 = 0.0421, R1 = 0.0418,
wR2 = 0.0885 wR2 = 0.0923 wR2 = 0.0965 wR2 = 0.0952
5.3.2.3 Structural Motifs in Gm8m and Gm8p
The main objective of analysing the structural motifs of Gm8m and Gm8p polymorphs was to
ascertain which intermolecular interactions lead to the greatest shift in the absorption wavelength
of the molecules. The initial step was, therefore, to isolate the different possible interactions within
each structure.
Gm8m-O crystallises in the triclinic space group P1̄. Due to the complementary charges of the
1- and 3-ring of the molecule, both in-plane hydrogen bonding and stacking occur via inversion
symmetry. Interactions in the plane of the molecule are mediated by CH. . . O=C and CH. . . O2N
close contacts (Figure 5.9a). A stacking interaction, which maximises the overlap of the 1- and 3-
rings (which will be referred to as double 1,3-ring stacking), is present perpendicular to the plane
of the molecules, with further stacking mediated via 1-ring. . . 1-ring and 3-ring. . . 3-ring overlap
(Figure 5.9b).
Gm8m-Y crystallises in the monoclinic space group P21/c. Unlike the structure of Gm8m-O, there
is no double 1,3-ring stacking, and instead, a half-stacking motif forms via a translation of the b-
axis, extending into an infinite 1D stack (Figure 5.10a). Each 1D stack is related to a tilted stack via a
c-glide plane, leading to ’zigzagging’ 2D sheets at an angle of 64° to each other (Figure 5.10b). Finally,
in-plane interactions are mediated by CH. . . O=C and CH. . . O2N close contacts, which both form via
inversion centres (Figure 5.10c).
The structures of Gm8m-O and Gm8m-Y clearly have large differences in the packing motifs that
are present. Although the in-plane close contacts are very similar, the stacking interactions show
clear differences, with the Gm8m-Y structure favouring a half-stacking motif over the double 1,3-ring
stacking seen in Gm8m-O. Furthermore, the zigzag motif in Gm8m-Y leads to large deviations in the
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appearance of the final 3D structures. Due to these differences, only 3 molecules of a 15-molecule
cluster can be overlaid (RMSD3 = 0.441 Å).
Figure 5.9: Bonding motifs in Gm8m-O. a) In-plane close-contact interactions. b) Inter-
actions in the stacking direction. Molecules are coloured by symmetry operation: white
- identity, orange - inversion. Inversion centres are shown by oranges spheres. Short
contacts are highlighted with black dashed lines
Figure 5.10: Bonding motifs in Gm8m-Y. a) 1D stack mediated by the half-stacking motif.
b) 2D zigzagging sheets, highlighting molecules at a 64° angle. c) In-plane CH. . . O=C
and CH. . . O2N close contacts. Molecules are coloured by symmetry operation: white -
identity, orange - inversion, purple - c-glide, green - 21 screw axis. Inversion centres are
shown by oranges spheres, and glide planes are highlighted in purple. Short contacts are
highlighted with black dashed lines.
Gm8p-R crystallises in the monoclinic space group P21/n. Similarly to Gm8m-O, dimerisation of
molecules is present via the double 1,3-ring stacking motif; however, the para-substitution of the nitro
group means that the molecules are shifted along the short axis relative to each other, compared to
Gm8m-O. This shift allows for a greater overlap of the conjugated chain of each chalcone in the dimer,
highlighted by a greater number of short-contacts. The dimers are extended into a 1D stacking motif
via CH. . . O2N interactions (Figure 5.11a). The 1D chains of stack dimers for a 2D zigzag structure
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with adjacent tilted chains at an angle of 83° (Figure 5.11b). The 2D sheets translate along the a-axis
to form the final 3D structure (Figure 5.11c).
Figure 5.11: Bonding motifs in Gm8p-R. a) 1D stack mediated by double 1,3-ring stacking
and CH. . . O2N interactions. b) 2D zigzagging sheets, highlighting molecules at a 83°
angle. c) Translation of molecules along the a-axis. Molecules are coloured by symmetry
operation: white - identity, orange - inversion, purple - c-glide, green - 21 screw axis.
Inversion centres are shown by oranges spheres, and glide planes are highlighted in
purple. Short contacts are highlighted with black dashed lines.
Gm8p-B crystallises in the monoclinic space group P21/c. A double 1,3-ring stacking interaction
is present, similar to the Gm8p-R structure, with further offset stacking between the dimers. Although
this offset stacking involves no close contacts, the overlap of the rings is far greater than in Gm8p-R
(Figure 5.12a). Translation along the long-axis of the molecule forms 2D sheets of stacked dimers
(Figure 5.12b). Adjacent tilted dimers sit at 62° to each other, forming alternating stacks throughout
the crystal structure (Figure 5.12c).
5.3.2.4 Solvent Evaporation Screen
A screen of crystallisation conditions via solvent evaporation was carried out to determine methods
for producing quantitative yields of each polymorph of Gm8m and Gm8p. Three different crystallisa-
tion vessels were used to allow different rates of solvent evaporation and crystallisation surface. These
vessels included 10 mm (diameter) x 50 mm (height) curved-bottomed test tubes, 10 mm (diameter)
x 50 mm (height) flat-bottomed vials and 100 mm (diameter) x 10 mm (height) flat-bottomed Petri
dishes. Solutions were made up to a known solute concentration and filtered into crystallisation
vessels using 0.2 µm PTFE syringe filters. Polymorphs were identified by comparison of their pXRD
patterns to a generated pattern of each solved crystal structure. Along with the polymorph produced,
the morphology of each sample was noted, which was particularly important for Gm8p-R due to
multiple morphological observations (needles, plates and garnets). These different morphologies
appeared to depend on the evaporation rate of the solvent and the particular solvent used. It was
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Figure 5.12: Bonding motifs in Gm8p-B. a) 1D stack mediated by double 1,3-ring stacking
and NO2. . . H3C interactions. b) Translation of molecules along the long axis of the
molecule. c) Molecules tilted at 62° relative to the stacked dimers. Molecules are coloured
by symmetry operation: white - identity, orange - inversion, purple - c-glide, green - 21
screw axis. Inversion centres are shown by oranges spheres, glide planes are highlighted
in purple, and screw axes in green. Short contacts are highlighted with black dashed
lines.
also noted that samples of Gm8m grown via solvent evaporation of toluene produced an amorphous
sample within test tubes. Crystallisation results are highlighted in Table 5.2 - Table 5.4.
The solvent screen allowed for the identification of crystallisation parameters to produce poly-
morphs of Gm8m and Gm8p reproducibly. In Gm8m, most conditions appeared to favour the growth
of Gm8m-O, which seemed to frequently nucleate on the surface of the crystallisation vessels, pos-
sibly due to crystals having a higher surface area than crystals of Gm8m-Y. Gm8m-Y was favoured
when crystals were grown via solvent evaporation of alcohols in round-bottomed vessels, presumably
to minimise adherence to the surfaces.
The crystallisation of Gm8p from narrow crystallisation vessels highly favoured the formation of
Gm8p-R, which grew in several different morphologies depending on the evaporation rate and the
solvent used. In general, crystals of Gm8p-B were much larger and of higher quality than Gm8p-R,
suggesting that the surface of the Petri dish helped in the nucleation of this polymorph. A third
polymorph of Gm8p was also observed (Gm8p-O), which formed very thin low-quality crystallites.
When formed, the pXRD pattern of this third polymorph did not closely match generated patterns
from the solved structures of Gm8p-R or Gm8p-B; however, the quality of these crystals did not allow
for a structural solution via sc-XRD.
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Table 5.2: Results from evaporative crystallisation experiments for Gm8m.
Gm8m Vial Test Tube
Concentration 5 mg.mL−1 10 mg.mL−1 5 mg.mL−1 10 mg.mL−1
Methanol O/Y O/Y Y Y
Ethanol O/Y O/Y Y Y
Chloroform O/Y O/Y O/Y O/Y O/Y O/Y O/Y O/Y
Toluene O O O O Am Am Am Am
Ethyl Acetate O O O O O O/Y O O
Tetrahydrofuran O O O O O O O/Y O/Y
Acetone O O Y Y O O Y Y
Table 5.3: Results from evaporative crystallisation experiments for Gm8p.
Gm8p Test Tube Vial
Concentration 5 mg.mL−1 10 mg.mL−1 5 mg.mL−1 10 mg.mL−1
Methanol R (N) R (N) R (P) R(N)
Ethanol
Chloroform R (P) R (P) R (P) R (P) R (P) R (P) R (P) R (P)
Toluene R (N) R (N) R (N) R (N) R (N) R (N) R/B R/B
Ethyl Acetate 3 R (P) 3 3 R (N) R (N) R (N) R (N)
Tetrahydrofuran R R R R 3 3 R R
Acetone 3 3 R(N) R(N) 3 R (N) R (N) R (N)
Table 5.4: Results from evaporative crystallisation experiments for Gm8m and Gm8p
within a Petri dish.
Gm8m Petri Dish 10 mg.mL−1
Acetone Y/O Y/O Y/O Y Y Y/O Y O Y/O
Gm8p Petri Dish 10 mg.mL−1
Acetone B R(G)/B R(G)/B B B R(G)/B B B B
5.3.2.5 Magnetic Field Growth
Magnetic anisotropy calculations for each polymorph of Gm8m and Gm8p were carried out using the
methods described by Guo et al.222 The diagonal elements of the diamagnetic susceptibility tensors
are highlighted in Table 5.5, indicating the magnitude in the direction of the minimum, maximum
and middle susceptibilities, along with the isotropic susceptibility and the magnetic anisotropy
(χmax −χmi n). All values in the table are negative as the diamagnetic susceptibility always opposes
an applied magnetic field.
It has been suggested that the application of a magnetic field during crystal growth may al-
low selectivity between polymorphs, given that they lay close in energy and differ in magnetic
anisotropy.71,222 For the data given, this suggests that the magnetic field may favour the growth of
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Table 5.5: Magnetic susceptibility tensors for Gm8m and Gm8p polymorphs.










Gm8m-Y -109.5 -138.7 -222.1 -156.8 -112.6
Gm8m-O -100.2 -108.1 -258.3 -155.5 -158.2
Gm8p
Gm8p-R -104.7 -168.9 -196.3 -156.6 -91.6
Gm8p-B -110.7 -148.4 -232.8 -164.0 -122.2
Gm8m-O and possibly Gm8p-B. Gm8p-B is only possibly favoured, as χmi n is lower in Gm8p-R. As
such, crystallisation experiments were carried out via the cooling of a saturated solution under the
application of different external fields. Crystallisation conditions for the formation of Gm8m-O and
Gm8p-R under no external field were initially formulated, which both grew from slow cooling of
saturated ethanol solutions in flat-bottomed vials. The solutions were cooled from 65 °C to 0 °C over
three days. A small hole in the lid of the vial allowed a slow rate of solvent evaporation to further
increase the supersaturation over the three days. External magnetic fields between 0 T and 1.6 T were
investigated; however, no clear evidence of polymorph selectivity was seen. Gm8m-Y was seen when
a magnetic field of 1.6 T was applied, highlighting the proximity of the energy of the polymorphs,
but there did not seem to be a clear switch at this field when further experiments were carried out.
Crystallisation experiments carried out under external magnetic fields are highlighted in Table 5.6.
Table 5.6: Crystallisation of Gm8m and Gm8p via colling crystallisation of a saturated
ethanol solution under external magnetic fields of 0 - 1.6 T.
Magnetic Field / T Run 1 Run 2 Run 3 Run 4 Run 5 Run 6
0 Gm8m-O Gm8m-O Gm8m-O Gm8m-O Gm8m-O Gm8m-O
0.5 Gm8m-O Gm8m-O Gm8m-O Gm8m-O
1 Gm8m-O Gm8m-O Gm8m-O Gm8m-O
1.5 Gm8m-O Gm8m-O Gm8m-O Gm8m-O
1.6 Gm8m-Y Gm8m-Y Gm8m-O Gm8m-O Gm8m-O Gm8m-O
Magnetic Field / T Run 1 Run 2 Run 3 Run 4 Run 5 Run 6
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5.3.3 3D Electron Diffraction and Crystal Structure Prediction on the Third Polymorph
of Gm8p
As previously mentioned, a third polymorph of Gm8p was seen crystallising from many of the evapo-
rative crystallisation experiments. The crystals produced were low-quality, twinned, thin needles,
which meant they were not adequate for structural-solution via sc-XRD. Powder diffraction of the
crystals resulted in characteristic peaks; however, this was also of low-quality. Such data suggests that
the crystallinity of the sample on a large-scale is likely poor, and changes in crystallisation conditions
appeared to have little consequence on the quality of samples produced. Figure 5.13 shows crystals
of Gm8p-O, highlighting the poor-quality nature of the sample.
To assess the crystal structure of this unknown polymorph, 3-dimensional electron diffraction
(3DED) experiments were employed. Recent advances in the technique have allowed the structural
solution of organic crystals by utilising a single-photon detector, which resulted in the first ab-initio
structural solution via the technique.5 The poor quality of Gm8p-O crystals meant that ab-initio
structural solution was not possible; however, it was possible to determine the crystal system and unit
cell parameters. Volume reconstructions from 3DED of two different crystals of Gm8p-O are shown
in Figure 5.14, highlighting the construction of the unit cell. The crystal system was determined
to be triclinic, highlighting that the space group could be either P1 or P1̄. The size of the cell also
highlighted that two molecules of Gm8p should be present (P1 Z’=2 or P1̄ Z’=1).
Figure 5.13: Optical images of crystals of Gm8p-O.
As the possible space groups of the crystal structure of Gm8p-O was dramatically reduced
by using 3DED, it was possible to run crystal structure prediction calculations within a reduced
crystallographic phase space. The calculations produced a large number of possible configurations;
however, comparison to the experimental powder diffraction matched very closely to three of the
predicted low-energy structures (Figure 5.15). Additional structural refinement of the closest structure
resulted in a greater similarity with the experimental pattern. Although not a perfect match, the
similarity highlights the likelihood that the structure predicted from crystal structure prediction
contains much of the crystallographic order. Moreover, the predicted structure distinctly resembles
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that of the known crystal structure of Gp8m (3’-Dimethylamino-4-Nitrochalcone).223
.
Figure 5.14: 3DED volume reconstructions of two different crystals inside the orange
Gm8p sample. Cell edges are sketched in black. Top data from a crystal with 1st 3D
ED cell, bottom data from a crystal with 2nd 3DED cell. Figure produced by Dr. Iryna
Andrusenko.184
Figure 5.15: Powder X-ray diffraction patterns comparing Gm8p-O to structures from
crystal structure prediction.
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5.3.4 UV-Vis Spectroscopy
The optical properties of Gm8m and Gm8p in a number of solvents were assessed using UV-Vis
spectroscopy. The solvents ethyl acetate, toluene, ethanol and chloroform were chosen due to their
differing protic nature and polarity, along with having reasonably low solvent optical absorption
cut-offs. To assess if any absorption was caused by the effects of molecular agglomeration, solutions
were prepared at several known concentrations. Optical images show that the colour of the solutions
varies by only a small amount, as shown in Figure 5.16. Gm8m samples range from light yellow to a
darker yellow, and Gm8p samples from a dark yellow to orange. The colour appears to shift towards
to red end of the spectrum as the solvents range from ethyl acetate, toluene, ethanol and is darkest
for chloroform. These differences are challenging to make out by eye. However, this suggests that the
solvent has little effect on the electronic configuration of Gm8m and Gm8p molecules. The aprotic
nature of ethyl acetate likely means that it interacts least with the π-system of the chalcone molecules,
which may be why it has the least effect on the colour. Toluene will also have little interaction with
π-electrons due to it having a non-polar nature. Both chloroform and ethanol are more likely to
interact with the π-system of the chalcones due to their intrinsic dipole moment.
Figure 5.16: Optical images highlighting the difference in colour between Gm8m and
Gm8p dissolved in ethyl acetate, toluene, ethanol and chloroform.
UV-Vis spectroscopy was initially carried out using 0.25 mg.ml−1 solutions of Gm8m and Gm8p.
Experiments were carried out using 3 ml quartz cuvettes, which held sample and reference solu-
tions. The reference cuvette held pure solvent and the sample cuvette held the solution of interest.
Figure 5.17 shows the UV-Vis absorbance for 0.25 mg.ml−1 Gm8m and Gm8p solutions. Due to the
solute concentration, the absorbance at low wavelengths was too high to give a reasonable signal.
However, an absorption feature was observable at higher wavelengths for both samples. In Gm8m
(Figure 5.17a), a secondary peak could be seen around 400 nm, which shifted to higher wavelengths
in the order of solvents: ethyl acetate, toluene, ethanol and finally chloroform. The maximum of these
peaks is highlighted with an arrow for each solvent. A similar pattern was seen in Gm8p (Figure 5.17b),
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where a shoulder was seen around 450 nm. It was harder to determine the shift of this shoulder to
higher wavelengths, but analysis of the inflexion points show the same shifting trend as the Gm8m
sample. The inflexion point of each of the shoulders of the Gm8p absorption spectra is highlighted
with an arrow. These absorption features at higher wavelengths are likely to be very important when
considering the observed colour of the sample, as they sit within the wavelengths of the optical
spectrum.
Figure 5.17: UV-Vis spectra of Gm8m and Gm8p dissolved in ethyl acetate, toluene,
ethanol and chloroform at a concentration of 0.25 mg.ml−1.
It is obvious from the initial UV-Vis experiments that a solute concentration of 0.25 mg.ml−1 did
not give a clear UV-Vis absorption profile across the spectrum for any of the samples. Therefore, the
samples were sequentially diluted until there was no longer any saturation of the absorption profile.
UV-Vis spectra for solute concentrations of 0.008 mg.ml−1 are shown in Figure 5.18. The data below
the solvent cut-off wavelength has been removed from each spectrum and marked with a vertical
line for clarity. The solvents cut-off makes it difficult to directly compare the data for the different
solvents for wavelengths below 300 nm; however, the profiles of each solvent look very similar for
both Gm8m and Gm8p. Moreover, the region below 300 nm will have little effect on the colour of the
sample, as these wavelengths sit within the UV region. In Gm8m, two overlapping features are seen in
ethanol, with maxima at 265 nm and 295 nm. These features overlap slightly more in ethyl acetate and
chloroform, with the second maximum disappearing in chloroform, leaving a shoulder. The features
cannot be seen in toluene due to the solvent cut-off. In all Gm8p solutions, a peak centred around
330 nm can be seen, which is shifted to lower wavelengths in ethanol and chloroform. An additional
peak can be seen in the ethyl acetate, ethanol and chloroform solutions, with maxima at 260 nm in
ethyl acetate and ethanol, shifted to 270 nm in chloroform. In summary, only small changes in the
absorption spectra are seen between solutions of Gm8m and Gm8p in different solvents, which is
expected from the observations of their colour. The small changes seen in Figure 5.8 are due to shifts
in small absorption peaks seen in both Gm8m and Gm8p at wavelengths above 400 nm.
When analysing UV-Vis data of solutions, it is important to determine whether absorption peaks
are due to the electronic distribution of isolated molecules or molecular agglomeration. This is
possible by analysing the relative intensity of absorption peaks as the concentration of the solutions
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is reduced. Figure 5.19 and Figure 5.20 show the full set of absorption spectra for sequential dilutions
of Gm8m and Gm8p solutions from 0.5 mg.ml−1 to 0.008 mg.ml−1. An inset within each graph shows
an enhanced view of the feature appearing at higher wavelengths for Gm8m and Gm8p. Analysis of
the exact proportionality of peaks is difficult due to the initial saturation of the most intense peak;
however, analysis of the lower concentration peaks shows that the ratio is constant. This highlights
that the intensity of the feature is proportional to the concentration of the solution. Thus, the
absorption arises from isolated molecules within the solution, meaning computational predictions
based on an isolated molecule should predict absorption at this wavelength.
Figure 5.18: UV-Vis spectra of Gm8m and Gm8p dissolved in ethyl acetate, toluene,
ethanol and chloroform at a concentration of 0.008 mg.ml−1.
Figure 5.19: UV-Vis spectra of Gm8m dissolved in ethyl acetate, toluene, ethanol and
chloroform at concentrations ranging from 0.5-0.008 mg.ml−1.
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Figure 5.20: UV-Vis spectra of Gm8p dissolved in ethyl acetate, toluene, ethanol and
chloroform at concentrations ranging from 0.5-0.008 mg.ml−1.
Solid-state UV-Vis was carried out using pure samples of each polymorph of Gm8m and Gm8p,
produced using the crystallisation parameters discussed in Section 5.3.2.4. To ensure each sample
contained a single polymorph, pXRD analysis was carried out prior to UV-Vis measurements. Diffuse
reflectance data was taken using a spectralon sample as a reference. The raw diffuse reflectance data
for each sample is shown in Figure 5.21a. Although the reflectance data appears relatively featureless,
a clear shift of wavelength at which the samples start reflecting the majority of incoming radiation
can be seen. Moreover, this onset matches the colour of the samples, following the expected trend:
yellow, orange, red and black.
Although the reflectance data trend is as expected, it is more common to view UV-Vis data in
terms of absorbance. The reflectance data can be transformed to absorbance via the Kubela-Munk
transformation,224 approximating the sample to that of infinite thickness. As this transformation
depends on the particle size and packing of the sample, care was taken to prepare samples in the
same manner. All samples were ground with a pestle and mortar, and it was ensured that enough
sample was used to cover the whole sample holder. The Kubelka-Munk transformation is given by
the equation:






where F (R) is the Kubelka-Munk function, k is the absorption coefficient of the sample, s is the
scattering coefficient (which is assumed to be independent of wavelength), and R∞ is the experi-
mental diffuse reflectance. Figure 5.21b shows the absorbance data for samples of Gm8m and Gm8p
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transformed via the Kubelka-Munk transformation of their diffuse reflectance. The samples are
stacked based on their observed colour, and a horizontal dashed line is used to highlight the onset of
the absorbance of each sample.
Figure 5.21: a) Solid-state UV-Vis reflectance of each of the polymorphs of Gm8m and
Gm8p. b) Reflectance data transformed to absorbance via the Kubelka-Munk transfor-
mation.
Using the Tauc relationship and assuming a direct bandgap (Eg ) allows one to equate the ab-
sorbance of a sample to the equation,225
(F (R)hν)2 = B(hν−Eg ), (5.6)
where hν is the energy of the transition and B is the band-tailing parameter. By plotting (F (R)hν)2
against hν, an estimate for the bandgap can be made via extrapolation of the onset of the broad
absorption peak. This process is used to discard the effect of the band-tailing parameter. Extrapo-
lation for Gm8m and Gm8p samples is shown in Figure 5.22, where the x-axis is shown in eV. The
approximated bandgaps are summarised in Table 5.7. As can be seen, the band gap of the sam-
ples progressively gets smaller as the colour changes from yellow to black. This is expected, as the
appearance of the samples is based on the contrasting wavelengths of visible light that are absorbed.
Table 5.7: Band gaps calculated for each of the polymorphs of Gm8m and Gm8p.
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Figure 5.22: Construction of Tauc plots to estimate the band gaps of each of the poly-
morphs of Gm8m and Gm8p.
5.3.5 Fluorescence Spectroscopy
Fluorescence spectroscopy of Gm8m and Gm8p was carried out in the solution and solid states.
Similarly to UV-Vis spectroscopy, modifying the molecular environment of the species can have a
stark effect on the fluorescent wavelength and yield. The initial observation of fluorescence was
carried out via optical imaging under a 365 nm UV lamp. An obvious difference in fluorescence was
seen between the polymorphs of Gm8m, as shown in Figure 5.23. The yellow polymorph emitted a
strong yellow fluorescence, and the orange polymorph emitted minimal radiation. This luminescence
made the observation of concomitant polymorphism very easy in cases where crystallisation yielded
only small amounts of polycrystalline material. A similar analysis of Gm8p polymorphs highlighted
that neither sample showed strong fluorescence in the solid-state. An observation of the fluorescence
of all four polymorphs was made by crushing each sample and placing them in vials with a white
background. Figure 5.24 shows the four samples under ambient light and 365 nm UV radiation, where
the stark difference in fluorescent intensity of the Gm8m-Y sample is clear.
Similarly to the UV-Vis absorption spectra, it is useful to record fluorescence spectra both in the
solution and solid-state to assess the effect of intermolecular interactions. Figure 5.25a shows the
excitation and emission fluorescence spectra for 0.5 mg.ml−1 ethanol solutions of Gm8m and Gm8p.
Both samples fluoresce, with the excitation and emission red-shifted for the Gm8p sample, which
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Figure 5.23: Optical images of Gm8m polymorphs under broadband light (left) and 365
nm UV radiation (right).
Figure 5.24: Powders of Gm8m and Gm8p polymorphs imaged under broadband and
365 nm UV light.
may be expected due to the colour of the solution observed in the previous section. The spectra
for Gm8p are boarder than for Gm8m, with a smaller maximum intensity. For perspective, spectra
were also taken for a similar fluorescent molecule, 4-dimethylaminochalcone. Figure 5.25b shows
a comparison of the fluorescence spectra, highlighting that the Gm8m and Gm8p samples have a
comparatively low fluorescent intensity.
To quantify the fluorescence of Gm8m and Gm8p in the solid-state, fluorescence spectra of
powders of all four samples were recorded. The excitation spectra for all samples were broad and
featureless; however, the emission for Gm8m-Y, Gm8m-O and Gm8p-R showed clear features. The
Gm8p-B powder did not show any appreciable emission or excitation fluorescence intensity. The
emission spectra for Gm8m-Y, Gm8m-O and Gm8p-R are shown in Figure 5.26. As the excitation
spectra were broad, each sample was excited at 365 nm. It is clear to see that the emission intensity
of Gm8m-Y is far larger than for Gm8m-O and Gm8p-R, and an expected shift in the wavelength of
the maxima is seen. Interestingly, the most fluorescent sample in the solid-state is the only structure
not containing the double 1,3-ring stacking motif. The reduction in fluorescence intensity in the
other samples is likely because the double 1,3-ring stacking motif allows the nitro group to sit in
the proximity of the π-conjugated system. Nitro groups are known to quench fluorescence in the
solid-state due to their electron-withdrawing nature, which allows the decay of excited states via
non-radiative pathways.226–228
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Figure 5.25: a) Fluorescence spectra of 0.5 mg.ml−1 ethanol solutions of Gm8m and
Gm8p. b) Comparison of the same data with the fluorescence spectra of a 0.5 mg.ml−1
ethanol solution of 4-dimethylaminochalcone. Emission spectra are shown with solid
lines and excitation with dashed lines.
It should be noted that the fluorescence experiments conducted here only scratch the surface of
the possible information that can be extracted in both the solid and solution states. A full description
of fluorescence requires the calculation of quantum yields by carefully assessing the difference in
photons absorbed and emitted in each system, along with information about excited-state life-
times. The field of fluorescent imaging uses this information to give information about molecular
environments far more precisely and conclusively than discussed in this work. The differences in
fluorescence between the solid-state samples show a clear case of an aggregation-induced phe-
nomenon, of which aggregation-induced fluorescence and aggregation-caused quenching have both
been heavily studied in the literature. Without a quantitative comparison of solvent and solid-state
fluorescence quantum yields, it is difficult to say which type of aggregation phenomena is being seen
in the Gm8m and Gm8p systems. Moreover, fluorescence in solution can be highly dependent on
solvent polarity and solute concentration, so additional experiments would have to be carried out. As
the nitro group often acts to quench fluorescence, an increase in solute concentration would likely
increase the amount of quenching taking place in solution. However, from the experiments that have
been carried out, it is still clear to see that Gm8m and Gm8p both fluoresce in solution, and it is likely
that the proximity of the nitro and dimethylamino groups in the solid-state dictates the fluorescent
yield.
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Figure 5.26: Solid-state fluorescence emission spectra from Gm8m and Gm8p poly-
morphs.
5.3.6 Thermal Analysis
5.3.6.1 Thermograms of Gm8m and Gm8p
The thermodynamic landscape of polymorphs of Gm8m and Gm8p were analysed by producing
differential scanning calorimetry (DSC) thermograms between room temperature the melting points
of the respective polymorphs. Initial scans were taken at 5 °C.min−1 and 10 °C.min−1 to assess the
melting point of each structure and any obvious phase transitions. A summary of thermograms is
shown in Figure 5.27, highlighting the heating of all four polymorphs above their melting points. All
samples were crushed and structurally analysed via pXRD before experiments were run.
Interestingly, in both Gm8m-O and Gm8p-R there appear to be multiple thermodynamic events.
At 100 °C an event involving an endotherm followed by an exotherm is seen in Gm8m-O. This type
of event is indicative of a melt-mediated phase transition to a lower energy crystalline state. The
depth of the initial endotherm gives information about the speed of the transition, as there will
be a maximum overlap of the melting (endothermal) and crystallisation (exothermal) events for
rapid transitions. When the Gm8m-O sample is heated beyond this initial phase transition, a melting
endotherm is seen at 120 °C. Comparing the thermogram of Gm8m-O to the thermogram of Gm8m-Y,
which has only a single endothermic transition at 122 °C, it appears that Gm8m-O is transforming
to Gm8m-Y and subsequently melting upon further heating. As there is no structural data taken
concomitantly with these experiments, further experimental data are needed to confirm this.
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Figure 5.27: Thermograms of Gm8m and Gm8p polymorphs from DSC. The inset shows
an enhanced view of the event seen at ~100 °C in Gm8m-O. The units for the y-axis in
the inset is W.g−1.
A similar transition occurs in Gm8p-R, where an initial endothermic and subsequent exothermic
event is seen at 152 °C. This is again followed by a further endothermic event at 167 °C. The final
endothermic event is also seen in the thermogram of Gm8p-B, suggesting that Gm8p-R transforms
to Gm8p-B at 152 °C, which subsequently melts at 167 °C. Interestingly, the initial endothermic event
seen in Gm8p-R is far larger than that of Gm8m-O, which suggests that the transition from Gm8m-O
to Gm8m-Y is faster than the transition from Gm8p-R to Gm8p-B.
As the polymorphic transformations in Gm8m-O and Gm8p-B appear to be melt-mediated, it
should be the case that their thermograms are dependent on the rate of heating. As the rate of heating
of the sample is increased, the amount that melts before the polymorphic transformation takes place
should increase. To evaluate this pattern, samples of Gm8p-R and Gm8m-O were heated at rates
between 5 °C.min−1 and 100 °C.min−1. Regardless of the heating rate, only a small amount of the
Gm8m-O sample melted before the transformation took place. This is highlighted by only a small
endothermic event appearing before the melting of Gm8m-Y, even when the sample was heated at
100 °C.min−1. Thermograms showing the heating of Gm8m-O at 5 °C.min−1 and 100 °C.min−1 are
shown in Figure 5.28.
As the heating rate of Gm8p-R samples is increased, more of the sample melts before the trans-
formation takes place. Thermograms of Gm8p-R samples heated at rates between 5 °C.min−1 and
50 °C.min−1 are shown in Figure 5.29a, where it is clear to see an increase in the size of the first
endotherm and a decrease in the size of the second endotherm as the heating rate is increased. The
broadening of the endotherm as the heating rate is increased may be masking a small amount of the
second endotherm still present; however, it is clear that by a heating rate of 50 °C.min−1 almost all of
the sample is melting during the first transition, with no transformation. Mapping of the enthalpy of
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Figure 5.28: DSC thermograms of Gm8m-O heated at rates of 5 °C.min−1 and 100
°C.min−1. The heat flow is divided by the ramp rate to normalise the intensity of each of
the thermograms.
the endothermic transitions supports this hypothesis (Figure 5.29b), as heating rates of 20 °C.min−1
and above show a consistent value for the enthalpy of the first endotherm. This allows a prediction
for the enthalpy of fusion for the Gm8p-R samples using heating rates above 20 °C.min−1. However,
for complete conformation, structural information should be obtained to ensure no polymorphic
transformation occurs.
Figure 5.29: a) DSC thermograms of Gm8p-R heated at rates between 5 °C.min−1 and
50 °C.min−1. b) Plot of the enthalpy of the first (black) and second (red) endotherms for
each ramp rate of the data in a).
5.3.6.2 Low-Temperature Powder X-ray Diffraction
To assess the stability of Gm8m and Gm8p polymorphs at temperatures lower than the range accessi-
ble via DSC measurements, low-temperature pXRD was carried out down to 12K. During the cooling
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of powders of each of the polymorphs, continuous shifts in the pXRD peaks represent the contraction
or expansion of the unit cells. Unit cell changes with temperature are often anisotropic, as they are
caused by slight relaxations in molecular configurations or changes in intermolecular bonding motifs.
Phase transitions can be detected by looking for discontinuous changes in the pXRD patterns as the
samples are cooled, representing a more rapid change of molecular configuration or intermolecular
bonding over a small temperature range. The temperature dependence of lattice parameters is useful
to identify when computationally assessing crystal properties, as the disregard for such information
can cause large errors in predicted free energies.229 In particular, phonon modes can be affected by
large expansions/contractions, which play a role in determining temperature-dependent polymorph
stability.
The temperature dependence of crystallographic parameters for polymorphs of Gm8m and Gm8p
is highlighted in Table 5.8, with the differences shown in Table 5.9. The unit cells of polymorphs
at 300K and 12K are shown in Figure 5.30, with molecules at 300K shown in red and 12K shown in
blue. The unit cells were produced by carrying out Rietveld refinement on the powder diffraction
patterns for samples at the two temperatures. These experiments show that the unit cell of Gm8m-Y
contracts substantially in the direction of the c-axis as the crystal is cooled, with a small expansion in
the direction of the b-axis. This change is due to a relaxation of the zigzag motif, leading to a more
acute angle between molecules. In contract, the unit cells of Gm8m-O and Gm8p-R contract by a
small amount in all axes due to a reduced distance between molecules in the 1,3-stacking motif on
cooling. The only outlier is the a-axis direction in Gm8m-O, which is perpendicular to these stacks
and, therefore, increases by a small amount.
Figure 5.30: Unit cells of each polymorph of Gm8m and Gm8p at 12K (blue) and 300K
(red). a) Gm8m-Y b) Gm8m-O c) Gm8p-R.
As the powder of Gm8p-B is cooled, a sharp discontinuity is seen in the pXRD data between
110-170 K. Although the changes in the position of the peaks are not large, the fact that they do not
match the continuous trend seen at higher temperatures suggests a phase transition rather than a
simple temperature dependence of lattice parameters. As the original structural solution from Gm8p-
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Table 5.8: Crystallographic data from low-temperature pXRD of Gm8m-Y, Gm8m-O and
Gm8p-R at 300K and 12K.
Identification code Gm8m-Y Gm8m-O Gm8p-R
Temperature / K 300 300 300
a / Å 12.6332(12) 8.3370(9) 8.386(2)
b / Å 6.2561(8) 9.5613(9) 8.1743(5)
c / Å 18.942(2) 10.3919(8) 22.013(2)
α / ° 90 103.544(5) 90
β / ° 92.647(6) 103.003(8) 91.751(13)
γ / ° 90 104.395(7) 90
Temperature / K 12 12 12
a / Å 12.5644(14) 8.341(11) 8.3232(14)
b / Å 6.3401(12) 9.415(12) 8.0437(6)
c / Å 17.882(2) 10.059(9) 21.583(3)
α / ° 90 102.056(6) 90
β / ° 92.910(7) 102.46(11) 91.010(9)
γ / ° 90 105.018(8) 90
Table 5.9: Difference in crystallographic parameters of Gm8m-Y, Gm8m-O and Gm8p-R
between 300K and 12K.
Identification Code Gm8m-Y Gm8m-O Gm8p-R
a / Å -0.0688 0.004 -0.0628
b / Å 0.084 -0.1463 -0.1306
c / Å -1.06 -0.3329 -0.43
α / ° 0 -1.488 0
β / ° 0.263 -0.543 -0.741
γ / ° 0 0.623 0
B was carried out at 100 K, this transition suggests a different structure exists at room temperature.
Figure 5.31 shows a trace of the diffraction data for a powder of Gm8p-B cooled from 300 K to 12 K.
The reverse transition occurs on heating, which highlights that the change is enantiotropic.
To assess the differences in the crystal structure of Gm8p-B before and after the phase transition,
sc-XRD data was collected of a crystal of Gm8p-B at 300 K, before being cooled to 100 K and rerun.
The unit cell for each structure is shown in Figure 5.32a, which highlights a change in the angle
between the double 1,3-ring stacked dimers, causing a reduction in the a-axis for the low-temperature
structure. Thermal ellipsoid plots for the asymmetric unit of Gm8p-B at 100 K and 300 K are shown
in Figure 5.32b, highlighting that there is little change in the conformation of the molecular unit. The
unit cell parameters for Gm8p-B at both temperatures are highlighted in Table 5.10, which shows that
there are only small changes in the unit cell lengths between polymorphs; however, there is a large
change in the β angle, increasing by over 5 ° in the low-temperature structure. It should be noted that
this is only being classified as a polymorphic transition due to the rapid change of cell parameters
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Figure 5.31: Low-temperature pXRD of Gm8p-B plotted from a cooling ramp between
300K and 12K.
over a small temperature range. A more definitive observation of polymorphism would be to observe
an enthalpic change between the two structures. DSC down to the temperatures required to observe
this transition was not possible, meaning the polymorphic transition is defined tentatively. Indeed,
the structures converged to a single energy minimum during structural optimisations, meaning any
calculations can be carried out on this single optimised structure.
Figure 5.32: a) Difference in molecular packing in Gm8p-B low-temperature struc-
ture (blue) and high-temperature structure (red). b) ORTEP plots of the high and low-
temperature polymorphs of Gm8p-B.
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CCDC Identifier 1983904 1983908
Space group P21/c P21/c
a / Å 7.8167(2) 8.1180(5) -0.3013
b / Å 13.4438(4) 13.3417(7) 0.1021
c / Å 13.7862(5) 13.6713(8) 0.1149
α / ° 90 90 0
β / ° 97.413(2) 92.261(4) 5.152
γ / ° 90 90 0
Z 4 4
Final R indexes [I>=2σ (I)] R1 = 0.0336, R1 = 0.0465,
wR2 = 0.0860 wR2 = 0.1124
5.3.6.3 Analysis of Polymorphic Transitions of Gm8m and Gm8p
The polymorphic transitions between structures of Gm8m and Gm8p should be visible by eye due to
their stark differences in optical properties. In Section 5.3.5, it was highlighted that the fluorescent
intensity of Gm8m-Y was observably higher than Gm8m-O when illuminated with UV light. Therefore,
the transition of Gm8m-O to Gm8m-Y should be able to be mapped via time-lapse imaging of a
powder sample on a heated stage under UV lighting. This experiment was carried out using a heating
rate of 1 °C.min−1 and a 365 nm UV lamp. A sample of Gm8m-O was grown from solvent evaporation
of a toluene solution. Images from the time-lapse are shown in Figure 5.33a, highlighting the clarity
of the polymorphic transition when viewed under UV light. To ensure that the transition was taking
place between the expected crystal structures, pXRD was taken before and after the heating ramp,
shown in Figure 5.33b. The diffraction patterns clearly show the transition between the expected
polymorphs; however, the background increase suggests that the Gm8m-Y formed after the transition
is of lower quality, either due to fracturing of the crystals or partial melting causing amorphisation of
some of the material.
As the rate of transformation between Gm8p-R and Gm8p-B was slow enough to measure the
heat of fusion of Gm8p-R, additional analysis of the Gibbs free energy of each crystal structure could
be carried out. To ensure that no intermediate phases were forming during the transformation, which
may lead to an inaccurate heat of fusion, a concomitant synchrotron X-ray diffraction and DSC
heating ramp was carried out. This allowed analysis of the structure of the sample throughout the
whole of the polymorphic transition. The synchronised DSC thermogram and diffraction data are
shown in Figure 5.34. The experiment was carried out by heating a powdered sample of Gm8p-R
at a ramp rate of 10 °C.min−1. A clear transition between two crystalline phases can be seen in the
diffraction data around 165 °C, which coincides with the appearance of two endothermic transitions
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Figure 5.33: a) Time-lapse images of the transition between Gm8m-O and Gm8m-Y with
increased temperature under 365 nm UV light. b) Powder X-ray diffraction patterns
before and after the time-lapse.
in the DSC thermogram. It is clear that the transition is melt-mediated, as an amorphous background
appears around the point of the transition in the diffraction data, and there is no point where the
second crystalline structure appears without any amorphous material.
Rietveld analysis of diffraction patterns before and after the transition confirmed that the crys-
talline phases were Gm8p-R (before) and Gm8p-B (after). Given that there appear to be no intermedi-
ate phases (other than the melt) during the transformation, it can be assumed that the calculated
enthalpy of fusion for Gm8p-R is accurate. As described in the previous section, the acquisition of
this value is possible using a ramp rate of 50 °C.min−1. Additionally, it is simple to determine the heat
capacities of both polymorphs of Gm8p and the liquid state via modulated DSC. The heat capacities
from modulated DSC experiments run on powders of Gm8p-R and Gm8p-B are shown in Figure 5.35.
The heat capacity of each phase is shown fitted to a second-order polynomial (black line), and
heat capacities during phase transitions (dotted line) are disregarded due to the dramatic divergence
of the data at these temperatures. After the melting of both phases, the heat capacity of the liquid
(blue) is the same for both samples. By extrapolating the heat capacity of all phases across the range
of interest, which is valid in the range of a few hundred of Kelvin, the Gibbs free energy of Gm8p-R
and Gm8p-B can be plotted with respect to the Gibbs free energy of the liquid phase. The Gibbs free
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Figure 5.34: Concomitant synchrotron powder diffraction and differential scanning
calorimetry of Gm8p-R. A black arrow shows the direction of the temperature ramp.
energy of each crystalline phase is given by combining equations 1.8 and 1.7 from Chapter 1,
∆GC (T ) =−∆H f us −
∫ T f us
T









where ∆GC (T ) is the difference in Gibbs free energy between the crystalline and liquid states at
temperature T , ∆Cp (T ) is the difference in heat capacity between the crystalline and liquid states at
temperature T , ∆H f us is the enthalpy of fusion of the crystal, and T f us is the melting temperature
of the crystalline state. The integrals can be analytically solved by writing the heat capacity of each
phase as a power series,





where Cp,i (T ) is the heat capacity of phase i at temperature T , m represents the order of the power
series, and an are the coefficients of the nth term. In general, heat capacities are fit to order 1 or 2
over small temperature ranges. This allows for a full energy diagram of the two polymorphs to be
produced, which is shown in Figure 5.36. The energy diagram highlights that there is no cross-over
between the free energies of Gm8p-R and Gm8p-B, confirming that the transition from Gm8p-R to
Gm8p-B is monotropic. This type of analysis is critical when looking at new polymorphic systems as
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it allows a clear view of the structural landscape of a molecule. This type of transition could have been
determined using Burger’s rules, as the enthalpy of fusion of Gm8p-R is less than that of Gm8p-B.230
Figure 5.35: Heat capacity of Gm8p-R and Gm8p-B calculated using modulated differen-
tial scanning calorimetry.
Figure 5.36: Phase diagram highlighting the relative free energies, entropies and en-
thalpies of Gm8p-R and Gm8p-B.
5.3.6.4 Disorder in Gm8m-Y
The structural solution of Gm8m-Y highlighted that there was an element of disorder present in
the nitro group. Disorder within crystal structures can be either dynamic or static, highlighting
whether the atoms of a single molecule can transform between the different configurations. Dynamic
disorder becomes a problem when carrying out quantum chemistry calculations, as the harmonic
approximation is often a fundamental element of the computation. If there is a large amount of
dynamic disorder, then the harmonic approximation will not hold.
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To test if the disorder is static or dynamic, the same single-crystal of Gm8m-Y was solved via
sc-XRD at temperatures between 100 K and 250 K. If the disorder is static, then the percentage
occupation of the different configurations will stay constant, whereas they will change if the disorder
is dynamic. Structural solution of Gm8m-Y was carried out at 100 K, 150 K, 200 K and 250 K. The
same experimental method was used for diffraction data collection at each temperature, which
meant that the quality of the data did decrease slightly as the temperature was varied; however, all
cells were of publishable quality (CCDC reference codes: DUZQOH05, DUZQOH04, DUZQOH01,
DUZQOH). ORTEP plots of the asymmetric unit of Gm8m-Y at the different temperatures are shown
in Figure 5.37, which highlights the difference in thermal motion of the atoms. Although the thermal
ellipsoids changes in size, the disorder is shown to be in a similar position for each temperature.
Modelling of the disorder highlighted that as the temperature of the sample was increased, the
occupation of the minor component increased. A summary of the occupancies is shown in Table 5.11.
This shows that the order within the Gm8m-Y crystal structure is dynamic, and should be consid-
ered when commenting on the accuracy of calculations that utilise the harmonic approximation.
Helmholtz free energy calculations of Gm8m-Y and Gm8m-O, without modelling disorder, predict
Gm8m-O to be the stable polymorphs until temperatures above the melting points of both solids.
This highlights the stabilisation that can arise due to disorder, and that care must be taken when
modelling crystal structure energies at non-zero temperatures.
Figure 5.37: ORTEP plots showing the asymmetric unit of Gm8m-Y at temperatures
between 100 K and 250 K. Covalent bonds in the disordered fragment are shown with
dotted lines.
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Table 5.11: Major and minor occupancies of the disordered component in Gm8m-Y.





5.3.7 Computational Prediction of Colour
A full description of the thorough calculations carried out are covered in the supplementary information
of the publication: Color Differences Highlight Concomitant Polymorphism of Chalcones.184 In this
section, I will summarise the computational predictions in reference to the experimental results shown
in the previous sections.
As discussed in the introduction to this chapter, the colour of a particular sample is based on the
electronic and vibrational transitions that occur when a sample is excited by electromagnetic radia-
tion. In a physical sense, these transitions are well understood; knowledge of the potential caused
by the atoms of a molecule allows us to calculate the molecular orbitals dictating electronic energy
levels, which allows us to calculate dipole transition integrals between different states. However, as a
system becomes more complex, our ability to run ab initio calculations diminishes, and experimental
analysis is often more time-efficient than the necessary computationally-expensive calculations.
As the Gm8m and Gm8p systems offer four polymorphs that exhibit distinctive structurally-
dependent optical absorption properties, they were proposed as an example system for the prediction
of colour in the solid-state. The computational method to be tested was to take small clusters of
molecules from each crystal structure, and see how the absorption spectra were shifted depending on
the differing intermolecular interactions. The utilisation of this method allows TD-DFT calculations
to be carried out without the need for periodic-boundary conditions, greatly reducing the compu-
tational expenditure. This reduction allows for the use of a range-separated functional. The more
molecules included in the calculations, the closer the calculations should get to the true absorption
spectra of the materials. However, the systematic nature of these calculations allows one to determine
the most important intermolecular interactions for absorption, and should indicate the number of
molecules needed for convergence to crystallographic spectra.
Figure 5.38 highlights the predicted absorbance for each of the investigated polymorphs, from
a variety of TD-DFT calculations. The shape of the curve for the monomer matched well with the
experimental UV-Vis from solution, presented in the previous section. The predictions are blue-
shifted with respect to the experimental data by ~100 nm, but clearly show the appearance of
two peaks, with a greater overlap between the peaks in Gm8p. The blue-shift is likely due to the
absence of solvent interactions and the tendency for range-separated functions blue-shift the entire
spectrum.231
Numerous calculations were carried out on different dimers cut from crystal structures of each
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Figure 5.38: Computational predictions of the absorbance spectra of polymorphs of
Gm8m and Gm8p.
polymorph. These dimers were found by isolating molecules within a molecular shell of 3.2 Å of the
asymmetric unit. This resulted in 15-molecule clusters for Gm8m-Y, Gm8m-O and Gm8p-R, and a
19-molecule cluster for Gm8p-B. Calculations on these full clusters were carried out for Gm8m-Y
and Gm8m-O; however, not enough computer time was available to run the full clusters of Gm8p
molecules. Following this, each of the individual pairs of molecules were isolated, and separate
TF-DFT calculations carried out. Analysis of the absorption spectra of these pairs of molecules
highlighted that stacking interactions led to the largest red-shifts in absorption for Gm8m-O, Gm8p-R
and Gm8p-B, with the double 1,3-ring stacking motif present in all of these structures leading to the
largest red-shifts in absorption. Conversely, in Gm8m-Y, the only stacking motif led to a blue-shift in
the absorption peak. For Gm8m-Y, the structural motif leading to the greatest red-shift in absorption
was an offset dimer involving the carbonyl oxygen and a hydrogen from the 3-ring.
For the motifs that red-shifted the absorption spectra the most, extended stacks of molecules
were input into the TD-DFT calculations, to see if this resulted in a further red-shift of the spectra.
Four different calculations were carried out for comparison, systematically increasing the length of
the stack from a dimer (two molecules) to an octamer (eight molecules). The molecular stacks are
shown in Figure 5.39, with each of the clusters calculated shown within a dashed red box. Views both
perpendicular to the short- and long-axis of the molecules are shown. This figure helps to highlight
the different amount of overlap of the stacking interactions within each polymorph. The overlap
in the short-axis of the molecule of Gm8m-O is greater than that of Gm8p-R, however the overlap
in the long-axis is greater for Gm8p-R. The overlap for Gm8p-B is similar to that of Gm8m-O along
the short-axis of the molecule and to that of Gm8p-R along the long-axis. Therefore, the extended
stacking in Gm8p-B involves the largest amount of molecular overlap. There is very little overlap for
the stack shown in Gm8m-Y.
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Figure 5.39: Stacks within the crystal structures of Gm8m-Y, Gm8m-O, Gm8p-R and
Gm8p-B leading to spectra red-shifted by the greatest amount. The dimer motif from
each stack is shown on the left. On the right, extended stacks are shown perpendicular to
the short and long axes of the molecules. Molecules are coloured by symmetry operation,
with white showing the asymmetric unit (or translated molecule) and yellow showing an
inverted molecule.
126
5.3. POLYMORPHISM IN GM8M AND GM8P
The effect these stacking interactions have on the bandgap of each polymorph is highlighted in
Table 5.12 and Table 5.13, where the transition energy of the lowest-lying transition is shown for each
motif, along with the oscillator strength (OS), which is proportional to the transition dipole moment.
It is clear that there is a trend towards a lower energy bandgap as the size of the stack is increased.
Something not shown in these tables is that the number of transitions around these wavelengths
increases as the size of the stack increases, which itself induces a red-shift in the absorption peak.
Referring back to Figure 5.38, it is clear that the extended stacks cause a much larger red-shift than
the 15-molecule cluster.
Table 5.12: Transition energies of the lowest energy transition and oscillator strengths of
Gm8m-Y and Gm8m-O. Data is shown for the monomer and stacks of molecules up to
an octamer (eight molecules).
Intermolecular Motif Transition Energy / eV ( / nm) Oscillator Strength
Gm8m-Y
Monomer 3.89 (318.4) 0.0607
NO2-Opposite dimer 3.83 (323.4) 0.0811
Tetramer 3.77 (329.1) 0.0467
Hexamer 3.77 (329.2) 0.0559
Octamer 3.76 (329.4) 0.0622
Gm8m-O
Monomer 3.89 (318.9) 0.0769
Double 1-3 Ring Stacking Dimer 3.49 (355.4) 0.0174
Tetramer 3.39 (365.5) 0.0106
Hexamer 3.38 (367.3) 0.0090
Octamer 3.38 (367.3) 0.0121
Table 5.13: Transition energies of the lowest energy transition and oscillator strengths of
Gm8p-R and Gm8p-B. Data is shown for the monomer and stacks of molecules up to an
octamer (eight molecules).
Intermolecular Motif Transition Energy / eV ( / nm) Oscillator Strength
Gm8p-R
Monomer 3.83 (323.8) 0.1066
Double 1-3 Ring Stacking Dimer 3.57 (349.6) 0.0400
Tetramer 3.55 (349.6) 0.0285
Hexamer 3.51 (353.6) 0.0097
Octamer 3.51 (353.7) 0.0155
Gm8p-B
Monomer 3.78 (327.8) 0.0917
Double 1-3 Ring Stacking Dimer 3.45 (359.2) 0.0513
Tetramer 3.39 (365.6) 0.0138
Hexamer 3.38 (367.2) 0.0079
Octamer 3.38 (366.9) 0.0087
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It is important to note the change in OS as the size of the stacks increases, as this will determine
the contribution that each transition has to the final absorption spectra. In general, for polymorphs
excluding Gm8m-Y, the OS for the lowest energy transition decreases as the size of the stack is
increased. This is the case up until the octamer stack, where the OS increases for all of the polymorphs,
although it is still far less than the OS seen for the transition in the monomer. In Gm8m-Y, the OS
is actually larger for the octamer than for the monomer and increases as the stack is increased in
size. The differences in the OS of the lowest-lying transitions may explain the differences in the
fluorescent behaviour between the different polymorphs. The OS in Gm8m-Y is five times larger than
that of Gm8m-O and over seven times larger than Gm8p-B when considering the octamer stacks.
This difference means that the lifetime of the lowest energy state will be lower for Gm8m-Y, which
will certainly increase the fluorescent yield.
Overall it is clear that the calculated absorption spectra are substantially blue-shifted when
compared to the experimental absorption spectra. Although the functional used is known to blue-
shift spectra, it is clear that the number of molecules used in the clusters did not result in convergence
to accurate crystallographic data. Indeed, a change could be seen when increasing the extended
stacks to more molecules, even up to the octamer. However, this study does allow the identification
of certain structural motifs that cause particularly large red-shifts in absorption spectra. It has been
shown with a high level of confidence that the change in colour of Gm8m and Gm8p polymorphs
from yellow to black is a result of the increased overlap of molecules within the stacking motifs.
Moreover, these trends will undoubtedly be useful when considering the design of molecules with
particular optical properties, as they can be engineered with such structural motifs in mind.
5.4 Conclusion
This chapter has highlighted the experimental analysis of two sets of polymorphic chalcones, exhibit-
ing colours ranging across the optical spectrum. Their colours aided in identifying the crystallisation
of the different polymorphs, and later helped in following the thermodynamic transition between
Gm8m-O and Gm8m-Y. This chapter highlights a range of techniques available to a crystallogra-
pher in determining both the structural and thermodynamic properties of organic crystals. Each
crystal structure was solved using sc-XRD, allowing computational studies to be carried out. The
structural properties of Gm8m and Gm8p are highlighted in Figure 5.40, where the conditions for the
crystallisation parameters used for structural determination are shown.
The experiments carried out demonstrate the structural complexity that can arise even in simple
organic systems. The results in the chapter highlight chalcone molecules as a useful backbone for
the systematic study of properties stemming from the structure of materials. From a study based on
systematically realising the differences between current theory and experimental data, it is clear that
there is still a way to go before the accurate prediction of material properties such as colour can be
achieved. However, the use of functionalised chalcones has allowed the observation of clear trends in
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structural, thermodynamic and spectroscopic properties, which has set the foundation for a much
broader systematic study in the future.
Figure 5.40: Experimental solid form landscape of Gm8m and Gm8p, summarising the













6.1 Summary and Outlook
Throughout this work, the crystallisation of pharmaceutically relevant compounds has been carried
out to elucidate novel routes of crystallisation, the rationale behind the tracking of such crystallisation
pathways, and the factors affecting the properties of the final crystalline products. The project was
generally split into two parts, although the intricacies present in crystallographic studies meant that
there are many possible divergences from the main topics, with much promise for future work.
The first two chapters of this thesis highlight the development of volatile deep eutectic solvents
(VODESs) as a novel crystallisation medium for the control of crystalline structure and properties. As
a result of this crystallographic medium, polymorphic control of paracetamol was incontrovertibly
obtained, with the metastable form II crystal structure forming from VODESs where the molar ratio
was above 6:1 phenol:paracetamol. Time-lapse imaging of the formation of paracetamol crystals
from VODES showed that the formation of form II paracetamol occurred at a far later time than that
of form I, accentuating the idea that the internal structure of the VODES changes as the molar ratio
of the internal constituents is changed. In turn, it was hypothesised that the internal structure of
VODESs leads to the formation of metastable crystalline phases, which act as intermediaries to the
formation of hard-to-reach and novel crystal structures. Direct and indirect observation of these
metastable phases in several systems strengthened this hypothesis, including the crystal structure of
a 2-ethoxybenzamide phenol co-crystal.
Studies of crystallisation from VODES solutions were performed with a variety of pharmaceuti-
cally active molecules, each with differing functional groups and flexibility. Evaluation of benzamide
solutions afforded the first crystallisation of the metastable form III structure from a binary system.
Supplementary work highlighted morphological control of crystallites in the metacetamol system,
without affecting the structure of the resultant crystal. Furthermore, it was shown that the VODES
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system containing metaxalone allowed enantiomeric control over the crystal structure. Studies on
VODES systems of 2-methoxybenzamide, verapamil and estradiol did not result in any direct crys-
tallographic control, but did highlight the widespread applicability of VODESs as a crystallographic
medium.
The second experimental chapter delved more thoroughly into the crystallographic pathway
leading to a final crystalline form from the VODES medium. This analysis was carried out by monitor-
ing the thermodynamic landscapes of VODESs via differential scanning calorimetry. This initial work
highlighted an important subtlety about the thermodynamics of eutectic systems: upon crystallisa-
tion of a eutectic system, multiple phases may form, including structural polymorphs, co-crystals
and amorphous phases. Co-crystalline phases require exact ratios of constituent components so that
translational symmetry can form throughout the structure. In contrast, the liquid state is far more
malleable in the composition it can possess. Indeed, the difference in energy between the possible
crystalline states and the eutectic liquid is the driving force causing the melting point suppression
of molecular mixtures. During the thermal cycling of VODESs, the formation of a hierarchy of crys-
tal structures of varying stability was seen. Moreover, glass transitions were seen in most systems,
indicating that some of the eutectic liquid was not crystallising.
To further investigate the hierarchy of crystal structures formed from VODESs, concomitant
synchrotron powder X-ray diffraction and differential scanning calorimetry (CXRD-DSC) were used,
utilising the I12 beamline at the Diamond synchrotron. This combination of experimental techniques
allowed for the correlation of thermodynamic and structural changes in VODESs during thermal
cycling. From these experiments, unknown crystalline phases were found in VODESs containing 2-
ethoxybenzamide, metacetamol and benzamide. Supplementary experiments following the detection
of these phases also highlighted that additional phases could be produced by re-cooling the remaining
glassy component after the crystallisation of the first unknown phase. Structurally, it is clear that
there is still a lot to learn about the formation of these systems, the understanding of which can
only aid in utilising them to their full extent. For the VODESs, CXRD-DSC studies added significant
weight to the hypothesis that metastable crystalline phases impact the crystallisation phenomena
observed. However, on a larger scale, these experiments elucidate the inherent complex structure
of deep eutectic systems that is still not well understood. The formation of co-crystals bears a
striking resemblance to the formation of alloys in the eutectic systems of metals, which may lead
to a convergence of these systems that involve seemingly-divergent length scales. The structural
understanding of the crystallisation of deep eutectic solvents is undeniably an understudied area;
however, the evolution of CXRD-DSC can now be used as an invaluable tool to revolutionise our
knowledge of this area.
The second section of the project was dedicated to the study of functionalised chalcones as
materials to readily analyse the crystal engineering of small, flexible, pharmaceutically-relevant
molecules. The third experimental chapter focused on two particular chalcones, functionalised
with dimethylamino and nitro groups. These chalcones both exhibited crystal polymorphism, form-
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ing structures that exhibited colours ranging across the optical spectrum. These structures were
thoroughly analysed in terms of their structural, optical and thermodynamic properties to allow
a detailed comparison of properties with those predicted from modern theoretical calculations.
In particular, the optical properties of the chalcones were evaluated using quantum chemical cal-
culations using a novel technique, which involved cutting clusters of molecules from each of the
experimental crystal structures. The technique highlighted relative shifts in the bandgaps of each
of the crystal structures, clearly outlining the bonding motifs leading to the largest red-shifts in
the optical spectra. Knowledge of these optically-active bonding motifs affords a clear foundation
that can be utilised during the process of crystal engineering. Moreover, the use of functionalised
chalcones allows for thorough systematic studies of the effect of intermolecular interactions on both
the crystal structure of molecules and their subsequent properties, bringing into line our current
theoretical and experimental knowledge.
The field of organic crystal engineering is still at an exciting point in its expansion. Although
far more is now known about the field since the invention of X-ray crystallography and subsequent
structural solution techniques, it is still the case that absolute property-driven crystal design is
far from reality. Experimentally, crystallographers rely on a toolbox of generally well-established
techniques to examine as much of the crystal landscape of a molecule as possible, and subsequently
measure the crystal properties of each polymorph produced. The use of such a variety of tools is now
commonplace in industries, including pharmaceutical and agrochemical crystal design, with more
advanced methods and precise equipment constantly appearing. It is hoped that the crystallographic
tools and systematic studies laid out in this thesis will sit as part of the foundation and growth for the
vast amount of crystallographic knowledge that is still left to be uncovered, and in turn, aid in the











AN EXPERIMENTAL AND COMPUTATIONAL STUDY INTO THE CRYSTALLISATION
PROPENSITY OF SECOND-GENERATION SULFLOWER
The publication based on this work was first-authored by Dr T Jensen. The complementary computa-
tional work that I carried out for this study is highlighted below. The work is published in [4].
A.1 Context
Second-generation sulflower (SGS) is a planar heterocyclic circulene, consisting solely of carbon and
sulfur atoms. It is the second in the series of perfulfurated circulenes, making it the analogue of the
polyaromatic hydrocarbon coronene (Figure A.1). Curiously, it was found that there was no simple
route to producing SGS in the crystalline state; powder X-ray diffraction and 3D electron diffraction
always showed an amorphous phase after attempted crystallisation of SGS. This case is very different
from that of both coronene and sulflower, which are both known to be polymorphic.71,232
Figure A.1: Molecular scheme for coronene, sulflower and second-generation sulflower.
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A.2 Molecular Optimisations
In an attempt to decipher the reasoning behind the non-crystallinity of SGS, molecular optimisa-
tions were carried out to pin-point differences in bonding motifs with respect to coronene. The
functional/basis-set combination B3LYP/6-31G(d,p) was used to calculate the electron distribution
of each molecule. Repeat molecular optimisations were carried out in ORIENT for clusters up to a
size of 10 molecules, which were initialised using random positions and orientations of molecules on
a sphere. After 100 repeat calculations, the final state of each cluster was categorised to allow trends
in intermolecular interactions to be observed. For two and three-molecule clusters, the molecules
optimised to a small number of final states. The optimised configurations for two molecules of
coronene and SGS are summarised in Figure A.2. Highlighted in the figure are the energy of each
configuration (shown with respect to the lowest energy configuration per cluster size and molecule),
the offset perpendicular to the molecular stacking direction (o), the distance between molecules in
the stacking direction (d), and the twist about the molecular centre of mass parallel to the stacking
direction (φ). In each case, there are two different possible conformations that involve the face-face
π-stacking of the molecules. In one of the optimised conformations, the molecule is offset a small
amount perpendicular to the stacking direction with no rotation. In contrast, there is no offset in the
other case, but the molecule is rotated by an angle φ. Analysis of the energy of each conformation
shows stark differences. In coronene, both optimised conformations have very comparable energies
(<kB T = 2.479 kJ.mol−1 at room temperature), whereas the zero-offset stack has a much lower energy
in SGS (7.7 kJ.mol−1).
When the size of the cluster is increased to three molecules, there is an increased number of
possible configurations for SGS; however, coronene is only seen in two configurations (Figure A.3).
The introduction of the third molecule allows for both face-face and edge-face interactions. However,
the face-face interaction is more favourable. Nevertheless, it can be seen that the difference in energy
between the face-face and edge-face conformations is far greater for SGS than for coronene. In
terms of the relative energies of the different face-face interactions, it appears that the zero-offset
stack is not energetically viable in coronene as the number of molecules increases, whereas several
SGS configurations are seen incorporating both the zero-offset and offset conformations. As the
number of molecules in the cluster is increased, a similar trend is seen, with the zero-offset face-face
stack becoming more energetically dominant with more molecules. In essence, this alone allows a
hypothesis as to why a crystalline structure of SGS is not observed. If the extended face-face stacking
motifs are too energetically dominant, it may be the case that the formation of a 3-dimensional
structure of SGS is energetically inviable, meaning a reasonable crystalline state is difficult to nucleate.
Additional crystal structure prediction and electrostatic potential analyses support this hypothesis,4
highlighting that the 1-dimensional face-face stacks are far more energetically favourable than a
3-dimensional structure. Interestingly, there are also two small features in the X-ray diffraction of a
powder of sulflower at 8.31 ° and 25.55 °, representing symmetry over 5.3 Å and 1.8 Å respectively,
which may indicate the presence of stacks of molecules with internal symmetry.
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Figure A.2: Conformations of coronene and sulflower molecules after the optimisation
of two molecules using the program ORIENT. Views parallel and perpendicular to the
stacking direction are shown. Molecules are coloured to allow them to be easily distin-
guishable. a) and b) highlight the conformations of coronene, and c) and d) those of SGS.
Energies are shown with respect with the lowest energy configuration per molecule.
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Figure A.3: Conformations of coronene and sulflower molecules after the optimisation
of three molecules using the program ORIENT. Molecules are coloured to allow them to
be easily distinguished. a) Shows optimisations of coronene molecules and b) of SGS.











DESIGN OF A COPPER CRYSTALLISATION COOLING RIG
B.1 Cooling Rig
Figure B.1: Design for the cooper housing of the cooling rig. The circular elements are
pipes that allow cooling fluid through.
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B.2 Cooling Rig Inset
Figure B.2: Design for the copper inset of the cooling rig, which can hold up to six
samples.
Figure B.3: An image of the cooper cooling rig, which sits in a polystyrene case to











SCRIPTS FOR ORIENT OPTIMISATIONS






















APPENDIX C. SCRIPTS FOR ORIENT OPTIMISATIONS
UNITS Angstrom
MOLECULE Paracetamol AT x1 y1 z1
O -3.780346304 3.05446869 1.611640751 Rank 4 Type O
-0.386659624
-0.132523628 0.193608709 0.649400202
-0.277648253 -1.24635215 0.336105164 -0.077755768 -0.335317637
-0.484237294 0.210927329 0.296965209 -0.441004979 -0.101360654
1.045918758 0.263280949
0.922511194 -0.264664966 0.469173648 -0.520067241 -0.347763026
1.023695245 0.694101309 -0.174336464 -0.532753001
N 0.468699294 4.12703868 -1.839358273 Rank 4 Type N
-0.134144826
0.008698428 0.03318198 0.030302028
-0.70975778 -1.272094691 0.038145192 -0.45555778 -0.070415711
0.307035525 -0.274770944 -0.714474172 0.464258989 0.237818874
-0.723655344 -1.122651069
1.13739089 -1.369119022 0.72937012 -0.823286243 -0.348234002
-0.397358302 -0.139054484 0.700133529 -0.716716094
Further multipoles omitted due to space.
END
MOLECULE Phenol AT x2 y2 z2
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APPENDIX C. SCRIPTS FOR ORIENT OPTIMISATIONS
sub main {
my $file = "input";
open(FILE, "<$file") or die "Can't open $file: $!\n";
my @lines = <FILE>;
close FILE;
my $currentRun = 1;
my $numberOfRuns = 10000;
while(1){
my $random_numberU = rand(2)-1;
my $random_numberV = rand(2)*pi;
my $distance = 40.0;
my $x = sqrt(1-$random_numberU**2)*cos($random_numberV)*$distance;
my $y = sqrt(1-$random_numberU**2)*sin($random_numberV)*$distance;
my $z = $random_numberU*$distance;
my $directory = "Phenol-Paracetamol"."$currentRun";
unless(-e $directory or mkdir $directory) {
die "Unable to create $directory\n";
}
my $path = Cwd::abs_path()."/".$directory."/input";
$lines[10] = "x2 ".$x." Angstrom\n";
$lines[11] = "y2 ".$y." Angstrom\n";
$lines[12] = "z2 ".$z." Angstrom\n";









$currentRun = $currentRun + 1;
if ($currentRun%50 == 0) {
sleep(300);
}

















THE CRYSTAL STRUCTURE OF ORTHOCETAMOL SOLVED BY 3D ELECTRON
DIFFRACTION
The publication based on this work was first-authored by Dr I Andrusenko. The complementary
computational work that I carried out for this study is highlighted below. The work is published in [5].
D.1 Context
Orthcetamol (2-acetamidophenol) is a structural isomer of paracetamol that has escaped crystal-
lographic structural solution since it was first synthesised in 1876.233 Its propensity to grow in a
polycrystalline manner meant that structural solution was unobtainable through single-crystal X-
ray diffraction. To rectify this gap in the structural knowledge of the cetamol family, 3D electron
diffraction was utilised to solve the ubiquitous crystal structure of othocetamol. This successful ex-
perimental procedure stands as the first ab initio structural solution of an organic molecule without
using single-crystal X-ray diffraction to confirm the final structure.
D.2 Computational Space Group Analysis
Although accurate molecular positions can be successfully obtained via 3D electron diffraction,
it is often difficult to determine the exact space group due to secondary electron scattering. Due
to the higher cross-section for electron scattering than X-ray scattering, it is possible to get finite
intensities at points in reciprocal space were a systematic absence would be expected. During
the final refinement of the orthocetamol structure, there was a choice of space group, either the
centrosymmetric C 2/c or the non-centrosymmetric C c . To analyse the differences in these structures,
optimisations were carried out using fixed unit cells and restraints based on the individual space
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groups in CRYSTAL14. Calculations were carried out using the function/basis-set combination
PBE0/6-31G. The results of the optimisations are highlighted in Figure D.1, which shows that both
optimisations resulted in the molecular coordinates of the centrosymmetric space group C 2/c . Thus,
this symmetry reduction was used to re-refine the original 3D electron diffraction data.
Figure D.1: The unit cell of orthocetamol before (blue) and after (red) structural optimi-
sations in CRYSTAL14 restrained by the space groups C 2/c and C c. The right-hand side
shows the 2 molecules in the asymmetric unit of the C c structure before and after opti-











PHASE DIAGRAMS OF VOLATILE DEEP EUTECTIC SOLVENTS
The data presented in this section are part of the second round of experiments run on the volatile
deep eutectic solvents at Diamond Light Source, using concomitant powder X-ray diffraction and
Differential Scanning Calorimetry. I would like to thank Dr Asma Buanz and Dr Oxana Magdysyuk for
carrying out the synchrotron experiments.
E.1 Context
The data shown in chapter 4 highlights the complexities that can arise during the thermal cycling
of binary systems. The use of concomitant synchrotron X-ray diffraction and differential scanning
calorimetry (CXRD-DSC) allowed direct detection of the crystallographic ordering during these
cycles, allowing an experimental interpretation of the eutectic phase diagram. Such an interpretation
of the structure of deep eutectic mixtures is an important step in creating a model to predict and
understand their formation, kinetics and thermodynamics.
As a large set of complementary information is needed to form a phase diagram, this section is
written in the style of a tutorial, explaining how the data was interpreted at each step. The formation
of the phase diagram used data collected by a TA Instruments Discovery DSC25, and structural
information was gleaned using the CXRD-DSC data. Due to the ease of forming a eutectic with
phenol, an amino-substituted analogue of paracetamol was used. 2’-aminoacetanilide (2AM - Fig-
ure E.1) produced a VODES with phenol over the range 1:1 - 10:1 VC:NVC, which formed almost
spontaneously on contact. During the exploration of VODES containing paracetamol analogues, the
crystal structures of the pure phases of 2AM and 3’-aminoacetanilide (3AM) were solved for the first
time.234,235 Interestingly, the structures contained sterically hindered hydrogen bonding between the
amino and carbonyl functional groups (Figure E.2, similarly to the OH. . . O=C hydrogen bonds seen
in metacetamol and paracetamol. Indeed, analysis of the melting points of the pure phases of 2AM
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and 3AM via DSC showed melting points of 131.74 °C and 86.50 ° C, lower than the hydroxy cetamols.
3AM formed VODES down to a ratio of 1:1 VC:NVC; however, it was not used due to glass transitions
occurring at a temperature too low to be seen on the discovery 25 DSC.
Figure E.1: Chemical scheme of 2’-aminoacetanilide.
Figure E.2: Hydrogen-bonding interactions present in the crystal structures of 2’-
aminoacetanilide and 3’-aminoacetanilide.
E.2 Phase Diagrams of phenol:2’-aminoacetanilide Volatile Deep Eutectic
Solvent
The phase behaviour of VODESs consisting of various ratios of phenol and 2AM were assessed via
differential scanning calorimetry (DSC). The variable considered was the relative molar concentration
of 2AM with x = 0 denoting 100% phenol and x = 1 denoting 0% phenol. Samples were prepared
by weighing and mixing both phenol and 2AM on a 4-point balance and allowing them to become
a liquid at room temperature. Once a homogeneous liquid appeared, a drop of the sample was
transferred to a hermetic DSC pan, weighed and sealed. Moderate heat (60 °C) was used to speed
the process of eutectic formation in cases where mixing was slow. If no liquid occurred below room
temperature, the sample was directly weighed into the DSC pan. In general, a standard heat-cool-
heat run was used to assess phase transitions, between the temperatures of 70 °C and -70 °C. If no
melt occurred by 70°C, then the sample was further heated up to the temperature of the melting
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point of the 2AM. Throughout the experiments, at least three different types of transition were
seen: crystallisation, melting and glass transition. For systems where x < xe (the eutectic point), a
crystallisation transition was most often seen upon cooling of the liquid. At low temperatures, a glass
transition may then occur for any remaining liquid. On heating, a broad endotherm is seen, which
is taken as the melt of the eutectic mixture and used to determine the point at which the system
becomes liquid. An example of such a thermogram is shown in Figure E.3.
Figure E.3: Thermogram of a 7:1 phenol:2AM mixture highlighting a crystallisation, glass
transition and melt. The start and end of the run are highlighted by black dots, while a
dashed line indicates the initial heating ramp.
Initially, samples of the pure components were acquired for the melting points at x = 0 and x =
1. Polymorph screening was carried out for 2AM using a variety of solvents to check for any effect
this may have on the melting point of the sample. From this preliminary screen, only one crystal
structure was found, which also formed from the melt. Figure E.4 shows the thermograms of pure
phenol (Tm = 40 °C) and 2AM (Tm = 135 °C).
In cases where x is close to xe often a cold-crystallisation occurs, where an endotherm is seen
on heating (Figure E.5). This is likely due to the increased viscosity of the system slowing down the
nucleation rate of the crystallisation components. Three separate cases can occur: two endotherms
are seen on heating; two endotherms are seen, one on cooling and one on heating; one endotherm is
seen on heating. This may suggest that two separate components are crystallising out, one whose
nucleation is hindered more by the viscosity of the system than the other. However, structural analysis
would be needed to prove this.
In some cases, the cold-crystallisation of the sample overlaps with the subsequent melt, making
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Figure E.4: Thermographs of pure phenol and 2AM highlighting the onset of the melting
phase transition. Arrows indicate the direction of heating, with exothermic shown as a
positive divergence from the baseline.
Figure E.5: Thermograms of 5:1 and 6:1 phenol:2AM mixtures, highlighting the two
different cases of cold-crystallisation. The start and end of the run are highlighted by
black dots, while a dashed line indicates the initial heating ramp. Arrows highlight the
direction of the heat cycle. Exothermic events are shown as a positive divergence from
the baseline.
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it more difficult to isolate the exact melting point of the system. When this happens, the DSC method
is changed to hold the temperature (isotherm) at the peak of the cold-crystallisation, cool back down
to -70°C and then heat past the melting point (Figure E.6a). If the endotherm is removed on the
second pass, it can be assumed that the system has fully crystallised. Interestingly, the glass transition
often changes upon crystallisation and re-cooling, indicating a change in the composition of the
amorphous component. Holding the isotherm for a variety of temperatures indicates how long is
needed for the system to fully crystallise (Figure E.6b), for the phenol:2AM 5:1 system, there are only
minimal changes for isotherms longer than 60 minutes.
Figure E.6: a) Thermogram of a 5:1 phenol:2AM mixture highlighting the removal of
the cold-crystallisation endotherm by re-cooling the system after crystallisation. The
orange dot indicates that the system was held at a constant temperature (isotherm) for
60 minutes. Dashed lines indicate the initial ramps. b) Overlaid thermograms of 5:1
phenol:2AM VODES heated after an initial thermal cycle with an isothermal hold at -17
°C for times between 1 hour and 5 hours. Arrows highlight the direction of the heat cycle.
Exothermic events are shown as a positive divergence from the baseline.
Above xe is a range of concentrations where the only phase change seen is a glass transition
(Figure E.7a). It is likely that either the viscosity of the system is high in this region, leading to kinetic
frustration, or there is a ratio of VODES where it is not thermodynamically (or kinetically) favourable
for a crystal for form. At larger volumes, it is commonly seen that one of the components crystalises
out; however, this may be because or local fluctuations or nucleation sites on a larger scale. For these
concentrations, we define the phase as a low-temperature transition mixture (LTTM) to differentiate
it from the eutectic mixtures where a clear melting point (of a crystalline phase) is defined. To ensure
that crystallisation cannot be reasonably obtained from these mixtures, thermograms were also
obtained at a ramp rate of 1 °C.min−1. In cases where the mixture was not liquid before placing in in
the DSC pan, samples were initially run up to the melting point of the non-phenol component to
ensure that the whole mixture was in the liquid state.
An interesting feature of the glass transitions exhibited by these phases and the cold-crystallisation
phases is the appearance of a relaxation enthalpy on heating from below the glass transition. This
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enthalpy represents a local ordering of a glass phase to a more stable configuration while the mixture
is in an amorphous state. A larger relaxation can take place if the sample is held for a longer period
under the glass transition temperature (Figure E.7b), meaning a larger relaxation enthalpy is seen
on heating (Figure E.7d). The rate of enthalpy change gives information about the mobility of the
sample in the glassy state and the accessibility of an ordered configuration. The glass transitions
shown are defined by a midpoint (the temperature at half the glass transition height) and width (glass
temperature end – glass temperature onset). The enthalpy relaxation is calculated using the baseline
after the transition has taken place, as shown in Figure E.7c.
Figure E.7: Glass transitions of low-temperature transition mixtures. a) Thermogram of
phenol:2AM 2:1 mixture. b) Thermogram of phenol:2AM 2:1 mixture with a 30-minute
isotherm below the glass transition temperature. c) Glass transition on heating annotated
with the parameters used to describe the transition. d) Glass transitions of phenol:2AM
2:1 upon heating for isotherms from 0 – 2 hours. Arrows indicate the direction of heating,
with exothermic transitions shown as a positive divergence from the baseline.
At concentrations above the LTTM phase there is another region of cold-crystallisation mixtures.
In this region the melting point of the VODES is often above room temperature and therefore the
samples need to be weighed into the hermetic pan and heated above the temperature of 2AM. The
acquisition of phase changes can be carried out in the same way as for cold-crystallisation systems
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under the LTTM concentrations. On the first heating an endotherm will be seen for the initial melting
of the system, however as the system will not be homogenous this melting point should not be used
(Figure E.8).
Figure E.8: a) Thermogram of Phenol:2AM 1:3 mixture showing an isotherm at the cold-
crystallisation point, followed by a melt between the melting point of pure phenol and
2AM. b) Thermogram of Phenol:2AM 1:7 mixture showing a crystallisation on cooling
from the melt and a single exotherm on heating. Arrows indicate the direction of heating,
with exothermic shown as a positive divergence from the baseline.
Given the descriptions above, phase transitions of mixtures of 2AM and phenol at all mole
fractions can be assessed. It is common to present such data as a phase diagram so that it is possible
to assess what phase the mixture will be present in, given a particular temperature and concentration.
Figure E.9 shows the phase diagram for mixtures of phenol and 2AM. Melting point onsets are
calculated using a linear extrapolated onset of the melting endotherm, and the midpoint of the glass
transitions are plotted.
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Figure E.9: Phase diagram for the eutectic system of phenol and 2AM, each point repre-
sents a phase transition as recorded from DSC.
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Looking at trends with concentration, the three main sections described above are clear: the
low x region where the mixture is a room temperature liquid; the LTTM region, where only glass
transitions are seen; and the high x region where the crystallisation of the eutectic solvent occurs
above room temperature. The phase diagram includes the metastable zone present because of the
cold-crystallisation (CCZ) that occurs in many of the mixtures.
One of the most interesting features of the phase diagram is the trend in the position of the glass
transitions that occur at low temperatures. There appears to be a glass transition temperature for all
mixtures where there is a crystallisation (orange line – after cold-crystallisation), which suggests an
optimum ratio for an amorphous phase that will always form.
To assess the stoichiometry of this amorphous phase, a 10 ml sample of 7:1 phenol:2AM was
made and placed in the fridge (-6 °C) to crystallise. After crystallisation, the LTTM + solid mixture
was gently stirred and then inverted. Over a time period of 24 hours, the liquid had drained to the
bottom of the vial, with the solid remaining at the top. NMR of the extracted liquid was then carried
out, and the stoichiometry determined by comparing the integrals of the phenol OH peak and 2AM
NH peak (secondary amine). The resultant stoichiometry was close to a 4:1 mixture phenol:2AM. To
follow on from this, the same procedure was carried out on a sample containing a 4:1 phenol:2AM
mixture. Although some solid was still seen when the sample of this volume was cooled, the resulting
stoichiometry from NMR was again close to a 4:1 phenol:2AM mixture.
Figure E.10: 1H NMR of the extracted liquid from cooled samples of 7:1 and 4:1 phe-
nol:2AM. Representative peaks for both phenol and 2AM are highlighted with their
chemical scheme, with an arrow pointing to the relevant hydrogen. Relative peak inte-
grals are shown to give an approximate stoichiometry for each mixture.
To assess each of the points on the phase diagram more thoroughly, CXRD-DSC experiments were
carried out of phenol:2AM VODES. For the first time, this study allowed a thorough analysis of both
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the thermodynamics and structure across the phase diagram of a deep eutectic mixture. An example
of the CXRD-DSC data is shown in Figure E.11. These data will allow for the phases presented in
Figure E.9 to be analysed, which, along with the enthalpy data, allows for the stoichiometry of the
glassy phases to be determined.
Figure E.11: CXRD-DSC measurements for VODES of 2AM:phenol of ratio a) 5:1 and b)
9:1. For each sample, both diffraction patterns (top) and DSC traces (bottom) are shown.
The x-axis is shown with respect to time; however, the temperature is shown on the
same axes to indicate the temperatures at which transitions occur. Integration of the
diffraction peaks is shown to give an idea of how much crystalline material is present.
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Evaluation of the diffraction patters from the CXRD-DSC highlighted that the crystalline struc-
tures formed below xe was phenol and above xe was 2AM. Using the known enthalpies of these
phases, the glass compositions after crystallisation could be calculated, which are shown in Fig-
ure E.12. It is interesting to see that there are two different ratios of glassy solvents that form: a 4:1
phenol:2AM glass below xe and a 1:2 phenol:2AM glass above xe . Analysis of this data is ongoing,
and it is hoped that this tutorial can set a strong foundation for the future structural analysis of deep
eutectic systems.
Figure E.12: Ratio of glassy phases formed after crystallisation events in VODESs con-
taining phenol and 2’-aminoacetanilide. The blue line represents the concentration of













• Color Differences Highlight Concomitant Polymorphism of Chalcones, Hall, C. L., Guo, R.,
Potticary, J., Cremeens, M. E., Warren S. D., Andrusenko, I., Gemmu, M., Zwijntenburg M. A.,
Pridmore, N. E., Sparkes, H. A., Price., S. L. & Hall, S. R., Crystal Growth & Design, Aug 2020, 20,
10, 6346–6355.
• Crystal structures of three functionalized chalcones: 4’-dimethylamino-3-nitrochalcone, 3-
dimethylamino-3’-nitrochalcone and 3’-nitrochalcone, Hall, C. L., Hamilton, V. A., Potticary,
J., Cremeens, M. E., Pridmore, N. E., Sparkes, H. A., D’ambruoso, G. D., Warren S. D., Matsumoto,
M. & Hall, S. R., Acta Crystallographica E, Aug 2020, 76, 1599-1604.
• Metastable Crystalline Phase Formation in Deep Eutectic Systems Revealed by Simultaneous
Synchrotron XRD and DSC, Hall, C. L., Potticary, J., Hamilton, V. A., Gaisford, S., Buanz, A. &
Hall, S. R., Chemical Communications, Aug 2020, 56, 10726-10729.
• Racemic Conglomerate Formation via Crystallization of Metaxalone from Volatile Deep
Eutectic Solvents, Hamilton, V. A., Andrusenko, I., Potticary, J. L., Hall, C. L., Stenner, R. A.,
Mugnaioli, E., Lanza, A., Gemmi, M., & Hall, R. S., Crystal Growth & Design, Jun 2020, 20, 7,
4731–4739.
• Crystallization of Volatile Deep Eutectic Solvents, Potticary, J. L., Hall, C. L., Hamilton, V.,
McCabe, J. F. & Hall, S. R., Crystal Growth & Design, Apr 2020, 20, 2877-2844.
• The Solubility and Stability of Heterocyclic Chalcones Compared to Trans-Chalcone, Sweet-
ing, S., Hall, C. L., Potticary, J. L., Pridmore, N. E., Warren, S., Cremeens, M., D’Ambrusco, G.,
Matsumoto, M. & Hall, S. R., Acta Crystallographica B, Feb 2020, 76, 1, p. 13-17.
161
APPENDIX F. LIST OF PUBLICATIONS
• Crystal structure and Hirshfeld surface analysis of (E)-3-(3-iodophenyl)-1- (4-iodophenyl)prop-
2-en-1-one, Spruce, K., Hall, C. L., Potticary, J. L., Pridmore, N. E., Cremeens, M., D’Ambrusco,
G., Matsumoto, M., Warren, G., Warren, S. & Hall, S. R., Acta Crystallographica E, Jan 2020, 76, 1,
p.72-76.
• An Experimental and Computational Study into the Crystallisation Propensity of 2nd Gener-
ation Sulflower, Jensen, T. T., Hall, C. L., Potticary, J. L., Andrusenko, I., Gemmi, M. & Hall, S. R.,
Journal of the Chemical Society: Chemical Communications, Nov 2019, 58, 32, p.14586-14589.
• The Crystal Structure of Orthocetamol Solved by 3D Electron Diffraction, Andrusenko, I.,
Hamilton, V., Mugnaioli, E., Lanza, A., Hall, C. L., Potticary, J., Hall, S. R. & Gemmi, M., Ange-
wandte Chemie, Aug 2019, 58, 32, p.10919-10922.
• Lamotrigine Ethanol Monosolvate, Hall, C. L., Potticary, J., Sparkes, H. A., Pridmore, N. E. &
Hall, S. R., Acta Crystallographica E, May 2018, 74, p.678-681.
162
REFERENCES
(1) Desiraju, G. R.; Vittal, J. J.; Ramanan, A. In Crystal Engineering: A Textbook, 2011; Chapter 1.
(2) Bernal, J. D. Proceedings of the Royal Society of London. Series A, Containing Papers of a
Mathematical and Physical Character 1924, 106, 749–773.
(3) Dunitz, J. D.; Bernstein, J. Accounts of Chemical Research 1995, 28, 193–200.
(4) Jensen, T. T.; Hall, C. L.; Potticary, J.; Andrusenko, I.; Gemmi, M.; Hall, S. R. Chemical Commu-
nications 2019, 55, 14586–14589.
(5) Andrusenko, I.; Hamilton, V.; Mugnaioli, E.; Lanza, A.; Hall, C.; Potticary, J.; Hall, S. R.; Gemmi,
M. Angewandte Chemie - International Edition 2019, 58, 10919–10922.
(6) Burckhardt, J. J. Archive for History of Exact Sciences 1967, 4, 235–246.
(7) Nespolo, M.; Aroyo, M. I. Acta Crystallographica Section A: Foundations and Advances 2016,
72, 523–538.
(8) Pauling, L. In Journal of Chemical Education, 1992; Chapter 1.
(9) Li, X.; Yang, X.; Zheng, X.; Bai, M.; Hu, D. International Journal of Molecular Sciences 2020, 21,
1–16.
(10) Lin, X.; Li, X.; Lin, X. Molecules 2020, 25, 1375.
(11) Li, T.; Mattei, A. In Pharmaceutical Crystals: Science and Engineering, 2018; Chapter 1, pp 1–
512.
(12) Wan, X.; Woods, A. T.; Salgado-Montejo, A.; Velasco, C.; Spence, C. Food Quality and Preference
2015, 45, 171–182.
(13) Singh, H.; Tiwari, K.; Tiwari, R.; Pramanik, S. K.; Das, A. Chemical Reviews 2019, 119, 11718–
11760.
(14) Moran, M. J. In The Mechatronics Handbook, 2002; Chapter 5.
(15) Ansermet, J.-P.; Brechet, S. D. In Principles of Thermodynamics, 2018; Chapter 4, pp 388–398.
(16) Marti, E. Journal of Thermal Analysis 1988, 33, 37–45.




(18) Braga, D.; Grepioni, F.; Maini, L.; Polito, M. Structure and Bonding 2009, 132, 25–50.
(19) Lévesque, A.; Maris, T.; Wuest, J. D. Journal of the American Chemical Society 2020, 142, 11873–
11883.
(20) Censi, R.; Di Martino, P. Molecules 2015, 20, 18759–18776.
(21) Beyer, T.; Day, G. M.; Price, S. L. Journal of the American Chemical Society 2001, 123, 5086–
5094.
(22) Braun, D. E.; Gelbrich, T.; Kahlenberg, V.; Laus, G.; Wieser, J.; Griesser, U. J. New Journal of
Chemistry 2008, 32, 1677–1685.
(23) Nangia, A. Accounts of Chemical Research 2008, 41, 595–604.
(24) Debye, P. Annalen der Physik 1912, 344, 789–839.
(25) Lutsko, J. F. New Journal of Physics 2018, 20, 103015.
(26) Karthika, S.; Radhakrishnan, T. K.; Kalaichelvi, P. Crystal Growth & Design 2016, 16, 6663–6681.
(27) Vekilov, P. G. Nanoscale 2010, 2, 2346–2357.
(28) Vekilov, P. G. In ACS Symposium Series; American Chemical Society: 2020; Vol. 1358, pp 19–46.
(29) Gebauer, D.; Cölfen, H. Nano Today 2011, 6, 564–584.
(30) Sauter, A.; Roosen-Runge, F.; Zhang, F.; Lotze, G.; Feoktystov, A.; Jacobs, R. M.; Schreiber, F.
Faraday Discussions 2015, 179, 41–58.
(31) Warzecha, M.; Safari, M. S.; Florence, A. J.; Vekilov, P. G. Crystal Growth & Design 2017, 17,
6668–6676.
(32) Cookman, J.; Hamilton, V.; Hall, S. R.; Bangert, U. Scientific Reports 2020, 10, 19156.
(33) Shahar, C.; Dutta, S.; Weissman, H.; Shimon, L. J. W.; Ott, H.; Rybtchinski, B. Angewandte
Chemie International Edition 2016, 55, 179–182.
(34) Van Santen, R. A. Journal of Physical Chemistry 1984, 88, 5768–5769.
(35) Bauer, J.; Spanton, S.; Henry, R.; Quick, J.; Dziki, W.; Porter, W.; Morris, J. Pharmaceutical
Research 2001, 18, 859–866.
(36) Lee, E. H. Asian Journal of Pharmaceutical Sciences 2014, 9, 163–175.
(37) Aguiar, A. J.; Krc, J.; Kinkel, A. W.; Samyn, J. C. Journal of Pharmaceutical Sciences 1967, 56,
847–853.
(38) Liebenberg, W.; De Villiers, M. M.; Wurster, D. E.; Swanepoel, E.; Dekker, T. G.; Lötter, A. P.
Drug Development and Industrial Pharmacy 1999, 25, 1027–1033.
(39) Price, S. L. Chemical Society Reviews 2014, 43, 2098–2111.
(40) Price, S. L. Acta Crystallographica Section B: Structural Science, Crystal Engineering and
Materials 2013, 69, 313–328.
164
REFERENCES
(41) Haüy, R. J. Gogué et Née de La Rochelle 1784.
(42) Docherty, R.; Clydesdale, G.; Roberts, K. J.; Bennema, P. Journal of Physics D: Applied Physics
1991, 24, 89–99.
(43) Donnay, J. D. H.; Harker, D. Am. Mineral. 1937, 22, 446.
(44) Stone, A. J.; Price, S. L. The Journal of Physical Chemistry 1988, 92, 3325–3335.
(45) Pudasaini, N.; Upadhyay, P. P.; Parker, C. R.; Hagen, S. U.; Bond, A. D.; Rantanen, J. Organic
Process Research and Development 2017, 21, 571–577.
(46) Waknis, V.; Chu, E.; Schlam, R.; Sidorenko, A.; Badawy, S.; Yin, S.; Narang, A. S. Pharmaceutical
Research 2014, 31, 160–172.
(47) Park, Y.; Koo, J. Y.; Choi, H. C. Crystal Growth & Design 2018, 18, 7239–7243.
(48) Zhu, D.; Zhang, S.; Cui, P.; Wang, C.; Dai, J.; Zhou, L.; Huang, Y.; Hou, B.; Hao, H.; Zhou, L.;
Yin, Q. Crystals 2020, 10, 316.
(49) Rosbottom, I.; Ma, C. Y.; Turner, T. D.; O’Connell, R. A.; Loughrey, J.; Sadiq, G.; Davey, R. J.;
Roberts, K. J. Crystal Growth & Design 2017, 17, 4151–4161.
(50) Lechuga-Ballesteros, D.; Rodríguez-Hornedo, N. International Journal of Pharmaceutics 1995,
115, 151–160.
(51) Munk, T.; Baldursdottir, S.; Hietala, S.; Rades, T.; Kapp, S.; Nuopponen, M.; Kalliomäki, K.;
Tenhu, H.; Rantanen, J. Molecular Pharmaceutics 2012, 9, 1932–1941.
(52) Simone, E.; Steele, G.; Nagy, Z. K. CrystEngComm 2015, 17, 9370–9379.
(53) Constance, E. N.; Mohammed, M.; Mojibola, A.; Egiefameh, M.; Daodu, O.; Clement, T.;
Ogundolie, T.; Nwawulu, C.; Aslan, K. Journal of Physical Chemistry C 2016, 120, 14749–14757.
(54) Song, L.; Zhao, F. Q.; Xu, S. Y.; Ju, X. H.; Ye, C. C. Scientific Reports 2020, 10, 2317.
(55) Aaltonen, J.; Allesø, M.; Mirza, S.; Koradia, V.; Gordon, K. C.; Rantanen, J. European Journal of
Pharmaceutics and Biopharmaceutics 2009, 71, 23–37.
(56) Getsoian, A.; Lodaya, R. M.; Blackburn, A. C. International Journal of Pharmaceutics 2008,
348, 3–9.
(57) Parmar, M. M.; Khan, O.; Seton, L.; Ford, J. L. In Crystal Growth & Design, 2007; Vol. 7, pp 1635–
1642.
(58) Ostergaard, I.; Szilagyi, B.; Nagy, Z. K.; De Diego, H. L.; Qu, H. Crystal Growth & Design 2020,
20, 1337–1346.
(59) Cavallo, D.; Gardella, L.; Alfonso, G. C.; Portale, G.; Balzano, L.; Androsch, R. Colloid and
Polymer Science 2011, 289, 1073–1079.
(60) Hu, C.; Testa, C. J.; Shores, B. T.; Wu, W.; Shvedova, K.; Born, S. C.; Chattopadhyay, S.; Takizawa,
B.; Mascia, S. CrystEngComm 2019, 21, 5076–5083.
165
REFERENCES
(61) Bobrovs, R.; Seton, L.; Dempster, N. CrystEngComm 2015, 17, 5237–5251.
(62) Trask, A. V.; Shan, N.; Motherwell, W. D.; Jones, W.; Feng, S.; Tan, R. B.; Carpenter, K. J. Chemical
Communications 2005, 880–882.
(63) Boldyreva, E. V.; Shakhtshneider, T. P.; Ahsbahs, H.; Sowa, H.; Uchtmann, H. In Journal of
Thermal Analysis and Calorimetry, 2002; Vol. 68, pp 437–452.
(64) Smith, S. J.; Montgomery, J. M.; Vohra, Y. K. Journal of Physics Condensed Matter 2016, 28,
035101.
(65) Bai, Y.; Yu, Z.; Liu, R.; Li, N.; Yan, S.; Yang, K.; Liu, B.; Wei, D.; Wang, L. Scientific Reports 2017,
7, 5321.
(66) Okumura, T.; Ishida, M.; Takayama, K.; Otsuka, M. Journal of Pharmaceutical Sciences 2006,
95, 689–700.
(67) Adrjanowicz, K.; Paluch, M.; Richert, R. Physical Chemistry Chemical Physics 2018, 20, 925–
931.
(68) Alexander, L. F.; Radacsi, N. CrystEngComm 2019, 21, 5014–5031.
(69) Garetz, B. A.; Matic, J.; Myerson, A. S. Physical Review Letters 2002, 89, 175501.
(70) Alexander, A. J.; Camp, P. J. Journal of Chemical Physics 2019, 150, 040901.
(71) Potticary, J.; Terry, L. R.; Bell, C.; Papanikolopoulos, A. N.; Christianen, P. C. M.; Engelkamp, H.;
Collins, A. M.; Fontanesi, C.; Kociok-Köhn, G.; Crampin, S.; Da Como, E.; Hall, S. R. Nature
Communications 2016, 7, 11555.
(72) Yang, H.; Song, C. L.; Lim, Y. X.; Chen, W.; Heng, J. Y. CrystEngComm 2017, 19, 6573–6578.
(73) Parambil, J. V.; Poornachary, S. K.; Tan, R. B.; Heng, J. Y. CrystEngComm 2014, 16, 4927–4930.
(74) Parambil, J. V.; Poornachary, S. K.; Tan, R. B.; Heng, J. Y. Journal of Crystal Growth 2017, 469,
84–90.
(75) Parambil, J. V.; Poornachary, S. K.; Heng, J. Y.; Tan, R. B. CrystEngComm 2019, 21, 4122–4135.
(76) Hiremath, R.; Basile, J. A.; Varney, S. W.; Swift, J. A. Journal of the American Chemical Society
2005, 127, 18321–18327.
(77) Caridi, A.; Kulkarni, S. A.; Di Profio, G.; Curcio, E.; Ter Horst, J. H. Crystal Growth & Design
2014, 14, 1135–1141.
(78) Case, D. H.; Srirambhatla, V. K.; Guo, R.; Watson, R. E.; Price, L. S.; Polyzois, H.; Cockcroft, J. K.;
Florence, A. J.; Tocher, D. A.; Price, S. L. Crystal Growth & Design 2018, 18, 5322–5331.
(79) Foster, J. A.; Steed, J. W. Angewandte Chemie - International Edition 2010, 49, 6718–6724.
(80) Foster, J. A.; Damodaran, K. K.; Maurin, A.; Day, G. M.; Thompson, H. P.; Cameron, G. J.; Bernal,
J. C.; Steed, J. W. Chemical Science 2016, 8, 78–84.
166
REFERENCES
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